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PREFACE 
 
 
Substance dependence is increasingly seen as a chronic, relapsing disorder 
(McLellan et al., 2000). Often, also problems in various other life domains are 
present, such as unemployment, homelessness, relational conflicts, and problems 
with the judicial system (Storbjörk, 2006). Furthermore, psychiatric comorbidity 
is found to be very high (Brooner, King, Kidorf, Schmidt & Bigelow, 1997; 
Petrakis, Gonzalez, Rosenheck & Krystal, 2002) and problem substance users 
often report a poor Quality of Life (QoL) on various domains (De Maeyer, 
Vanderplasschen, Lammertyn, van Nieuwenhuizen & Broekaert, 2011). 
Although studies have demonstrated that recovery is possible (Bischof, Rumpf, 
Meyer, Hapke & John, 2005; De Leon, 1996), most substance users are involved 
in long substance use careers (Dennis et al., 2005), frequent and multiple 
utilization of a wide variety of medical, social and substance abuse treatment 
services (Booth et al., 2001; Sandell & Bertling, 2009) and high rates of relapse 
(Fiorentine, 1999; Grella et al., 2003). However, the number of studies 
examining the nature and extent of multiple service use among users of psycho-
active substances remains rather limited and therefore, also efforts to improve the 
continuity and co-ordination of care for these individuals can possibly be 
hampered. 
  
According to the “Lexicon of Alcohol and Drug Terms” published online by the 
World Health Organization (WHO), the term “psychoactive substance or drug” 
is a neutral and descriptive term that refers to the whole spectrum of substances 
and can be defined as: “A substance that, when ingested, affects mental 
processes, e.g. cognition or affect” (WHO, 2012a). A distinction can be made 
between socially acceptable substances such as alcohol, tobacco and medication 
and socially not acceptable substances such as heroin, cocaine, amphetamines 
and synthetic drugs (Dom, 2000). To a certain degree this distinction is legally 
formalized in international conventions and national legislation, resulting in a 
distinction between licit and illicit substances. Throughout history, the governing 
ideas regarding the relationship or interconnectedness between tobacco, alcohol 
and other drugs have shifted from seeing them as linked phenomena, over seeing 
them as separate phenomena to seeing them again as very closely linked 
(Courtwright, 2005). The establishment of a separate treatment system for illicit 
drug users in Belgium in the seventies and eighties (Vanderplasschen et al., 
2002), can be seen as an example of seeing alcohol and illicit drug problems as 
two separate phenomena requiring different treatment methods, approaches and 
organizational structures. Whereas professional treatment and care for problem 
Preface 
 
ii 
alcohol users was developed within a mental health and psychiatric discourse, 
professional treatment and care for illicit drug users was initially developed from 
a more educational discourse, as seen in the establishment of several drug-free 
therapeutic communities in Belgium, based on principles of self-help and social 
learning (Broekaert, Kooyman & Ottenberg, 1998).  
 
Research has demonstrated indeed that large differences exist between problem 
alcohol and illicit drug users with regard to a number of socio-demographic 
variables, but also with regard to addiction severity, criminal behavior, and 
psychiatric comorbidity (Edens & Willoughby, 1999; Weisner, 1992). However, 
in most of these studies little attention was paid to the reality of persons with 
alcohol problems also using other illicit drugs and persons with illicit drug 
problems also using alcohol. Indeed, poly substance use is found to be the rule 
rather than the exception and alcohol takes up a prominent role in poly substance 
use patterns (Byqvist, 2006). More specific, few studies have focused on the 
specific profile of persons who have problems with both alcohol and illicit drugs 
with regard to socio-demographics, treatment utilization patterns, psychiatric 
comorbidity and quality of life. Furthermore, few studies have regarded the type 
of substance use problem (alcohol, illicit drugs or both alcohol and illicit drugs) 
as a possible determinant of psychiatric comorbidity and quality of life. 
Obtaining more insight in the proportion and the specific profile of persons 
having problems with both alcohol and illicit drugs can help to improve 
treatment organization and planning which in its turn can possibly affect 
treatment outcomes of substance users seeking treatment in a positive way. This 
way, this dissertation wants to contribute to the overall objective of the 
orthopedagogical discipline: to improve the situation of youngsters and adults in 
difficult living situations in a meaningful way (Broekaert et al., 2004).  
 
In chapter 1, the prevalence and consequences of alcohol and illicit drug use as 
well as the organization of treatment for problem alcohol and illicit drug users 
are addressed. In this chapter, specific attention is paid to the interconnectedness 
between alcohol and other licit and illicit drugs throughout time and to the level 
of integration between alcohol and drug treatment in Belgium. At the end of 
chapter 1, the overall aim of the study, the specific research questions and some 
terminological issues are presented. In chapter 2, we analyze the phenomenon of 
multiple service utilization among illicit drug users in the province of East-
Flanders and search for socio-demographic and substance-related determinants. 
In chapter 3, the proportion of individuals in substance abuse treatment with co-
occurring alcohol and illicit drug problems is estimated and their socio-
demographic, substance-related and treatment utilization characteristics are 
compared to those of individuals having problems with either alcohol or illicit 
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drugs only. Chapter 4 reviews the available literature on the socio-demographic 
characteristics, the addiction severity and psychopathological profile of persons 
with co-occurring alcohol and drug use problems and identifies gaps in 
knowledge and methodological caveats. Chapter 5 examines the prevalence of 
personality disorders among alcohol-, drug- and dual-dependent patients 
admitted to substance abuse treatment units within psychiatric hospitals and 
explores the association between addiction severity, type of dependence and 
personality disorders. Chapter 6 evaluates substance abusers’ Quality of Life at 
the start of treatment and the impact of addiction severity, type of dependence 
and the presence of current mood, anxiety and personality disorders on overall 
Quality of Life and perception of health. Chapter 7 provides a general 
conclusion and discussion.  
 
This dissertation is a compilation of various papers which all have been 
submitted for publication, are currently under review or have been published in a 
peer-reviewed journal. As a result, the content of some of the papers may overlap 
and terminology between the papers may differ. These interventions were 
necessary in order to make sure that the papers could be read as stand-alone 
papers and that the editors’ requirements were met. 
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General Introduction 
 
 

General Introduction 
 
1 
Abstract 
 
 
In this chapter, the prevalence and consequences of alcohol and illicit drug use 
are discussed. Particular attention is given to the socio-cultural and juridical 
distinction between alcohol and illicit drugs and to their interconnectedness. 
Over time, significant changes have occurred in the way that society views 
substance use and substance-related problems. These changes are closely linked 
to the shifts in governing ideas on the interconnectedness between alcohol and 
other drugs: sometimes very closely linked, sometimes very far apart. Third, 
some figures on the number and characteristics of persons with co-occurring 
alcohol and illicit drug problems are presented. As this dissertation focuses on 
problem substance users seeking treatment, a description of the foundations and 
present-day situation of alcohol and drug treatment in Belgium is included, as 
well as an evaluation of the level of integration between alcohol and drug 
treatment. Finally, the overall objective and the specific aims of this dissertation 
are described as well as some terminological issues. 
 
 
Chapter 1 
 
2 
1.1. Prevalence and consequences of alcohol use  
 
 
Worldwide, alcohol is one of the oldest and most commonly used psycho-active 
substances (Hanson, 1995). Historical research has found evidence for the use of 
alcoholic beverages in the Neolithic period (about 10.000 years before Christ) 
and since then, references to the use of beer and wine were found in documents 
and objects related to the Egyptian, Greek and Roman cultures. Throughout 
history, alcohol has played an important role in most societies and was 
considered a basic and well-established part of daily life, which can be illustrated 
by the fact that fermented beverages were used as a means of payment, played an 
important role in religion, were regarded as an important source of calories and 
nutrients and were used as a safe thirst quencher. Obviously, alcohol was also 
used for its positive and mood-altering effects: pain relief, increasing pleasure 
and quality of life, entertainment, relaxation, etc … (Hanson, 1995; Levinthal, 
2012). 
 
Of all psycho-active substances, alcohol is estimated to be the most commonly 
used substance with an estimated 2 billion users worldwide, followed by tobacco 
(1,3 billion users) and illicit drugs (185 million users) (WHO, 2012a). The use of 
alcohol is reported in nearly all societies but the adult per capita consumption 
varies considerably between countries. On the one hand, low levels of alcohol 
consumption are reported in regions such as sub-Saharan Africa with large 
populations of the Islamic faith, which have high rates of abstinence. On the 
other hand, high levels of consumption are reported in the developed countries, 
Belgium included. The most recent Health Interview Survey (HIS), carried out in 
2008, shows that 81% of Belgian citizens older than 15 years have used alcohol 
in the 12 months preceding the interview (Gisle, 2010), indicating alcohol use to 
be widespread in our society.  
 
Although the majority of alcohol users do not develop alcohol-related problems, 
a certain percentage will develop an alcohol use disorder in the course of their 
life1
                                                          
1 This paragraph is partly based on: Vanderplasschen, W., Colpaert, K. & Broekaert, E. (2009). 
Determinants of relapse and re-admission among alcohol abusers after intensive residential treatment. 
Archives of Public Health, 67, 194-211. 
. Worldwide, the global prevalence of alcohol use disorders (harmful use and 
dependence) has been estimated to be around 1.7% (WHO, 2001). As is the case 
for alcohol consumption levels, also the prevalence rates of alcohol use disorders 
vary widely across different countries and regions with significantly higher rates 
reported in North America and Europe. In the beginning of the 2000s, the 
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prevalence of DSM-IV alcohol abuse and dependence in the United States (US) 
was estimated to be 4.7% and 3.8% respectively (Hasin, Stinson, Ogburn & 
Grant, 2007). Prevalence of alcohol use disorders among men is nearly three 
times as high as among women (12.4% vs. 4.9%). Besides the risk of developing 
an alcohol use disorder, alcohol use is an important risk factor for disease, 
disability and mortality and can also cause significant harm for other people and 
for society at large (WHO, 2011). 
 
Based on the most recent HIS, we know that 12% of the Belgian citizens older 
than 15 years old have daily drunk alcohol during the past year and 10.2% of the 
Belgians who have used alcohol in the past year can be regarded as problem 
alcohol users as measured via the CAGE. The CAGE is a screening instrument 
that consists of four yes/no questions (Ewing, 1984). In the HIS, a positive 
answer on at least two out of four questions is considered an indication for 
problem alcohol use (Gisle, 2010). Whereas the overall use of alcohol seems to 
have stabilized over the years, the number of daily alcohol users and problem 
alcohol users has increased over the years. The percentage of daily alcohol users 
has risen from 9% in 2001 to 12% in 2008 and the number of problem alcohol 
users has risen from 7% in 2001 to 10% in 2008 (Gisle, 2010). The European 
Study of the Epidemiology of Mental Disorders (ESEMeD), in which Belgium 
was one of the six participating European countries, provides data on current and 
lifetime prevalence of alcohol abuse and dependence (Alonso et al., 2004). 
Overall, 7.7% of the Belgian respondents had met the criteria for alcohol abuse 
and 1.7% for alcohol dependence at some point in their lives. In addition, 1.7% 
met the criteria for current alcohol abuse and 0.3% for current alcohol 
dependence. This implies that according to these estimates about 640.000 
Belgians would have met the criteria for an alcohol use disorder at some point in 
their lives, of whom 140.000 in the past year (Bruffaerts, Bonnewyn, Van Oyen, 
Demarest & Demyttenaere, 2004).  
 
Large-scale population sample studies have demonstrated that the overall 
majority of persons who meet the criteria for current alcohol use disorders do not 
seek formal treatment (Cohen, Feinn, Arias & Kranzler, 2007; Oleski, Mota, Cox 
& Sareen, 2010; Stinson et al., 2005). Based on data from the National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC), it is 
estimated that only 6.1% of the persons with a 12-month DSM-IV alcohol use 
disorder had sought treatment in that same year (Stinson et al., 2005) and that 
only 14.6% of persons who had ever met the criteria for a lifetime alcohol use 
disorder, had received alcohol treatment at some point (Cohen et al., 2007). 
Overall, individuals meeting the diagnostic criteria for alcohol dependence have 
higher treatment rates as compared to those meeting the criteria for alcohol abuse 
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(Hasin et al., 2007). Treatment seeking often occurs more than ten years after the 
onset of the symptoms of the disorder and therefore a so-called “long lag time” 
can be observed between the onset of the problem and treatment seeking 
(Bruffaerts, Bonnewyn & Demyttenaere, 2007; Cohen et al., 2007; Kessler et al., 
2001; Simpson & Tucker, 2002). The overall majority of persons seeking 
specialized treatment for alcohol use problems is between 30 and 60 years old 
with a peak between 40 and 49 years old (Colpaert, Vanderplasschen, Van Hal & 
Broekaert, 2005; Laudens, 2006). For Belgium, overall national or regional 
figures on the number of problem alcohol users seeking treatment are not 
available. Only non-integrated data for a number of treatment modalities can be 
presented alongside each other (VAD, 2011). In 2008, about one fifth (19%; 
n=23,177) of all admissions to psychiatric hospitals referred to persons with an 
alcohol use disorder as main diagnosis upon admission. In the Flemish outpatient 
centers for mental health care, 3,355 episodes of treatment and care of 
individuals meeting the criteria for an alcohol use disorder were registered in 
2010.  
 
 
1.2. Prevalence and consequences of illicit drug use 
 
1.2.1. A historical perspective on illicit drug use  
 
Throughout history, not only the use of alcohol but also of other psycho-active 
substances such as opium, coca leaves, betel, peyote and marihuana is reported. 
The history of opium use can be traced back to the ancient Egyptian and Greek 
cultures and also the use of coca leaves was already reported in the Moche and 
Inca civilizations several thousands of years ago. Over the past 200 years, these 
so-called “old” drugs have been supplemented with new(er) drugs (such as LSD 
and amphetamines) and also the older drugs were chemically manipulated in 
order to increase or change their level and intensity of functioning (e.g. heroin as 
derivate of opium) (Lowinson, Ruiz, Millman & Langrod, 2005).  
 
Until the end of the 19th century, the use of substances like opium, coca leaves or 
hemp was predominantly associated with traditions in certain cultures and 
countries and wasn’t seen as potentially dangerous. Furthermore, many 
substances were first produced as medicines and used for therapeutic objectives 
(Levinthal, 2012). When also the mood-altering and pleasure-producing effects 
of certain medicines were discovered, a larger group of people began to use these 
substances recreationally (Courtwright, 2002). Furthermore, due to the new 
possibilities of chemistry and pharmacology, not only the number of newly 
developed substances and derivates increased substantially but also the quality 
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and strength of the substances were synthetically forced up (Dom, 2000). 
Combined with the new ways of consuming drugs, global migrations, increased 
possibilities of worldwide transportation and associated worldwide trade 
(Courtwright, 2002; Lowinson et al., 2005), not only the worldwide use but also 
the abuse of psycho-active substances increased significantly. Under the driving 
force of the US, an international drug control movement based on prohibition 
was established, starting with the first International Opium Convention, signed in 
1912 at The Hague (Boekhout van Solinge, 2002; UNODC, 2008). This first 
convention, followed by subsequent treaties, installed an international 
framework for the control of a broad range of narcotic and psychotropic 
substances (De Ruyver, Vermeulen, Vander Beken, Vander Laenen & Geenens, 
2002). Also the origin of the Belgian narcotic drug act of 1921 goes back to this 
convention but over the years, it has been subject to various important changes 
(Vander Laenen, 2007).  
 
This international drug control movement gave rise to a distinction between 
substances that are under “international control” and are included in the 
“Multilingual Dictionary of Narcotic Drugs and Psychotropic Substances under 
International Control” of the United Nations (UN, 2006) and those that are not. 
Also certain substances that are predominantly or exclusively used for medical 
purposes (so-called medicinal drugs) can have been placed under control. 
Definitions on licit versus illicit substances vary to a large extent (UNODC, 
2012; WHO, 2012b), especially with regard to the place and role of these 
medicinal drugs, depending on the context in which the terms are used. For the 
further course of this dissertation, the definitions of the World Health 
Organisation (WHO) on licit and illicit substances are used. An illicit drug is 
defined as: “a psychoactive substance, the production, sale, or use of which is 
prohibited. Strictly speaking, it is not the drug that is illicit, but its production, 
sale, or use in particular circumstances in a given jurisdiction” and a licit drug 
as “a drug that is legally available by medical prescription in the jurisdiction in 
question, or, sometimes, a drug legally available without medical prescription” 
(WHO, 2012b). So-called pharmaceutical or medicinal drugs and over-the-
counter medication are in this respect, and also in this dissertation, not 
considered as illicit drugs, although we agree with Klingemann and Hunt (1998) 
that the dividing line between licit and illicit drugs is fading, certainly when we 
look at the licit/illicit distinction from a broader perspective and go back to the 
question of socio-cultural acceptance. Indeed, alcohol and illicit drugs carry very 
different socio-cultural meanings and values (Weisner, 1992) and from this 
perspective, alcohol, tobacco and medication can be considered substances that 
are strongly interweaven in our culture, whereas for illicit drugs this is less the 
case (Dom, 2000). Our legislation reflects to a certain extent this idea of cultural 
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acceptance, but is on the other hand strongly influenced by the international drug 
control organizations. The socio-cultural and juridical position of cannabis use in 
Belgium can be considered as an interesting illustration of this fading line 
between licit and illicit substances. In 2003, the Belgian drug legislation made a 
formal distinction between cannabis and other illicit drugs and between 
possession in the framework of personal use and other offences. Possession of 
cannabis for personal use remains punishable by law, but since 2003 it has been 
given the lowest priority for prosecution when no disturbance of the public order 
or aggravating circumstances are present (Vander Laenen, 2007). In “Forces of 
Habit. Drugs and the making of the modern world”, Courtwright (2002) 
identifies international support of the industry, fiscal influence and the personal 
habits of important leaders, doctors and celebrities in society, as important 
elements that were responsible in the past for making alcohol and tobacco less 
vulnerable for prohibitive actions. Clearly, the use of certain substances is not a 
problem in itself but is the result of collectively stating that the use of this or that 
substance is not legitimate, should be regarded as problematic and is possibly 
declared illegal.  
 
Finally, it is important to stress that both licit and illicit substances involve 
important risks for the health and well-being of the user as well as his 
surroundings. The distinction does not say anything about the former holding 
less or no risks compared to the latter (Dom, 2000). The classification licit versus 
illicit drugs can be regarded as one classification next to other classifications, 
such as the classification based on the most prominent central nervous system 
effect (e.g. depressants, stimulants, opioids) (Schuckit, 2006). However, in the 
light of the societal responses to alcohol and drug (mis)use, the licit/illicit 
distinction has both nationally and internationally been more influential and has 
led to the establishment of separate structures in the domains of e.g. policy, 
legislation, research and treatment. 
 
 
1.2.2. Prevalence and consequences of illicit drug use  
 
The United Nations Office on Drugs and Crime (UNODC) estimates that 
between 149 and 272 million people between the age of 15 and 64 years old, had 
used illicit substances at least once in the year 2009 (UNODC, 2011). 
Worldwide, cannabis is the most commonly used illicit drug. The UNODC 
estimates the number of people who had used cannabis at least once between 
2.8% to 4.5% of the world population between 15 and 64 years old (between 125 
and 203 million). Their best estimates for other illicit substances range from 
0.3% to 0.5% for opiates, from 0.3% to 0.5% for cocaine, from 0.3% to 1.3% for 
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amphetamine-type stimulants and from 0.2% to 0.6% for the ecstasy-group. 
UNODC also observed the emergence of so-called “legal highs”: synthetic 
substances that are not under international control but have similar effects as 
illicit substances such as cocaine, ecstasy or cannabis. Over the years, a trend 
towards poly drug use can be observed (Byqvist, 1999; Latt, Conigrave, 
Marshall, Saunders & Nutt, 2009), in which the use of multiple substances either 
simultaneously or concurrently is the rule rather than the exception. 
 
It was only in the beginning of the 1970s, that Belgium was confronted with a 
substantial increase in the number of young adults who abused illicit drugs 
(mainly heroin). From then onwards, the availability of illicit drugs and 
consequent problems increased rapidly (Vanderplasschen, De Bourdeaudhuij & 
Van Oost, 2002). Based on the most recent HIS (Gisle, 2010), it can be estimated 
that 14% of the Belgian population between 15 and 64 years old has ever used 
cannabis (hasjiesj or marihuana), whereas 5% of the population has used it at 
least once during the past 12 months. Among adolescents and young adults, 
these prevalence rates are considerably higher. Among 15-24 year olds, 
prevalence rates are 21.3% (lifetime) and 11.9% (past year) and among 25-34 
year olds, the lifetime prevalence is 30.1% and the past year prevalence 10.5%. 
The HIS also included questions on the use of other illicit drugs, resulting in the 
following prevalence rates for use in the past 12 months: cocaine (0.9%), 
amphetamines (0.9%) and heroin or substitution substances (0.2%). The use of 
illicit drugs is associated with predominantly male adolescents and young adults 
between 15 and 34 years old and appears a pronounced urban phenomenon. 
Comparing the prevalence rates for the use of cannabis and other illicit 
substances with the average rates within the European Union, Belgium can be 
situated in the middle group.  
 
Illicit drug use and dependence contribute to a considerable extent to the global 
burden of disease (Degenhardt & Hall, 2012). Drug dependence, HIV infection, 
and drug overdose are considered important causes of drug-related disease 
burden and illicit drug use a significant cause of premature mortality. Although 
illicit drug use has lower prevalence rates than alcohol use, Degenhardt and Hall 
(2012) concluded that in high-income countries, the contribution of illicit drugs 
to the global burden of disease may be similar to alcohol. Belgium has no figures 
on the prevalence of drug-related disorders, but in the Netherlands the NEMESIS 
community sample study (de Graaf, ten Have & van Dorsselaer, 2010) showed a 
past 12-month prevalence of cannabis abuse of 0.4% and a past 12-month 
prevalence of cannabis dependence of 0.3%. Abuse or dependence upon other 
illicit drugs was practically non-existing as shown in the NEMESIS study. 
General population surveys, such as the HIS and the NEMESIS, can provide 
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accurate and rich information. However, they may underestimate drug use since 
certain groups of people are either excluded from the general survey’s sampling 
frame or have low response rates, such as homeless people, people who are 
currently living in an institution or are in prison, etc … These persons may well 
be among the most frequent users of illicit drugs (EMCDDA, 2009a; EMCDDA, 
2009b) since illicit drug use is often observed in “hidden” populations.  
 
Large-scale population sample studies in the US have demonstrated that the 
overall majority of persons who meet the criteria for current drug use disorders 
do not seek or receive formal treatment. Still, treatment rates are generally higher 
for drug use disorders than for alcohol use disorders. Grella and colleagues 
(2009) found that drug-dependent persons were four times more likely than 
alcohol-dependent persons to receive help. They explain this important 
difference to the licit versus illicit status of the substances. Misusing or being 
dependent on illicit drugs is regarded more often as problematic, as opposed to 
misusing alcohol, which is to a higher extent socially normative. Based on data 
from the National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC), it is estimated that 15.6% of the persons with a 12-month DSM-IV 
drug use disorder had sought treatment in that same year (Stinson et al., 2005). 
Treatment rates were considerably higher for persons meeting the criteria for 
dependence (30.7%) than abuse (6.1%). The majority of people that are seeking 
treatment for drug problems is between 18 and 40 years old (Colpaert et al., 
2005).  
 
Although in Belgium no integrated data exist on the total number of unique 
persons seeking illicit drug treatment (De Donder, 2009), several fragmented 
data sources are available (Deprez et al., 2012) that can increase our 
understanding of the number and characteristics of treatment-seeking drug users. 
In 2009, about 9,300 persons were registered in the Belgian Treatment Demand 
Indicator Register (BTDIR) (Deprez et al., 2012), predominantly containing 
information on clients registered in categorical treatment centers for illicit drug 
users and outpatient centers for mental health care. The large majority was 
registered in outpatient centers (78.3%) or low-threshold centers (8.6%). Only 
13.1% was registered in inpatient treatment centers. The primary drugs were 
mainly opiates (37.3%) and cannabis (27.5%). Other primary drugs were in order 
of importance: cocaine (14.1%), stimulants (10.2%), hypnotics and sedatives 
(3.7%) and unknown or other substances (7.2%). In addition to the data in the 
BTDIR, the Minimum Psychiatric Data (MPG/RPM) show that about 1,500 
admissions in general hospitals and about 6,000 admissions in psychiatric 
hospitals were related to persons who had drug abuse or dependence as main 
diagnosis in 2006 (De Donder, 2009). In 2010, 15,395 persons received 
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methadone substitution treatment and 2,227 persons received buprenorphine 
substitution treatment (Deprez et al., 2012).  
 
 
1.3. The interconnectedness between alcohol and illicit drugs 
 
Since the beginning of the 19th century, significant changes have occurred in the 
way that society views substance use problems in general and addiction more in 
particular. Several models can be distinguished, which all have implications for 
treatment (van den Brink, 2005), but also for the governing ideas on the 
connection or disconnection between alcohol, tobacco and other drugs.  
 
 
1.3.1. Addiction models  
 
According to van den Brink (2005), various models on addiction can be 
distinguished. Although they developed in a rather chronological order, most of 
them overlap to a certain extent and examples of more than one model can be 
observed in todays’ society. In the moral model (from the second half of the 18th 
century onwards), addiction is seen as a moral weakness and therefore the sole 
responsibility of the individual itself whereas in the pharmacological model 
(from the second half 19th century onwards), addiction is seen predominantly as 
an immediate consequence of the addictive substance itself. This model is linked 
to prohibition and temperance movements in the US and Europe, targeted at 
banning addictive substances from society (Edwards, 2009). During the 1950s-
1970s, a model gained ground in which addiction was seen as a symptom of an 
underlying (personality or other) problem, called the symptomatic model. Later, 
the educational theoretical model can be identified, linked to an increased 
awareness that not only biological or psychological factors within the person 
him- or herself but also the social context plays an important role in the 
development of an addiction problem. The development of therapeutic 
communities for drug users with a strong pedagogical orientation in which 
recovery is associated with making overall changes in identity, behavior and 
lifestyle (Goethals, Soyez, Melnick, De Leon & Broekaert, 2011), can be 
situated within the two models last mentioned.  
 
Since the seventies, the bio-psycho-social model is the most prevalent addiction 
model in society. In this model, it is assumed that biological as well as 
psychological and social factors are involved in addictive processes. However, in 
the nineties, the amount of literature focusing on the medical-biological aspects 
increased exponentially and addiction is more and more described and regarded 
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as a chronic relapsing disorder (McLellan, Lewis, O’Brien & Kleber, 2000) and 
brain disease (Leshner, 1997; van den Brink, 2005), also sometimes referred to 
as the “NIDA paradigm” (Courtwright, 2010). Although chronicity, frequent 
relapse and brain alterations are certainly characteristics that have been found to 
be linked with abuse and dependence of substances and the current biological 
and neurological research findings are of great importance, certain researchers 
raise some critical thoughts and underline the importance of not reducing 
substance use problems entirely to problems of the brain (Tatarsky, 2011). To 
fully understand the phenomenon, psychological, behavioral and social factors 
need to be taken into account as well as the societal and historical context in 
which these problems occur. 
 
 
1.3.2.  Shifts in the governing ideas on the interconnectedness between tobacco, 
alcohol and other drugs 
 
The prevailing addiction model(s) in society have an important influence on how 
the interconnectedness between alcohol, tobacco and other drugs or between licit 
and illicit substances is perceived. Over the years, Courtwright (2005) has noted 
shifting attitudes with regard to western (and more particularly Anglo-American) 
attitudes regarding the interconnectedness between alcohol, tobacco and other 
drugs. Governing ideas regarding these three classes of substances have swung 
back and forth from a tendency to see them as linked phenomena, the so-called 
Alcohol (A), Tobacco (T), Other (O) Drugs (D) or ATOD-paradigm, over seeing 
them as separate phenomena to seeing them again as interrelated (the so-called 
revitalized ATOD paradigm). Although other historians (Spode, 2005; Tyrrell, 
2005) argue that the first ATOD paradigm was not present in other, non-Anglo-
American, parts of the world, there is more or less consensus that the revitalizing 
ATOD paradigm can be seen as a global phenomenon.  
 
In the late nineteenth century, a so-called “unifying inebriety theory” was 
adopted in American and British societies in which alcohol, tobacco and other 
drugs were very closely linked to each other. Courtwright (2005) also calls this 
the ATOD-paradigm, which can be linked to the moral model. The first inebriety 
movement embraced ideas of biosocial linkages between all substances and saw 
tobacco as the worst of all drug habits since this substance opened the door to 
drinking and other undesirable behavior such as prostitution and gambling. In the 
1930s and 1940s, an important change occurred in which alcohol and tobacco 
were split off from other drugs or so-called “real” drugs. Also the establishment 
of a strong international drug control movement, under the influence of the US 
(Boekhout van Solinge, 2002; UNODC, 2008), contributed to this evolution. 
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National legislation was being developed following the ratification of 
international treaties, aimed at controlling the production and sale of opium, 
heroin, morphine, cocaine and other narcotic or psycho-active substances. When 
people used the word “drugs”, they started to exclude – instead of include – 
alcohol and tobacco and referred almost exclusively to other types of substances. 
Under the impulse of Haggard and Jellinek, alcohol was no longer seen as a vice 
but as a “harmless social condiment” (Courtwright, 2005, p.111). The idea that 
only a minority of all alcohol users developed alcohol use problems and became 
an alcoholic became commonly accepted. The same ‘normalization’ tendency 
could be observed for tobacco, used by many millions of people and at the time 
also frequently used by medical doctors. This division was also reflected in the 
distinct terminology that was used. Whereas around 1947 the term “inebriety” 
was replaced by “alcoholism” to refer to alcohol problems, the term “addiction” 
was used to describe problems related to illicit drug problems (Edwards, 2009). 
Whereas the use of tobacco and alcohol was de-stigmatized, the use of other 
drugs was more and more criminalized (White, 1999). Elements that have 
contributed to the desertion of the ATOD-paradigm were the lack of scientific 
evidence to support the ideas of interconnectedness, the upcoming alcohol and 
tobacco industry who could freely promote their products as “benign non-drugs” 
(Courtwright, 2005, p. 118) and the explosion of literature, which resulted in a 
forced specialization in (the effects of) one drug. Researchers were no longer 
able to cope with the enormous amount of research results and papers on alcohol, 
tobacco and other drugs (Courtwright, 2005).  
 
Courtwright (2005) identified a new shift in the late 20th century which he calls 
the revitalized ATOD paradigm. Both clinicians and researchers are re-analyzing 
and re-thinking concepts such as addiction, dependence and abuse and are in 
search of common theories and treatment approaches underlying all substances 
and associated problems. This new shift was influenced by advances in 
neuroscience, genetics and epidemiology. Neuroscience demonstrated how 
different drugs can act in different ways but ultimately share some common 
mechanisms and effects. Genetics showed that persons with a genetic 
predisposition for substance dependence are also more likely to have problems 
with e.g. pathological gambling. The idea of inheritable vulnerability has 
increasingly found evidence and also the role of personality traits is very 
important in this respect. In the third field, epidemiology, it became more and 
more clear that alcohol was very closely linked to accidents, chronic diseases, etc 
… These findings were so strong that the alcohol industry could no longer shut 
their eyes and present their product as a “benign non-drug”. Since the seventies, 
Kandel and colleagues (1992) have also gathered profound scientific evidence to 
support the existence of a so-called gateway theory in which the risk of moving 
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from licit drug use to illicit drug use was emphasized. Neuroscience, genetics as 
well as epidemiology have demonstrated that the line between tobacco, alcohol 
and other drugs should rather be regarded as a dotted line with many crossings 
from one side to the other. Also the increased attention for the reality and 
implications of poly drug use can be situated in this perspective (EMCDDA, 
2009c). 
 
 
1.3.3.  Facts and figures on co-occurring alcohol and drug use problems 
 
In Europe as well as in the US, poly drug use has become the rule rather than the 
exception and several researchers (e.g. Byqvist, 2006; Ives & Ghelani, 2006) 
have demonstrated an increase in poly drug use over the past few years. In a 
society in which a diversity of psycho-active substances is available, it is easy 
for users to experiment with various combinations or to look for other substances 
that replace their primary drug of choice (Klee, Faugier, Hayes, Boulton & 
Morris, 1990). Not only illicit substances, but also alcohol plays a very important 
role in these poly drug use patterns (Byqvist, 2006). Persons with illicit drug 
problems often also use or abuse alcohol but also persons with alcohol use 
problems often use or abuse other substances, etc … In literature, this 
phenomenon is described by a wide variety of terms: joint use of drugs and 
alcohol (Hakkarainen & Metso, 2009), concurrent or simultaneous drug and 
alcohol use (Midanik, Tam & Weisner, 2007), dual dependence (Gossop, 
Marsden & Stewart, 2002), concurrent drug and alcohol dependency (Johnson, 
2006) or co-occurring alcohol and other drug use disorders (Kranzler & Li, 
2008). 
 
In large epidemiological studies among the general population, high levels of 
comorbidity between DSM-IV alcohol and drug use disorders were found, which 
can be considered a specific type of homotypic (“occurrence of disorders within 
the same diagnostic class”) comorbidity (Angold, Costello & Erkanli, 1999; 
Stinson et al., 2005). Results from the cross-sectional 2001-2002 National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) show that 
55.2% of the persons who had a drug-related disorder in the past year also had an 
alcohol-related disorder in that same period, and that 13.0% of those with an 
alcohol-related disorder were also diagnosed with a drug-related disorder 
(Stinson et al., 2005). In Australia, Canada, and Europe, conclusions regarding 
this form of homotypic comorbidity went in the same direction (Bijl, Ravelli & 
van Zessen, 1998; Burns & Teesson, 2002; Degenhardt & Hall, 2003; Ross, 
1995). Studies carried out in clinical settings resulted in similar findings. First, 
various studies among drug treatment populations have demonstrated high rates 
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of high-risk drinking and alcohol dependence (Gossop, Marsden, Stewart & 
Rolfe, 2000; Miller, Klamen, Hoffman & Flaherty, 1996; Smart, Ogborne & 
Newton-Taylor, 1990). Especially among clients in methadone treatment 
programs, heavy drinking has been identified as a substantial problem (Best et 
al., 1998; Hillebrand, Marsden, Finch & Strang, 2001). Second, research among 
alcohol treatment populations has pointed out that alcohol is often not the only 
substance that is being (mis)used (Caetano & Schafer, 1996; Caetano & Weisner, 
1995; Martin et al., 1996; Staines et al., 2001).  
Few studies have focused on the specific characteristics, problems and treatment 
needs of persons having problems with both alcohol and drugs. Although poly-
drug use has become the rule rather than the exception, most research projects 
and publications are conceptualized from a substance-specific point of view 
(e.g., focus on cocaine or amphetamine users) (Schensul, Convey & Burkholder, 
2005). When studies compare profiles of alcohol and drug users, often no 
attention is paid to the fact that this distinction is not mutually exclusive and that 
alcohol users also use drugs and vice versa. The common knowledge on 
homotypic comorbidity between alcohol and drug-related disorders remains 
scarce, especially with regard to psychopathology. 
 
A number of studies have hypothesized on the basis of their findings that persons 
having co-occurring alcohol and drug use problems can be considered a group of 
substance users with own characteristics and a high problem severity on various 
domains. Stinson and colleagues (2005) found that compared with persons with 
alcohol or drug disorders only, persons with both alcohol and drug disorders 
appeared to be more often male, younger, and never married. In addition, 
compared to the alcohol-only group they were less likely to be white and more 
likely to have a lower socioeconomic status and comorbid personality, mood, 
and anxiety disorders. The percentage of people having sought substance abuse 
treatment appeared highest among persons with both alcohol and drug disorders: 
21.8% versus 6.1% (alcohol-only group) and 15.6% (drug-only group). Also in 
substance abuse treatment agencies, similar findings were reported. Gossop and 
colleagues (2002) compared drug-using clients who were concurrently high-
dependent on alcohol (so-called dual-dependence) with clients who were not 
dependent or rather low-dependent on alcohol. High-dependent drug users were 
less likely to use heroin or crack, but more likely to use benzodiazepines, 
cocaine, or amphetamines. They also had more often psychosocial or physical 
health problems and significantly more frequently reported one or more previous 
inpatient treatment admissions.  
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1.4. The development and present-day organization of alcohol and drug 
treatment in Belgium 
 
 
Belgium has a well-established and extensive treatment system for persons with 
alcohol and drug use problems which is embedded in an overall substance use 
policy that has made an explicit choice to consider substance use first and 
foremost as a public health issue (Deprez et al., 2012; Vanderplasschen et al., 
2002). This overall public health perspective is formally confirmed in the Joint 
Statement “A global and integrated drug policy in Belgium” of the Inter-
Ministerial Conference on Drugs, issued in January 2010. In this statement, the 
federal Minister of Public Health was confirmed in the role of overall drug 
policy coordinator across policy domains (public health, social welfare, interior 
affairs, justice, mobility, science policy and employment) and policy levels 
(federal, communities and regions, provinces and municipalities) 
(Interministeriële Conferentie Drugs, 2010).  
 
Substance users can rely on generic (mental) health or social services as well as 
categorical services for substance abuse treatment (Vanderplasschen et al., 
2002). A wide variety of treatment and general support initiatives were 
developed over time which are situated either in an abstinence-oriented or in a 
harm reduction paradigm. As this dissertation focuses on individuals with 
alcohol and/or drug problems seeking substance abuse treatment, we provide an 
overview of the present-day situation regarding alcohol and drug treatment in 
Belgium. Treatment centers are classified according to the primary, secondary 
and tertiary level of care and according to their categorical or generic nature. In 
order to fully understand the current situation, we start with a historical sketch of 
the early days of alcohol and drug treatment. The section is concluded with a 
discussion on the current level of integration between alcohol and drug treatment 
in Belgium.  
 
 
1.4.1. The development of alcohol and drug treatment in Belgium  
 
 Initiation of specialized treatment for persons with alcohol problems 
 
In the period preceding World War II, specialized treatment of alcohol users was 
practically non-existing in Belgium and in fact, until 1958 a large majority of 
alcoholics were supposed to find their own way. At the time, not being able to 
control one’s drinking behavior was not regarded as a disease and thus not the 
responsibility of medical doctors (cf. moral model). Persons who had problems 
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with alcohol were regarded as weak and good-for-nothing. They received few 
sympathy and understanding for their situation since they were considered as the 
sole responsible for their actions and associated consequences (De Boe, 1967; 
Heylen, 1961). Alcoholism was regarded as a vice and the overall opinion was 
that uncontrolled drinkers should simply learn to drink in the same way as 
everyone else (Snoeck, 1969). In that time, persons with alcohol problems 
sometimes received help and assistance of priests and Christian citizens, who - 
inspired by the idea of charity - wanted to help relieve the misery of others, 
including persons with alcohol problems. Also a limited number of medical 
doctors offered some help but overall, alcoholism was seen as the territory of 
religion, education, police and law. Belgium was well behind in addressing the 
alcohol issue, as compared to other countries (Bruwiers, 1965; De Boe, 1967; 
Hemmeryckx, 1960).  
 
When alcoholics were in a far advanced state of deprivation or showed additional 
psychiatric problems (delirium tremens, dementia, etc …), they were sometimes 
referred or sent to a neuro-psychiatric institute. Neuro-psychiatric institutes 
admitted persons with all kinds of mental illnesses and were not established 
solely for alcoholics. Since for a long time, no other possibilities existed, 
alcoholics were treated in these institutes together with persons having other 
mental illnesses (Hemmeryckx, 1960). However, these institutes were not 
specialized in treating alcoholics and since few general practitioners were aware 
of this possibility, persons were not often referred (Van Keirsbulck, 1958). 
Furthermore, alcoholics were often reluctant to an admission in a psychiatric 
hospital due to the stigma associated with mental illnesses and psychiatry (De 
Clerck, 2008, personal communication). Admission to a neuro-psychiatric 
institute was not always voluntary; in some cases family members, police or 
other social institutions took alcoholics who were in a “far advanced stadium” to 
the institute for a compulsory admission in the closed department (Hemmeryckx, 
1960). Besides the neuro-psychiatric institutes, alcoholics were also to a lesser 
extent helped in general hospitals, residential asylums for the mentally ill or in 
outpatient “Dispensaria voor Geesteshygiëne”.  
 
In 1949, the “Nationaal Comité tegen het Alcoholisme (NCA)” was established. 
The NCA was composed of a number of anti-alcoholic and other social 
organizations. From the beginning, the NCA was more liberal in its ideas (as 
opposed to the more traditional organizations undertaking a genuine fight against 
alcohol). The committee was inspired to a large extent by the ideas of the World 
Health Organisation (WHO) and observed closely what happened abroad in 
relation to the alcohol issue (De Boe, 1967). They actively engaged in spreading 
the idea that alcoholism needed to be seen as a disease and that alcoholics could 
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recover. They believed in the idea of alcohol treatment but also supported the 
establishment of self-help organizations. The information and education efforts 
of the NCA were an important stimulus for the development of (curative) 
support and specialized treatment initiatives for alcohol users. Under the impulse 
of De Boe, the first group of Alcoholics Anonymous (AA) was established in 
Brussels in 1953: “Les Amis de Marolles” and in the following years groups 
were established also in other Belgian cities (AA Vlaanderen, 2012). It took 
NCA about 10 years before the idea of alcoholism as a disease gradually got 
accepted in mental health care environments. Indirectly, their mission was 
strongly supported by AA members and groups who showed medical doctors, 
social workers and priests that recovery was possible (De Boe, 1967).  
 
From 1958 onwards, a number of non-profit organizations were established 
aimed at providing outpatient treatment to alcohol patients and their families. 
These “bureaus” were equipped with full-time social workers and also medical 
treatment was organized (De Boe, 1967). In 1963 the “Nationale Federatie van 
Konsultatiebureaus en Instellingen voor de Zorg aan Alkoholisten en andere 
Toxicomanen (N.F.K.A.T.)” was established, composed of representatives of the 
bureaus. However, also in the sixties, the enthusiasm to help alcoholics recover 
stayed limited and questions arose regarding the professional training of people 
working with alcoholics. In 1967, about 15 bureaus were established (De Boe, 
1967) but it took them mostly a few years before they were really fully 
operational due to the lack of financial means (Bruwiers, 1965). Gradually, by 
the end of the sixties and especially in the seventies and eighties, also within 
psychiatric hospitals the level of specialization increased; a division in acute and 
more chronic care was introduced and separate units for various target groups, 
including alcoholics, were established (De Clerck, 2008, personal 
communication). 
 
The very first specialized psychiatric hospital for alcoholics, De Pelgrim, opened 
its doors in 1973. De Pelgrim was founded by the vzw I.A.T. (“Instellingen voor 
de zorg voor Alcoholisten en andere Toxicomanen”). This clinic was – and still 
is – the first of its kind in Belgium. During the first year, alcoholics were 
admitted but very soon also drug addicts were admitted and treated in the clinic. 
Drug users saw a voluntarily admission to this long-term treatment program as 
an opportunity to avoid or delay prison sentences (Bruggeman, 2012, personal 
communication).  
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 Initiation of treatment for persons with illicit drug problems 
 
Most of the mental health care services that treated alcoholics were rather 
reluctant to provide treatment to persons with illicit drug problems because they 
feared that they would not be able to keep them “under control” within their 
organizational structures (Broekaert et al., 2010; Vanderplasschen et al., 2002). 
Also drug users themselves were not keen on asking help in the regular medical-
social or mental health care sector because they feared juridical consequences 
(Casselman, 1971). At the time, a need was felt for new initiatives, specifically 
set up for these young drug users (Casselman, 1971). Two drug-free therapeutic 
communities were established in the period 1972–1975 and in the years that 
followed, also other specialized treatment initiatives for drug users were set up, 
including day-care centers, crisis intervention centers, short-term therapeutic 
programs and additional therapeutic communities (Vanderplasschen et al., 2002). 
These centers have searched an own way to deal with illicit drug users and did 
not follow the existing treatment models for problem alcohol users. The 
specialized treatment initiatives, starting with the therapeutic communities, 
engaged in drug treatment from a pedagogical, rather than from a medical or 
psychiatric point of view. Therapeutic communities consist of (re)educative 
processes in which the belief in the potential growth and change of each 
individual makes up a central element. Developing from a person with problems 
into a balanced and mature individual can be considered as an important 
objective. Living their daily lives with others is considered the primary agent of 
the pedagogical process (Broekaert et al., 2010).  
 
As also seen in other countries, the emergence of a specialized, categorical 
treatment offer for illicit drug users often occurred because users of illicit drugs 
and their problems were often neglected by the major systems such as the health, 
welfare and disability systems. Not infrequently, these initiatives were 
established by charismatic leaders or non-professional groups and based on self-
help (Room, 2010).    
 
Since the 1990s, also street-corner work, social workplaces and medical-social 
centers for drug abusers were established. The latter were set up in the major 
cities in order to provide low threshold access to medical care, substitution 
treatment, counseling and outreach (Vanderplasschen, 2004). For a long time, 
methadone substitution treatment was provided in Belgium without a juridical 
basis. In 1994, a number of guidelines for the prescription of substitution 
substances resulted from a consensus conference on substitution treatment but 
the juridical gap remained until August 2002 when the prescription of substitute 
drugs for opiate-dependent persons was legalized. The further specifications 
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were included in the royal decrees of 19 March 2004 and 6 October 2006 
(Lamkaddem & Roelands, 2009; Pelc et al., 2005).  
 
From the 1980s onwards, the traditional (mental) health care gradually opened 
its doors to illicit drug users (Vanderplasschen et al., 2002). Residential 
treatment units for alcohol users within psychiatric hospitals also started to allow 
illicit drug users but thus far it is not yet examined what the actual proportions 
are of persons having alcohol and/or illicit drug problems. Besides broadening 
the target group of already existing units for alcohol treatment, certain 
psychiatric hospitals also created separate units for drug users and general 
hospitals installed units in emergency rooms specifically aimed at the 
detoxification and orientation of drug users. Also outpatient centers increased 
their efforts to offer support and treatment to illicit drug users (Broekaert et al., 
2010; Vanderplasschen et al., 2002). 
 
From the years 2000 onwards, efforts were increased to improve coordination 
and continuity of care in substance abuse treatment (Vanderplasschen, 2004). 
Following this trend, the case management approach was introduced in the 
region of Ghent as a demonstration project, but was quickly introduced also in 
other regions in Belgium. Case management is a complementary approach aimed 
at providing a more individualized support for drug users with complex and 
chronic problems. Additional objectives are to realize more continuity of care 
and an increased coordination between services (Broekaert et al., 2010). 
 
The province of East-Flanders, and the region around Ghent more in particular, 
currently has a high concentration of specialized treatment services for illicit 
drug users. In the seventies, this region was one of the first in Belgium to 
develop initiatives specifically targeted at illicit drug users (Broekaert et al., 
2010). From the beginning, the Department of Orthopedagogics at Ghent 
University was closely involved in these developments, both in the province of 
East-Flanders as in other provinces. Over the past 30 years, a strong tradition of 
science-practice collaboration has been set up, for instance while establishing the 
drug-free therapeutic community “De Kiem” (Broekaert, 1980), implementing 
case management for illicit drug users and striving for an increased co-operation 
between treatment agencies (Vanderplasschen, 2004). Always, the realization of 
a meaningful improvement in the lives of children and adults in difficult living 
circumstances, through action, was the underlying and central orthopedagogical 
objective (Broekaert, Van Hove, Bayliss & D’Oosterlinck, 2004).  
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1.4.2. The present-day organization of alcohol and drug treatment in Belgium 
 
Belgium has an extended and differentiated treatment offer for substance abusers 
(Vanderplasschen et al., 2002). Whereas since the seventies onwards, several 
treatment centers have been developed almost exclusively for illicit drug users 
(categorical treatment centers), other treatment centers providing substance 
abuse treatment are part of the more generic (mental) health care (generic 
treatment centers). Although in the latter organizations, persons with various 
(mental) health care problems can seek treatment, apparently over the years 
certain teams or units have specialized in the treatment of alcohol and/or illicit 
drug problems. Large differences exist between centers, depending on historical 
and contextual factors. 
 
Most of the categorical treatment centers have entered in a specific convention 
with the National Institute for Health and Disability Insurance (RIZIV/INAMI) 
and reside under the overall category of “revalidation centers for addicts” 
(RIZIV, 2001). These centers are autonomous centers that are not part of the 
generic mental health care system. Among the 30 centers with a current 
RIZIV/INAMI convention, one center is exclusively oriented towards problem 
alcohol users (L’Espèrance), one center predominantly focuses on problem 
alcohol users (Centre de post-cure Les Hautes Fagnes) and one center offers 
treatment to both problem alcohol as well as illicit drug users (Centre de jour 
L’Orée). All three are part of the French-speaking community. All other 27 
centers focus mainly and almost exclusively on illicit drug users 
(Interministeriële Conferentie, 2010; RIZIV, 2001). In Belgium, and especially 
in the Flemish-speaking community, the category “centers with a RIZIV/INAMI 
convention” makes up a clearly delineated group of treatment centers that are 
predominantly involved in the categorical treatment of illicit drug users.  
 
Below, professional services 2
                                                          
2 An overview of all available treatment centres in Belgium is available on the IDA-websites: 
 are described according to this categorical/generic 
classification and to the classification in primary, secondary and tertiary services, 
based on the publications of Verstuyf (2004), De Donder (2006), De Donder 
(2009), Möbius (2009) and Deprez and colleagues (2012). In addition to 
professional support and treatment possibilities at primary, secondary and 
tertiary level (cf. Table 1.1.), persons can also rely on informal care (e.g. of 
family members, neighbors or friends) or self-help organizations such as the 
“Anonymous Alcoholics (AA)” or “SOS Nuchterheid”. Also, street corner work 
www.ida-nl.be and www.ida-fr.be.  
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and or telephone help lines such as the “Infor-drogues” or “Druglijn” can be 
considered as a very low-threshold approach towards (especially) illicit drug 
users. 
 
Primary services or services on the first line can be described as low-threshold, 
non-specialized outpatient services. For many substance users, primary services 
are the first contact with professional help. Primary services are generic centers 
having contacts with people with various problems, including alcohol as well as 
illicit substances, without distinction.  
 
Secondary services consist of the more specialized outpatient services. Some are 
generic (psychotherapists and psychiatrists in private practices; outpatient 
centers for mental health care; day-care treatment in psychiatric hospitals) and 
some are categorical and almost exclusively oriented towards illicit drug users 
(medical-social centers providing methadone treatment and day-care centers).  
 
Table 1.1. : Overview of the present-day situation of alcohol and drug treatment in 
Belgium 
  
Categorical  
treatment centers  
 
Generic  
treatment centers  
 
Primary services  - General Practitioners (GP) 
  - Centers for General Welfare 
Work (CAW)  
  - Public Social Service 
Centers (OCMW) 
Secondary services - Day-care centers - Psychotherapists in private 
practice 
 - Medico-social centers - Psychiatrists in private 
practice 
  - Outpatient centers for 
mental health care 
  - Psychiatric hospitals (day-
care) 
Tertiary services - Crisis intervention centers  - General hospitals 
(emergency rooms; 
psychiatric wards) 
 - Short-term therapeutic programs  -    Psychiatric hospitals (units 
for intensive and long-term 
residential treatment) 
 - Therapeutic communities  
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Tertiary services are residential services. These services provide detoxification 
and/or long-term intensive treatment. These types of treatment programs can be 
found in the general hospitals (emergency room; psychiatric wards) and in the 
psychiatric hospitals (units for intensive, long-term substance abuse treatment). 
Treatment in general hospitals includes crisis intervention, detoxification and 
possible acute complications whereas treatment in psychiatric hospitals involves 
a global package of crisis intervention, detoxification, treatment, aftercare and 
sheltered living. Historically, the focus of these hospitals in the general (mental) 
health care was predominantly on problem alcohol users. In the beginning of the 
illicit drug epidemic, they were rather reluctant to admit drug users 
(Vanderplasschen et al., 2002) which resulted in the development of a separate 
treatment offer for illicit drug users. The therapeutic communities, crisis 
intervention centers and short-term therapeutic programs make up the categorical 
tertiary services.  
 
 
1.4.3.  Level of integration between alcohol and drug treatment in Belgium 
 
The gradual establishment of a separate, and therefore categorical, treatment 
offer for illicit drug users from the seventies onwards is still an important feature 
of the alcohol and drug treatment system in Belgium. Whereas in a number of 
other countries, alcohol and drug treatment traditionally have a high degree of 
integration or have been merged during the eighties and nineties (Bergmark, 
1998; Room, 2010), the categorical treatment centers for illicit drug users in 
Belgium have developed and maintained an own autonomous identity. Mostly, 
persons with primary alcohol problems are only allowed by exception. 
 
Apart from a few exceptions, all secondary and tertiary treatment services for 
problem alcohol users are provided within the framework of the generic (mental) 
health care system (centers for mental health care; psychiatric wards in general 
hospitals; units for substance abuse treatment in psychiatric hospitals; 
psychotherapists and psychiatrists in private practice). As opposed to some other 
countries like Sweden where alcohol and drug treatment services were separated 
from psychiatric services at some point in time (Storbjörk, 2006), only a few 
categorical initiatives specifically oriented towards problem alcohol users exist 
in Belgium. Also the 12-step Minnesota model, the treatment model most often 
used in the US and the United Kingdom (Snoek, van der Poel & van den Mheen, 
2011), was never introduced as such in Belgium except for the AA self-help 
groups. Over the years, both the in- and outpatient generic (mental) health care 
has started to welcome illicit drug users and at present some of them have in fact 
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a well-developed, specialized treatment offer for persons with illicit drug 
problems. 
 
In an international study of Klingemann and Hunt (1998) on the drug treatment 
systems of 20 different countries, comparable information was gathered on 
several issues such as an inventory of drug treatment activities and a description 
of the sociopolitical structure in the various countries. Bergmark (1998) has used 
this source of information to assess the degree of integration of alcohol and drug 
treatment systems. His assessment was based on three features (source of 
financing, treatment methods and dominant type of profession) and resulted in 
the assignment of either a low or a high level of integration between alcohol and 
drug treatment systems for the various countries. Examples of countries with a 
high level of integration are Austria, Canada and the Netherlands whereas 
examples of countries with a low level of integration are Spain, Japan and 
Colombia. Belgium was not included in this cross-national comparative study 
but below we discuss the three features for the Belgian situation of categorical 
treatment centers for illicit drug users versus the generic (mental) health care 
treatment centers. 
First, with regard to the sources of financing, the categorical residential treatment 
agencies for illicit drug users are financed by the same organism (RIZIV/INAMI 
of the federal government) but via other channels (RIZIV/INAMI-conventions) 
than the (psychiatric) hospitals (hospital financing structures) where most people 
with alcohol problems receive inpatient treatment. The categorical outpatient 
treatment agencies for illicit drug users are financed by the RIZIV/INAMI, 
whereas the generic outpatient mental health care centers where most alcohol 
misusers receive outpatient treatment are financed at the policy level of the 
Flemish, French and German-speaking communities.  
 
Second, with regard to the treatment methods3
                                                          
3 In this paragraph, the feature “treatment methods” is discussed in a broad sense and not only refers 
to methods and interventions but predominantly to the underlying paradigms of care and treatment.  
, we can observe that nearly all 
residential alcohol treatment is organized according to a psychiatric treatment 
model, whether in acute, psychiatric crisis units in general hospitals for 
detoxification or in psychiatric hospitals (units for substance abuse treatment). 
One of the exceptions is Kliniek De Pelgrim. In 1973, when Kliniek De Pelgrim 
was founded, it contained a new treatment model for alcohol and drug users as 
opposed to the residential treatment in psychiatric wards in general hospitals and 
psychiatric hospitals. The treatment of drug users evolved into the therapeutic 
community De Kiem. The clinic itself became officially recognized as a 
psychiatric hospital and also gradually evolved towards a psychiatric treatment 
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model. The categorical treatment initiatives for illicit drug users, both in- and 
outpatient, are characterized by different objectives, approaches and underlying 
paradigms. The generic treatment centers rely on medical, mental health and 
psychiatric frameworks and are situated in an abstinence-oriented paradigm. The 
categorical treatment centers on the other hand are partly based in this 
abstinence-oriented paradigm (e.g. therapeutic communities) and partly in a 
harm-reduction paradigm (e.g. medico-social treatment centers providing 
methadone substitution treatment). Furthermore, several categorical treatment 
centers are based on the therapeutic community method as a global pedagogical 
approach, including social learning, modeling, the establishment of a structured, 
therapeutic environment and the possibility of expression and openness in group 
meetings. Clearly, illicit drug users can rely on a wider variety of both 
categorical as well as more generic treatment methods and approaches as 
compared to problem alcohol users. Although the drug-free therapeutic 
community in itself is non-substance specific (Broekaert et al., submitted for 
publication), in the Belgian context this approach is only available for illicit drug 
users. 
 
Third, clear differences can be observed with regard to the dominant professions 
in the categorical versus the generic treatment centers. In the categorical drug 
treatment centers social workers, educators and (ortho)pedagogues can be 
considered the most dominant professions. In the generic (mental) health care 
centers physicians, psychiatrists and (psychiatric) nurses can be considered the 
most dominant professions. Partly, the same professions can be found in both 
alcohol and drug treatment (e.g. social workers, physicians, psychologists, and 
psychiatric nurses) but the relative weight of these professions is clearly 
different. Educators and orthopedagogues on the other hand were, until recently, 
not often employed in the second and third line generic (mental) health care. 
 
Based on these three features we can conclude that the categorical treatment 
centers for illicit drug users are clearly different in many ways from the generic 
(mental) health and psychiatric services providing substance abuse treatment. 
However, the categorical/generic distinction cannot simply be seen as 
synonymous for the drug/alcohol treatment distinction.  
Over the years, the generic treatment centers no longer exclusively focus on 
problem alcohol users but also developed a specific treatment offer for illicit 
drug users or eased the admission criteria of their alcohol treatment units. In 
many places, cannabis and/or other illicit drug users can now also be admitted or 
follow outpatient treatment (Vanderplasschen et al., 2002). Whether or not they 
will do so, depends also on other factors, such as the availability of categorical 
treatment centers for drug users in the area, waiting lists, preconceived ideas 
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about certain centers, … The categorical centers for drug users on the other hand 
are bound by their RIZIV/INAMI convention and have kept their main focus, 
with the exception of a few centers, on illicit drug users. In the most recent report 
of the Flemish Association of Substance Abuse Treatment Centers (VVBV), 
representing the Flemish categorical treatment centers for illicit drug users, it is 
demonstrated that the number of clients with alcohol as primary drug is very 
small (less than 5%) and hasn’t changed over the past 20 years (VVBV, 2009). 
In conclusion, categorical treatment centers have an own autonomous identity 
and predominantly focus on illicit drug users whereas the generic treatment 
centers historically had a strong alcohol focus but now also welcome drug users. 
On the side of the generic treatment centers a certain “erosion of the institutional 
border between alcohol and illicit drugs” can be observed (Bergmark, 1998, 
p.304). 
 
 
1.5. Problem definition, aims of the study and terminology 
 
1.5.1. Problem definition  
 
Although the joint (ab)use of illicit drugs and alcohol is for many substance users 
a daily reality, specialized treatment for illicit drug users has initially been 
developed within categorical treatment centers, separate from the treatment 
initiatives that were already in place for persons with alcohol problems within 
generic treatment centers for (mental) health care. The categorical and generic 
treatment systems are very different with regard to source of financing, treatment 
methods and dominant type of profession. Also in other countries such as Spain, 
Japan, Switzerland and Colombia rather low levels of integration between 
specialized alcohol and drug treatment can be observed, whereas in other 
countries such as Canada, Finland, China and the Netherlands high levels of 
integration are seen (Bergmark, 1998). Also in research, the world of alcohol 
research on the one hand and (illicit) drug research on the other hand have each 
developed an own “discursive reality” (Hakkarainen & Metso, 2009, p.114). 
Researchers, especially those studying the issue of supply control, are likely to 
focus on either alcohol or illicit drugs and also in research funding, different 
rules apply for alcohol and drug research (Cook & Reuter, 2007). Hence, 
although the distinction between licit and illicit substances is in the first place a 
matter of socio-cultural acceptance and juridical distinction, also in other areas a 
split situation can be observed, e.g. in treatment organization or in scientific 
research.  
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Since the early seventies, the phenomenon of simultaneous or concurrent (ab)use 
of multiple substances was known and referred to as poly drug (ab)use or poly 
substance (ab)use (Johnston, 1974). However, for a long time substance-related 
research and data monitoring systems tended to keep focusing solely on the 
primary substance of abuse without taking the use of additional substances into 
account (Schensul et al., 2005). Over the past few decades, an increased interest 
in the prevalence, nature and consequences of poly substance use, and the use of 
both alcohol and illicit drugs in particular, can be observed. Historically, this 
tendency can be situated in a broader societal phenomenon, which Courtwright 
(2005) has described as the “revitalized ATOD paradigm”, a paradigm in which 
alcohol, tobacco and other drugs are once again seen as very closely linked.  
 
The proportion of people having problems with both alcohol and illicit drugs 
appears to be quite high, as shown in both population and treatment samples 
(Gossop et al., 2000; Miller et al., 1996; Smart et al., 1990; Stinson et al., 2005). 
Furthermore, the limited research findings indicate that persons with both 
alcohol and illicit drug problems are possibly a specific subgroup of substance 
abusers with unique characteristics in need for special attention.  
 
Starting from an overall assessment of treatment utilization patterns of persons 
with drug problems, the overall objectives of this dissertation are to estimate the 
prevalence of co-occurring alcohol and drug use problems within substance 
abuse treatment settings, to gain more insight in the specific characteristics, the 
psychopathological profile as well as the quality of life of persons with co-
occurring alcohol and drug use problems and to look for similarities and 
differences with persons who have problems with either alcohol or illicit drugs 
only.    
 
 
1.5.2. Specific research questions and methodology 
 
1)  How large is the proportion of multiple agency attenders in the 
specialized drug treatment system? What are the socio-demographic 
and substance-related characteristics of multiple agency attenders? 
Which variables predict multiple service utilization?  
 
The aim of this first study was to get more insight in multiple service utilization 
and in the phenomenon of so-called “revolving door clients” or “multiple agency 
clients” more in particular within and across a wide variety of treatment services. 
Both in- and outpatient treatment services and both categorical as well as generic 
treatment services participated in this treatment systems study. For this study, 
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empirical data were collected among 1,139 persons who had an initial intake 
interview in one of the 18 specialized treatment services for drug users in the 
province of East-Flanders (Belgium) due to problems with illicit substances. 
These 18 centers represent the whole specialized treatment offer for illicit drug 
users in this province. The focus of this particular study was on illicit drug users. 
Clients with predominant alcohol and/or prescription drug problems were not 
included in this study (Vanderplasschen, Colpaert, Lievens & Broekaert, 2003). 
Based on the data gathered in this study, we wanted to estimate the proportion of 
multiple agency attenders and their socio-demographic, substance-related and 
treatment utilization characteristics. Moreover, we wanted to explore which of 
these factors could predict multiple service utilization among illicit drug users. 
The information on the treatment demanders’ characteristics was registered by 
treatment practitioners during the initial intake interview on a registration form 
developed especially for this study. The variables were based on questions or 
variables in the “Treatment Demand Indicator” protocol, developed by the 
Pompidou Group/European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) (Simon et al., 1999) and the European Addiction Severity Index 
(EuropASI) (Kokkevi & Hartgers, 1995; McLellan, Luborsky, Woody & 
O’Brien, 1980). The results of this study are reported in chapter 2 of this 
dissertation.  
  
 
2)  What is the proportion of clients seeking substance abuse treatment in 
in a clear-cut region in Belgium that experience problems with both 
alcohol and illicit drugs? What is the socio-demographic, substance-
related and treatment utilization profile of persons who abuse both 
alcohol and illicit drugs? How do these persons differ from those solely 
abusing either alcohol or illicit substances?  
 
An important observation resulting from the first study was that a large 
proportion of illicit drug users seeking treatment regularly used five or more 
glasses of alcohol next to their illicit drug use. Overall, this pattern of alcohol use 
is considered as a form of heavy (episodic) drinking or binge drinking (Wechsler 
& Nelson, 2001). Our finding is consistent with the international literature, 
which indicates that many drug users are drinking excessively (Gossop et al., 
2002; Stinson et al., 2005). The limited research findings suggest that persons 
with co-occurring alcohol and illicit drug use problems can be considered a 
specific subgroup of substance abusers, with some specific own characteristics 
and a potentially higher problem severity. Therefore, the aim of the second study 
was threefold. First, we wanted to identify which proportion of treatment-
seeking clients in a clear-cut region in Belgium regularly used both alcohol and 
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illicit drugs. Second, we wanted to gain more insight into the socio-demographic 
and substance-related similarities and differences between the dual group 
(regular use of both alcohol (>= 5 glasses) and illicit drugs) on the one hand, and 
those solely regularly using either alcohol (>= 5 glasses) or illicit substances on 
the other hand. Finally, we wanted to understand in what way dual abusers do or 
do not differ from the two other groups with regard to their utilization of the 
substance abuse treatment system, e.g., the number of treatment demands during 
a well-defined period.  
In this second study, not only persons with illicit drug problems but also persons 
with alcohol problems were included in the study in order to make comparisons 
possible between persons regularly using alcohol, illicit drugs or both. Again 
both categorical treatment centers as well as the more generic (mental) health 
care centers participated in the study, covering nearly the whole treatment offer 
for problem substance users (Colpaert et al., 2005). The same methodology was 
applied as in the first study, but the items on the registration form were slightly 
adjusted to meet the specific research context of the province of Antwerp 
(Belgium). Treatment practitioners gathered data on the socio-demographic and 
treatment utilization characteristics of 1,626 persons who had an initial intake 
interview in one of the 16 participating treatment centers due to problems with 
licit and/or illicit substances. The results of this study are reported in chapter 3 of 
this dissertation.  
 
 
3)  What is the available evidence regarding the unique socio-demographic 
and psychopathological characteristics of individuals with co-occurring 
alcohol and drug use problems? In what way are they similar or 
different from those of individuals with either alcohol or drug use 
problems only?  
 
In a third study, a systematic review of the literature was performed with a clear 
focus on co-occurring alcohol and drug use problems. With this review, we 
wanted to identify studies that had examined similarities and differences between 
persons with either alcohol or drug problems only versus persons with co-
occurring alcohol and drug problems with regard to socio-demographics (age, 
sex, ethnicity/nationality/country of birth, socio-economic status) and 
psychopathology (mood, anxiety and personality disorders and overall 
psychological problems or distress). Furthermore, the objective of this study was 
to identify possible gaps in knowledge and methodological caveats.  
A comprehensive review of the literature was carried out and database searches 
in the Web of Science and Pubmed took place. Studies were selected when they 
used statistical methods to analyses differences between persons with co-
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occurring alcohol and drug use disorders on the one hand and persons with either 
alcohol or drug problems on the other hand. Furthermore, studies had to be 
published in English, peer-reviewed journals between 1991 and 2011. The 
results of this study are reported in chapter 4 of this dissertation.  
 
 
4)  What is the prevalence of personality pathology among substance 
abusers starting residential substance abuse treatment? What are 
similarities and differences between alcohol-, drug- and dual-dependent 
patients with regard to the prevalence and type of personality disorders? 
Which socio-demographic or substance-related variables determine 
personality pathology?  
 
For a long time, both clinical as well as research attention have been 
predominantly focused on axis I disorders rather than on axis II disorders 
(Emmelkamp & Kamphuis, 2007). However, personality disorders are – by 
definition – associated with significant distress or negative consequences in 
different aspects of a person’s life (APA, 2000). In the general population, about 
one in every ten adults meets the criteria for a personality disorder 
(Lenzenweger, 2008). As personality pathology is shown to have a strong 
influence on the course of addiction problems after treatment, the fourth study 
focuses on assessing the prevalence of personality pathology among substance 
abusers starting treatment. Furthermore, similarities and differences between 
alcohol-, drug- and dual-dependent persons are assessed and the socio-
demographic and substance-related (addiction severity and nature of 
dependence) determinants of personality pathology are analyzed.  
The study was set up as a multi-center, cross-sectional study in 11 units for 
substance abuse treatment situated within a psychiatric hospital, in two specific 
regions in Belgium (East- and West-Flanders). As opposed to the first and 
second study, in which nearly all specialized treatment centers in a selected 
region were included (cf. Chapter 2 and 3), we decided to focus on one 
particular treatment modality in order to enhance the homogeneity of our 
treatment sample. We deliberately selected the units for intensive residential 
treatment of alcohol and/or drug abuse problems following an initial 
detoxification phase, situated in psychiatric hospitals. Although, historically, 
these units had a predominant focus on alcohol use problems, since the eighties, 
they have gradually opened up their doors to illicit drug users (Vanderplasschen 
et al., 2002). With this study, we also wanted to assess the current proportion of 
individuals with an alcohol versus illicit drug dependence in this particular 
treatment modality. 
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Data were collected among 274 persons who started a new treatment episode. 
Persons were interviewed between the 7th and 21st day after admission. Data 
were collected using the EuropASI (Kokkevi & Hartgers, 1995), the M.I.N.I. 
(Sheehan et al., 1998), the ADP-IV (Schotte, de Doncker, Vankerckhoven, 
Vertommen & Cosyns, 1998) and the WHO-QOL-BREF (Skevington, Lofty & 
O'Connell, 2004). The results of this study are reported in chapter 5 of this 
dissertation.  
 
 
5)  What is the overall Quality of Life (QoL) and perception of health of 
substance abusers starting residential substance abuse treatment? What 
is their domain-specific QoL (physical, psychological, social and 
environment)? What is the impact of the type of substance dependence 
on persons’ overall QoL and perception of health? Are psychiatric 
comorbidity, addiction severity and type of dependence independently 
linked to overall QoL and perception of health?  
 
Given the chronic nature of substance dependence and the various life domains it 
affects, there is a growing recognition that Quality of Life (QoL) can be a useful 
assessment tool and outcome measure in alcohol and drug treatment (Foster et 
al., 1999; Foster et al., 2000). QoL starts from a subjective and person-centred 
approach (Schalock et al., 2002) and is characterized by a multidimensional 
character that results in a holistic approach of an individual’s situation, having 
attention to problem areas as well as strengths in the individual’s life (Frost et 
al., 2007). In the previous studies, we predominantly examined whether alcohol-, 
drug- and dual-dependent patients differ with regard to socio-demographic and 
other characteristics and psychopathology. In this last study, we want to pay 
attention to the subjective perspectives of the individuals themselves, starting 
from the values, attitudes, beliefs and aspirations of the individual (Rapley, 
2003). In this fifth study, we want to evaluate persons’ QoL and simultaneously 
examine the independent impact of psychiatric comorbidity, addiction severity 
and type of dependence to determine the relative contribution of each factor. For 
this fifth study, we relied on the data gathered in function of the fourth study. 
The results of this study are reported in chapter 6 of this dissertation. 
 
 
1.5.3. Terminology 
 
As mentioned in the preface, the terminology across papers may differ due to the 
fact that papers were submitted to or published in different peer-reviewed 
journals with different guidelines for authors and editors’ requirements. 
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Terminology may also differ according to the measures and instruments that 
were used or to the setting in which individuals started alcohol or drug treatment.  
 
 
 Persons, clients and patients 
 
In the first two studies, we tried to consistently use the term “client” to refer to 
all persons who started either in- or outpatient treatment. In these studies, a wide 
variety of treatment modalities was included: both abstinence-oriented as well as 
harm reduction oriented and both categorical as well as mental health treatment 
settings) (cf. Chapters 2 and 3). Across these different modalities, the way that 
treatment-seeking persons are named or referred to can differ to a large extent, 
including residents (e.g. therapeutic communities), patients (e.g. psychiatric 
hospitals) or clients (e.g. outpatient centers for mental health care). Therefore, 
we have chosen for clients as the most neutral term. In the systematic review, we 
consistently referred to “individuals” or “persons” since this review not only 
reports findings on clinical samples but also on non-clinical samples (cf. Chapter 
4). In the fourth and fifth study on the other hand, rather the term “patient” was 
used (cf. Chapters 5 and 6). Individuals were interviewed in units for substance 
abuse treatment, situated within the walls of psychiatric hospitals, where the term 
‘patient’ was the common name.  
Overall, we have tried to stay as close as possible to the terminology as it was 
used in the treatment settings that participated in our studies. 
 
 
 Co-occurring alcohol and drug use problems 
 
Depending on the measure used in the various studies, we will refer to persons 
having problems with both alcohol and illicit drugs as “dual-dependent persons”, 
“dual substance abusers” or persons with co-occurring alcohol and (illicit) drug 
use problems.  
Following Gossop and colleagues (2002), in the fourth and fifth study of this 
dissertation we have used the term “dual-dependent” persons to refer to persons 
who are dependent on both alcohol as well as illicit drugs (cf. Chapter 5 and 6). 
More specifically, persons are concerned who meet the criteria for both DSM-IV 
current alcohol dependence as well as one of the following types of DSM-IV 
current drug dependence (amphetamines; cocaine; narcotics; hallucinogens; 
inhalants; cannabis; other substances). DSM-IV current substance dependence 
was assessed with the M.I.N.I. (Sheehan et al., 1998). However, only in case the 
dependence was related to an illicit drug (heroin, cocaine, amphetamines, 
ecstasy, hallucinogens, cannabis), this was regarded as dependence on an illicit 
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drug. In case the person was prescribed tranquillizers or other medication for 
medical or psychiatric reasons, it is possible that the person also meets the DSM-
IV criteria. However, in this dissertation being dependent on medication was not 
considered as dependence on illicit drugs (cf. definition of licit/illicit drugs in the 
WHO glossarium). Moreover, dependence on medicinal drugs is a huge point of 
discussion in the preparatory phase of the new DSM-5. In fact, for many years 
clinicians have pointed to the fact that the term “dependence” has a dual 
meaning. It not only refers to compulsive and uncontrolled drug-seeking 
behavior, but also refers to tolerance and withdrawal symptoms as normal 
adaptive processes that take place when medication is prescribed for depression, 
anxiety or pain treatment. This situation has led to confusion among medical 
doctors, who sometimes under-prescribed opioids for pain control for fear of 
creating “addiction” among their patients (Kranzler & Li, 2008; O’Brien, 2010). 
Therefore, the Working Group on Substance-Related Disorders now advises to 
no longer use the diagnosis “dependence” in the new DSM-5, nor for licit nor for 
illicit substances. Instead, the diagnosis “substance use disorder” is proposed. 
The option “with or without physiological dependence” will be kept, referring to 
the normal response to frequent use of certain substances. Furthermore, when the 
criteria tolerance and withdrawal symptoms are present in the context of 
appropriate medical treatment, they are not to be counted as symptoms for the 
diagnosis of a certain substance use disorder (O’Brien, 2010).  
 
In the second study (cf. Chapter 3) we use the term “dual substance abusers”, we 
refer to persons who have regularly (at least three days or two consecutive days a 
week) used both alcohol (>= 5 glasses) and illicit drugs (heroin, cocaine, 
amphetamines, ecstasy, hallucinogens, cannabis) in the three months preceding 
the intake interview. This criterion was derived from the substance use section in 
the European Addiction Severity Index (EuropASI) (Kokkevi & Hartgers, 1995). 
Overall, we consider the term dual-dependent persons as an internationally more 
comparable concept since most researchers use “dependence” more or less in the 
same manner, i.e. by using the criteria in the DSM-IV (Bergmark, 1998; 
Kranzler & Li, 2008). However, it was not possible to use a diagnostic 
instrument, such as the M.I.N.I., in all studies.  
 
The umbrella term “persons with co-occurring alcohol and (illicit) drug use 
problems” was used in the systematic review, introduction and conclusion of this 
dissertation to refer to all persons with both alcohol and drug use problems, 
whether or not this observation was based on formal screening or diagnostic 
instruments (cf. Chapter 1, 4 and 7). Besides this umbrella term, these chapters 
also used the terminology that was used by the cited authors themselves in order 
to stay as close as possible to the original papers.  
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Finally, in order to refer to illicit substances, we mostly used the term “illicit 
drugs” but in order to enhance the readability of our papers we often shortened to 
“drugs”. In other to refer to the whole of licit and illicit substances, we 
consistently used the term “substances”. 
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Abstract  
 
 
Background. Frequent and multiple service utilization among substance abusers 
is a well-known problem. However, little statistical evidence exists about 
overlapping agency populations.  
Methods. We studied this phenomenon in a clear-cut region in Belgium, based 
on intake information concerning all clients who addressed a drug treatment 
center within a 6-month period (n=1,139).  
Results. The results show that multiple service utilization during this particular 
registration period was rather common, though not omnipresent. Almost 15% of 
the clients were registered in more than one substance abuse treatment agency. 
Compared to single agency attendees, multiple agency clients appeared to be 
more often poly-substance abusers with a longer previous treatment history and 
greater problem severity.  
Conclusion. A continuous care perspective, interagency collaboration and a 
common tracking and documentation system are recommended to better address 
the needs of this specific subgroup of substance abusers. More research is needed 
to clarify whether these multiple service utilization patterns are caused by client-
related, agency-related or other factors. 
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2.1. Introduction 
 
 
Substance abuse is increasingly recognized as a chronic, relapsing disorder that 
is often accompanied by other significant problems such as unemployment, 
homelessness, poor (mental) health, relational conflicts, and problems with the 
courts (McLellan, Lewis, O’Brien, & Kleber, 2000). Although (spontaneous) 
recovery is possible (Bischof, Rumpf, Meyer, Hapke, & John, 2005; De Leon, 
1996), most clients’ treatment careers are characterized by various treatment 
episodes and utilization of a wide array of medical, social, and substance abuse 
services (Booth, Staton, & Leukefeld, 2001; Brindis & Theidon, 1997; Dennis, 
Scott, Funk, & Foss, 2005; Grella, Hser, & Hsieh, 2003; Keene & Bailey, 2000). 
 
 
2.1.1. Multiple and repeated service utilization among substance users  
 
Both the high relapse rates and prevalence of accompanying problems, make that 
substance abusers are known for their frequent and multiple service utilization 
(Sandell & Bertling, 1996). Particularly, frequent utilization of emergency 
rooms, crisis and detoxification centers, long-term inpatient treatment, and 
psychiatric services cause high health care costs (French, McGeary, Chitwood, & 
McCoy, 2000; Kent, Fogarty, & Yellowlees, 1995; McGeary & French, 2000; 
Rockett, Putnam, Jia, Chang, & Smith, 2005). Grella and colleagues (2003) have 
identified ethnicity, previous marriage, weekly cocaine use since discharge, and 
greater service needs at the start as important predictors of treatment re-entry in 
substance abuse agencies. Repeated use of detoxification centers has been 
associated with higher levels of depression, worse mental health, male gender, 
heroin as the main problem drug, and ethnic background (Shanahan et al., 2005). 
Lower treatment completion rates have been found among substance abusers 
with a higher number of previous residential treatment episodes (Ravndal, 
Vaglum, & Lauritzen, 2005). 
 
Despite much anecdotal evidence about persons who repeatedly use the same 
agency or a range of different agencies, relatively sparse empirical data are 
available about so-called “revolving door” or “shared” clients or “heavy users” 
(Keene, Bailey, Swift, & Janacek, 2000; Keene, Swift, Bailey, & Janacek, 2001; 
Kertesz, Horton, Friedmann, Saitz, & Samet, 2003; McCarty, Caspi, Panas, 
Krakow, & Mulligan, 2000; Roick, Gartner, Heider, & Angermeyer, 2002; 
Spiessl, Hubner-Liebermann, Binder, & Cording, 2002). This can be attributed to 
the lack of a common definition or operationalization of this phenomenon, little 
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specialist interest in this multi-problem population, and the lack of adequate 
research methods (Keene et al., 2001). 
A large-scale study in East England has indicated that about half of all clients 
(49%) contacting alcohol and drug agencies had been – in addition – registered 
at least once in another social or health care agency within a two-year period 
(Keene et al., 2000): 44% of all drug and 54% of all alcohol agency clients had 
used another agency, while 9.8% had used another drug agency, 0.7% another 
alcohol agency, and 5.2% both types of agencies in the same period (Keene & 
Bailey, 2000). Clients from alcohol and drug agencies who visited between 
seven and nine different agencies within this 2-year period had extensive police 
records, appeared frequently at emergency wards, and presented a combination 
of (mental) health and substance abuse problems. 
 
 
2.1.2. Towards more quality of health care 
 
During the past decades, quality of care has become a key issue in the 
organization and delivery of health services (Institute of Medicine, 2001). In 
various countries (e.g. Australia, Germany, the Netherlands, the United Kingdom 
and the United States) quality improvement became a major focus within the 
national health care policy and performance enhancing initiatives have 
increasingly been set up (McLoughlin, Leatherman, Fletcher, & Owen, 2001). 
Although no overall consensus exists regarding the meaning and definition of 
“quality” neither on how to measure quality, the American Institute of Medicine 
(IOM) has tried to introduce a global definition, which can now be considered 
one of the most widely cited (Blumenthal, 1996; Shaneyfelt, 2001). The IOM 
defines quality as: “the degree to which health services for individuals and 
populations increase the likelihood of desired health outcomes and are 
consistent with current professional knowledge” (Lohr, 1990, p.128). Quality of 
care is generally acknowledged to be a very complex and multifaceted concept 
(Blumenthal, 1996). Therefore, it is usually further specified and operationalized 
according to the specific characteristics of the situation in which it is applied, 
e.g. the level (micro, meso or macro) (Evans, Tan-Torres Edejer, Lauer, Frenk, 
& Murray, 2001).  
 
An important element in the discussion concerning quality of care is the fact that 
over the past decades, the needs of the population have shifted from acute care to 
care for chronic conditions. After all, chronic illnesses often imply the presence 
of accompanying problems and the involvement of various treatment providers, 
which makes that more sophisticated mechanisms are required for the co-
ordination of care (Institute of Medicine, 2001). Since substance dependence can 
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be regarded as a chronic relapsing disorder (McLellan et al., 2000; O’Brien & 
McLellan, 1996), co-ordination of care will become a key ingredient of quality 
of care for this specific population (Matlow, Wright, Zimmerman, Thomson, & 
Valente, 2006), besides the continuity, effectiveness and efficiency of care (De 
Weert-van Oene & Schrijvers, 1992). These four dimensions do not stand alone, 
but are to a large extent interconnected since, for example, greater continuity of 
care is associated with better co-ordination of care (Christiakis, Wright, 
Zimmerman, Bassett, & Connell, 2003).  
 
According to Lindeke and colleagues (Lindeke, Leonard, Presler, & Garwick, 
2002, p.290), co-ordination of care can be regarded as a complex process 
involving “assessment, planning, implementation, evaluation, monitoring, 
support, education, and advocacy”, which takes place within and across services. 
The idea of co-ordination of care is rather opposite to the traditional way that 
health care providers think and act and to the development and organization of 
health care systems in most countries. Typically treatment providers tend to 
operate as so-called separate “silos”, without having all relevant client 
information at their disposal (Institute of Medicine, 2001). Also substance abuse 
treatment agencies operate in a similar way and often rather resemble a 
patchwork than a well-coordinated network of services. Lack of follow-up, no 
standardized registration forms, little systematic transfer of information and 
inadequate communication between services, illustrate the absence of co-
ordination of care (Vanderplasschen, De Bourdeaudhuij, & Van Oost, 2002). 
  
 
2.1.3. Aims of the study 
 
Due to the deinstitutionalization of (mental) health care, specialized services 
were established for specific problems, increasing the probability of contacts 
with various agencies in case of multi-faceted and lasting problems. The more 
service providers that are involved in the treatment process, the greater the risk 
that the communication and collaboration between these services will not run 
smoothly. Consequently, not only the co-ordination of care, but also other 
aspects of the quality of care can be jeopardized. Furthermore, in an era of cost 
containment and increased focus on effectiveness and efficiency, questions can 
be raised concerning the application of scarce resources and the utilization of 
treatment services by substance abusers. Although relapse is considered a part of 
the natural course of substance abuse, unplanned utilization of multiple agencies 
at the same time or in short succession can be regarded as problematic (Swart, 
2005).  
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Since multiple agency attendees appear to make disproportionate use of available 
services and resources, accurate information is needed about the nature and 
extent of clients contacting simultaneously or within a short time on various 
agencies. Moreover, as traditional treatment agencies have proven to be 
relatively ineffective for this population (Keene et al., 2001; McCarty et al., 
2000; Okin et al., 2000; Roick et al., 2002; Thornquist, Biros, Olander, & 
Sterner, 2002), alternative approaches for dealing with this problem are needed. 
Therefore, the aim of this study was to collect empirical data in the clear-cut 
region of Ghent (Belgium) on the number of substance abusers that call upon 
various substance abuse agencies for treatment, their characteristics, and 
treatment utilization. Moreover, we wanted to explore factors that could 
differentiate between clients who asked for treatment in various substance abuse 
agencies within a relatively short period of time and those who did so in one 
single service. Ultimately, these empirical data should contribute to a better co-
ordination of service provision and to more quality of care for substance abusers 
(Broekaert & Vanderplasschen, 2003; Institute of Medicine, 2001; Thornquist et 
al., 2002).  
 
 
2.2.  Materials and methods 
 
2.2.1.  Sample  
 
The study sample consisted of all clients (n=1,139) who had an initial intake 
interview in a drug treatment center between December 3, 2001, and May 31, 
2002, due to problems with illicit substances. Given the separation of alcohol 
and drug treatment in Belgium, clients with alcohol and/or medication problems 
only were not included in the study. All 18 specialized treatment agencies for 
drug abusers in the region around Ghent (East Flanders, Belgium) participated in 
the study: two crisis and detoxification centers, three therapeutic communities, 
four psychiatric hospitals, two methadone clinics, and seven outpatient 
counseling centers. This specific region was selected for its density and diversity 
of treatment agencies, resulting in problems concerning continuity and co-
ordination of care according to caregivers (Vanderplasschen et al., 2002). These 
18 treatment centers were grouped into four clusters of services, based on the 
clusters distinguished in the Drug Abuse Treatment Outcome Study (DATOS) 
(Anglin, Hser, & Grella, 1997): outpatient drug-free treatment (=counselling 
centers (n=7)), outpatient substitution therapy (=methadone maintenance 
treatment) (n=2), detoxification treatment (n=2), and long-term inpatient 
treatment (=addiction units in psychiatric hospitals and therapeutic communities 
for substance abusers (n=7)).  
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2.2.2. Procedure and instrument 
 
Client information was registered during the initial intake interview, which was 
defined as the first face-to-face contact between a client and a health care 
professional (e.g., psychologist, social worker, counselor) in order to bilaterally 
exchange information. Since information was gathered and registered by 
practitioners, this contributed to the collection of high-quality data by persons 
specialized in this field and with close contacts with clients (Simon et al., 1999). 
On the other hand, registration by practitioners includes the risk of so-called 
“registration fatigue,” while staff turnover and the involvement of various 
persons registering may hamper perfect standardization of registration 
procedures (Soldz, Panas, & Rodriguez-Howard, 2002). These issues were 
addressed by limiting the registration to a six-month period, organizing several 
training sessions, giving financial incentives, elaborating an extended 
registration manual, and providing a helpdesk where practitioners could get 
prompt answers to their questions (Vanderplasschen, Colpaert, Lievens, & 
Broekaert, 2003). Furthermore, after finishing the research project, individual 
feedback was provided to all participating treatment agencies regarding the 
number and characteristics of their respective client populations, which could 
serve future service planning and development. 
 
Each agency sent the registration sheets on a monthly basis to the researchers, 
who entered the data in SPSS and performed a thorough data quality check. If 
necessary, the sheets were sent back to the person responsible for the registration 
in the center to be completed or corrected.  
  
In Belgian substance abuse treatment centers, a variety of treatment demand 
registration systems are applied (Colpaert & De Clercq, 2003). Although these 
systems adhere to the same objectives and share some common features, large 
differences exist with regard to the concrete architecture and functioning of these 
systems (e.g. inclusion criteria, variables registered, registration guidelines, 
operationalization of the variables). Due to the lack of a common registration 
instrument and the considerable differences between the existing systems, it 
appeared impossible to use existing treatment demand data through extraction or 
recoding procedures. Therefore, a specific registration instrument was developed 
for this study that reflected the core variables of the existing systems and the 
“Treatment Demand Indicator”-protocol. As this was an additional registration 
(besides the already-existing registration in each agency), only a limited number 
of variables was collected: socio-demographic data (sex, age, place of residence), 
treatment history (new client in this agency, other previous treatment episodes), 
substance-related information (use and dependence of various types of 
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substances, primary drug), injecting behavior (ever, during the last 12 months), 
and information on the current treatment demand (source of referral, outcome of 
the intake interview). A number of these variables are consistent with the 
“Treatment Demand Indicator”-protocol of the Pompidou Group/European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA), namely sex, age, 
treatment history, ever injected and primary drug (Simon et al., 1999).  
 
All treatment agencies were involved in the development and elaboration of the 
instrument and research design, in order to enhance participation. Since existing 
registration systems in Belgium do not make use of a common encrypted client 
code, double/multiple counts cannot be eliminated and may bias reported data. In 
other European cities and countries, this issue also appeared difficult to address, 
among others, due to legal limitations (Simon et al., 1999). In order to detect 
multiple agency users without violating clients’ privacy, a unique client identifier 
was introduced for this study which permitted tracking of individuals across 
treatment episodes and agencies. This identifier, in combination with other stable 
client information (e.g., age and sex), was used for eliminating multiple counts. 
Although some double counts will not have been recognized as such, absolute 
perfection is neither possible nor required (Stauffacher & Kokkevi, 1999). After 
all, the purpose was to reduce the probability of the number of multiple counts to 
a level that is a good estimation of the true number of unique clients (Simon et 
al., 1999).  
 
 
2.2.3. Data analysis 
 
After eliminating multiple countings from the original sample, frequencies and 
descriptive statistics were calculated for all variables. Subsequently, single and 
multiple agency attendees were compared on a number of variables. “Multiple 
agency attendees” were defined as clients who had (an) intake interview(s) in 
more than one of the 18 participating treatment agencies within the six-month 
registration period. “Single agency attendees,” on the other hand, were defined as 
clients who had one (or more) intake interview(s) in only one treatment agency. 
Chi-square tests were calculated from two-by-two contingency tables to test the 
significance of any independent differences with respect to categorical variables. 
T-tests for unpaired samples were used to test the significance of differences 
between the two groups with respect to the continuous variables. A p-value of 
5% was considered statistically significant.  
 
After the univariate comparisons, the variables that differed significantly 
between the two groups were entered in a stepwise logistic regression, in order to 
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assess their predictive value. When comparing single agency and multiple 
agency users, incomplete registration forms were excluded from the analysis. For 
client characteristics, analyses were based on the database with unique clients; 
for variables related to the intake interview or treatment started, analyses were 
based on the total database of all treatment demands. Unless mentioned 
otherwise, all percentages should be read as valid percentages.  
 
 
2.3. Results 
 
2.3.1.  Sample description and overlap between agencies  
 
During the six-month registration period, 1,500 registration forms were filled 
out, representing all treatment requests of clients asking for treatment in one of 
the 18 participating treatment agencies in the province of East Flanders. Almost 
two-thirds (60.9%) of all intake interviews occurred in residential facilities, 
39.1% in outpatient agencies.  
 
After a careful analysis of possible multiple countings on the basis of the unique 
client identifier, it was concluded that these 1,500 treatment demands concerned 
1,139 unique clients. 79.9% were men, 20.1% women. The mean age was 26.1 
years old. More than two-thirds (69.4%) of the people registered were living in a 
radius of about 30 kilometers around Ghent. Overall, cannabis was the most 
frequently used illicit substance (81.1%), followed by opiates (65.7%), cocaine 
(56.9%), amphetamines (35.8%), and ecstasy (32.2%). In addition, the regular 
consumption of legal substances such as alcohol (56.4%) and tranquillizers 
(43.0%) was fairly high in this population of illicit drug users. Almost three-
quarters (74.9%) had regularly used more than one substance in the three months 
preceding the intake interview and were regarded as poly drug users. 
 
During the six-month registration period, the vast majority (80.8%) of all 1,139 
unique clients was registered only once, while 147 (12.9%) were registered 
twice, 43 (3.8%) three times, and 29 (2.6%) four or more times. Consequently, 
219 clients (19.2%) accounted for 38.7% (n=580) of all intake efforts. Some of 
these clients always called upon the same agency (n=55; 25.1%), while most 
clients contacted various treatment centers (n=164; 74.9%) and could be 
described as an “overlapping agency population”. Of these 164 clients, 130 
(79.3%) were registered in two agencies, 26 (15.9%) in three, and 8 (4.9%) in 
four or more agencies. According to the definitions provided in the 
methodological section of this article, 164 clients can be considered “multiple 
agency attendees” and 975 as “single agency attendees”. 
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2.3.2. Overlap between treatment clusters 
 
Of the 586 intake interviews that were registered in outpatient facilities, the 
majority (66.9%) was registered in drug-free outpatient treatment centers, while 
about one-third (32.1%) of all clients were registered in outpatient methadone 
treatment. More than half (59.1%) of all 914 residential intake assessments were 
registered in crisis and detoxification centers, while 40.9% took place in long-
term treatment centers (≥ 3 months). The majority of all 164 multiple agency 
users contacted services from at least two clusters: two (79.9%), three (6.1%), or 
four (0.6%). 13.4% had intake interviews in various agencies within the same 
cluster.  
 
About one-quarter of all clients entering methadone substitution treatment or 
detoxification treatment were also registered in another cluster of treatment 
services (cf. table 2.1.). One-third (33.3%) of all clients who followed long-term 
residential treatment also contacted agencies from another cluster. 
Further analysis reveals that multiple agency use especially concerns overlap 
between residential detoxification and long-term treatment (87 clients), followed 
by outpatient substitution and residential detoxification (19 clients) and the 
clusters outpatient substitution and outpatient drug-free treatment (18 clients) (cf. 
table 2.2.).  
 
Table 2.1.: Clients registered in one versus multiple clusters 
  
Number of unique 
clients only in this 
cluster 
 
Number of unique 
clients in this and in 
at least one other 
cluster 
 
Total number of 
unique clients in 
this cluster 
 
 n % n % n 
      
Outpatient Drug-Free 346 90.1 38 9.9 384 
Outpatient Substitution 143 76.9 43 23.1 186 
Inpatient Detoxification 297 73.2 109 26.8 406 
Inpatient Long-Term 211 66.6 106 33.3 317 
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Table 2.2.: Overlap between the different treatment clusters 
 
 
Outpatient 
Drug-Free 
(n=384) 
n (%) 
Outpatient 
Substitution 
(n=186) 
n (%) 
Inpatient 
Detoxification 
(n=406) 
n (%) 
Inpatient 
Long-term 
(n=317) 
n (%) 
     
Outpatient Drug-Free - 18 (9.7) 15 (3.7) 12 (3.8) 
Outpatient Substitution 18 (4.7) - 19 (4.7) 16 (5.1) 
Inpatient Detoxification 15 (3.9) 19 (10.2) - 87 (27.4) 
Inpatient Long-Term 12 (3.1) 16 (8.6) 87 (22.6) - 
     
 
 
2.3.3. Differences between single and multiple agency clients 
 
   Characteristics 
 
Multiple agency users were not significantly different from single agency users 
regarding age and gender (cf. table 2.3.), but significant differences were 
observed concerning the use of substances. A significantly larger percentage of 
the overlapping agency population regularly used cocaine (Chi²=15.173; df=1; 
p=.000), opiates (Chi²=14.453; df=1; p=.000), and tranquilizers (Chi²=12.901; 
df=1; p=.000). However, no such differences could be observed concerning 
substance dependence. Multiple agency users had significantly more often 
“multiple substances” as their primary drug (Chi²=11.260; df=1; p=.001), while 
single agency attendees used significantly more cannabis as their primary drug 
(Chi²=16.787; df=1; p=.000). Moreover, the overlapping agency population was 
more apt to have injected drugs (Chi²=13.799; df=1; p=.000) and significantly 
more multiple agency clients already had a previous treatment history 
(Chi²=32.378; df=1; p=.000).  
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Table 2.3.: Differences in socio-demographic and substance-related variables between 
single agency and multiple agency attenders 
 
 Single agency 
users 
(n=627) 
 
Valid % 
Multiple agency  
users 
(n=111) 
 
Valid % 
     
Gender     
Male 80.4 76.6 
Female 19.6 23.4 
     
Age     
< 19 18.3 10.8 
20-29 53.6 56.7 
30-39 22.2 27.9 
> 40 5.9 4.5 
     
Mean age 26.20 year 26.89 year 
     
Treatment history **     
No 35.2 8.1 
Yes 64.8 91.9 
     
Substances used     
Alcohol 53.3 55.6 
Amphetamines 31.9 36.8 
Cannabis 78.3 84.6 
Cocaine ** 51.4 72.9 
Hypnosedatives ** 36.1 56.0 
Methadone 22.4 31.6 
Opiates ** 61.7 81.6 
Ecstasy 28.2 28.6 
     
Primary drug     
Alcohol 5.9 6.3 
Amphetamines 7.0 6.3 
Cannabis ** 22.2 5.4 
Cocaine 5.7 8.1 
Opiates 29.8 32.4 
Multiple ** 23.6 38.7 
Other 5.8 2.8 
     
Ever injected ** 38.0 56.8 
     
** p<0.01     
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All variables identified in the bivariate analyses as being significantly associated 
with having had intake interviews at multiple centers were entered in a binary 
logistic regression, except for the variables related to the use of substances. Since 
poly drug use was the rule (74.9%) rather than the exception, we assumed that 
“primary drug” would be a better variable to discriminate between single and 
multiple agency clients. In the best-fit model, data on 738 unique clients were 
included in the analysis. Two variables emerged as significant determinants for 
multiple service use within a six-month period (cf. table 2.4.). Clients who 
already had a treatment history were five times more likely (OR=5.090, 95% 
CI=2.474 - 10.472) to have contacted various treatment services, whereas clients 
with cannabis as their primary drug were three times less likely to have been 
registered by more than one agency (OR=.306, 95% CI= 0.124 - 0.752). 
 
Table 2.4.: Binary logistic regression predicting multiple service utilization by 
demographic variables, treatment history, substance use and injecting 
behavior 
 Β SE Wald Exp(β) p 
      
Sex: male -.189 .257 .538 .828 .463 
Age -.016 .016 1.054 .984 .305 
Treatment history: yes 1.627 .368 19.542 5.090 .000 
Cannabis as primary drug -1.186 .460 6.649 .306 .010 
Multiple substances as primary drug .388 .231 2.828 1.475 .093 
Ever injected: yes .173 .233 .553 1.189 .457 
      
 
 
   Treatment utilization during the six-month registration period 
  
Compared with clients who were treated in only one agency, multiple agency 
clients were significantly less likely to contact drug-free outpatient centers 
(Chi²=96.797; df=1; p=.000), but were more likely to have had an intake 
interview in a residential detoxification unit or long-term treatment center (cf. 
table 2.5.) (Chi²=15.735; df=1; p=.000; Chi²=39.021; df=1; p=.000). Multiple 
agency users contacted an agency significantly more often on their own initiative 
(Chi²=6.625; df=1; p=.010) or were referred by a specialized substance abuse 
treatment center (Chi²=22.855; df=1; p=.000). On the other hand, single agency 
users were more often sent to treatment by their social network (Chi²=7.451; 
df=1; p=.006), school (Chi²=11.542; df=1; p=.001), or general practitioner 
(Chi²=13.991; df=1; p=.000). Finally, intake interviews with multiple agency 
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attendees – as compared to single agency users – did not result more often in the 
effective start of a treatment episode. 
 
Table 2.5.: Differences in treatment utilization between single agency and multiple 
agency attenders 
 
  
Treatment demands 
of single agency users 
(n=995) 
 
Valid % 
 
Treatment demands of 
multiple agency users 
(n=451) 
 
Valid % 
   
 
Type of agency 
  
Outpatient drug-free ** 33.6 9.1 
Outpatient substitution  12.9 11.1 
Inpatient detoxification ** 33.1 43.9 
Inpatient long-term ** 20.5 35.9 
   
Source of referral   
No source of referral * 31.5 38.4 
Immediate surroundings ** 10.2 5.8 
Police or justice 19.0 15.7 
Specialized S.A.T.C. ** 13.1 23.1 
General hospital 2.5 2.7 
General practitioner ** 6.7 2.0 
Psychiatric hospital 4.2 5.8 
School ** 3.0 0.2 
Other 9.8 6.3 
   
Outcome of intake   
Start of treatment 81.2 82.4 
Immediate referral 6.8 8.9 
Without consequence 12.0 8.7 
   
* p<0.05, ** p<0.01   
   
 
All variables identified in the bivariate analyses as being significantly associated 
with having had an intake interview at various agencies were entered in a binary 
logistic regression. In the best-fit model, data on 1,445 treatment demands were 
included in the analysis. Four variables emerged as significant determinants for 
multiple service use within a six-month period (cf. table 2.6.). Clients who had 
an intake interview in an outpatient drug-free facility were almost three times 
less likely to be multiple agency users (OR=.337, 95% CI= 0.210 - 0.540), while 
for clients registered in residential long-term treatment the odds were almost two 
times higher (OR=1.937; 95% CI=1.305 - 2.876). In addition, clients referred by 
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a specialized substance abuse treatment center were 1.7 times more likely to 
contact various agencies (OR=1.710; 95% CI=1.212 - 2.411), while clients 
referred by a general practitioner were nearly 2.5 times less likely to be multiple 
agency users (OR=.418; 95% CI=0.199 - 0.880).  
 
Table 2.6.: Binary logistic regression predicting multiple service utilization by 
demographic variables, type of agency and source of referral  
 Β SE Wald Exp(β) p 
      
Sex: male -.062 .150 .169 .940 .681 
Age  -.005 .009 .313 .995 .576 
Type of agency:  
outpatient drug-free 
-1.089 .241 20.415 .337 .000 
Type of agency:  
inpatient long-term 
.661 .202 10.748 1.937 .001 
Type of agency:  
inpatient detoxification 
.330 .194 2.889 1.392 .089 
Source of referral:  
none 
.152 .150 1.025 1.164 .311 
Source of referral:  
immediate surroundings 
-.261 .253 1.068 .770 .301 
Source of referral:  
specialized substance abuse treatment 
.536 .175 9.339 1.710 .002 
Source of referral:  
general practitioner 
-.872 .380 5.269 .418 .022 
      
 
 
2.4.  Discussion 
 
2.4.1.  Nature and extent of the problem 
 
This study has shown that within a short period of time (six months), almost 15% 
of all clients registered in drug abuse treatment in the region around Ghent had 
an intake interview in more than one treatment agency. Similarly, the “tracking 
project” in the United Kingdom demonstrated that drug and alcohol agency 
clients cause a lot of overlap between health care and social welfare services 
(Keene & Bailey, 2000) and that about 15% of them also contacted at least two 
specialist drug/alcohol agencies within a two-year period (Keene et al., 2000). 
Although the reference period in our study was much shorter, parallel outcomes 
of both studies suggest that multiple agency attendance and re-admissions 
usually occur within a short period after the first contact with an alcohol or drug 
abuse agency (Swart, 2005).  
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These data further confirm the anecdotal observation that multiple service 
utilization and overlapping agency populations are rather common (Sandell & 
Bertling, 1996), though not omnipresent among substance abusers. Still, 
caregivers from treatment centers around Ghent estimated the extent of this 
phenomenon to be much bigger (Vanderplasschen et al., 2002). This 
overestimation may be caused by the fact that these clients accounted for almost 
one-third of all treatment requests during this registration period and, therefore, 
put a heavy burden on treatment services. In addition, these caregivers 
experienced the treatment of these clients as frustrating and challenging, since 
standard treatment usually fails with this population (Thornquist et al., 2002).  
Overlapping agency populations can be considered a complicating factor for 
good co-ordination of care and may complicate quality of care, certainly if these 
contacts with other agencies are “unplanned” or do not meet clients’ treatment 
needs (Swart, 2005). Clients in outpatient drug-free treatment had significantly 
fewer contacts with agencies in other treatment clusters than those in long-term 
residential treatment. Also, one in four clients in substitution and detoxification 
treatment had contacts with at least one agency from another cluster. Most 
overlap was observed between detoxification and long-term inpatient agencies, 
which suggests that many clients continue with long-term residential treatment 
(e.g., in a therapeutic community or psychiatric hospital) after detox. Overlap 
between these clusters may suggest a lot of “planned” referrals, but the fact that 
decisions to end treatment episodes are often unilaterally taken, the high number 
of self-referrals and a substantial amount of re-admissions rather indicate the 
opposite.  
 
Consequently, communication between agencies at referral and regular 
interagency client meetings are recommended to improve co-ordination of care 
(Vanderplasschen et al., 2002). Unplanned, multiple agency attendance suggests 
a lack of co-ordination of care across treatment agencies and inadequate and 
inefficient use of staff and resources. For, intake assessments can take a few 
hours and this procedure is often repeated all over again in another agency 
without any communication between the two. This may cause a great deal of 
displeasure and frustration among clients and caregivers, while coordinated and 
planned efforts (including clear responsibilities and arrangements) generate 
better results (Sandell & Bertling, 1996). 
Besides these structural adaptations, an alternative vision and approach to 
substance abuse problems are needed, since multiple treatment episodes can be 
regarded as evidence of chronicity (Dennis et al., 2005). Still, an abstinence-
oriented approach (detox followed by residential treatment) predominates in 
Belgian substance abuse treatment, while longer term recovery management 
models and a continuous care perspective are probably more appropriate 
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approaches to this problem (Dennis et al., 2005; Grella et al., 2003; McLellan, 
2002; Ravndal et al., 2005). 
 
 
2.4.2. Characteristics of multiple agency attendees 
 
This comparison of single and multiple agency attendees has shown that the 
former group consists of drug abusers who address drug-free outpatient centers, 
have cannabis as their primary drug, and are referred to treatment by their 
family, friends, or general practitioner. Single agency attendees are generally 
substance abusers at the beginning of their treatment career, with (still) 
significant social support and relatively few accompanying problems. On the 
other hand, multiple agency attendees more often contacted residential agencies; 
were more likely to use cocaine, opiates, and sedative drugs; and more often had 
a previous treatment history. Although relatively few variables were studied in 
this study, it appeared that drug use severity and a previous treatment history are 
associated with multiple agency attendance rather than socio-demographic 
characteristics (Keene et al., 2000). Similarly, Tomasson and Vaglum (Tomasson 
& Vaglum, 1998) found that re-admissions were related to poly-substance abuse 
and that the development of a revolving door career was rare among persons 
with less than four previous admissions.  
 
No information concerning clients’ mental health could be obtained, but multiple 
agency attendees had been previously treated significantly more often in 
psychiatric hospitals, suggesting a higher prevalence of mental health problems 
(Kertesz et al., 2003; Shanahan et al., 2005). Overall, relatively few differences 
between single and multiple agency attendees emerge from this study, so that 
only few guidelines can be provided to screen at-risk clients during intake 
assessments. Multiple agency attendees tend to be poly-substance users with 
multiple and complex problems and an extensive treatment history (Keene et al., 
2001; Tomasson & Vaglum, 1998). A comprehensive, coordinated and 
continuous approach – instead of isolated efforts of various agencies – seems 
best suited to address multiple agency attendees. 
 
Although this study was targeted at drug treatment centers, a large proportion of 
these clients (almost two thirds) also used legal substances (alcohol and/or 
tranquillizers) regularly. No detailed measures were used with regard to 
frequency, amount and patterns of alcohol use, but this finding is consistent with 
international literature, which indicates that many drug users are drinking 
excessively (Gossop et al., 2002; Stinson et al., 2005). Even though we found no 
differences between single and multiple agency users with regard to alcohol use 
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or dependence, other authors have demonstrated that those who are dependent on 
illicit drugs and alcohol have higher rates of psychiatric disorders and are in 
higher need of mental health services (Kandel, Huang, & Davies, 2001). 
Therefore, standard screening of (severity of) alcohol problems among drug 
abusers, based on standardized instruments is recommended, as well as screening 
for polydrug use and dependence (Gossop, 2001). 
 
Since high proportions of drug and alcohol agency clients attend other (mental) 
health care and social services (Gossop, 2001) and since one in seven drug 
abusers contact various treatment agencies within a relatively short period of 
time, co-ordination of care is required in and between specialized treatment 
agencies and other services involved (Vanderplasschen et al., 2002). The 
importance of co-ordination of care is illustrated by recent health care and social 
welfare reforms in several European countries (e.g., Germany, Norway, the 
Netherlands, Denmark). Also, in Belgium the field of mental health care is 
gradually being reorganized into integrated treatment systems (“zorgcircuits”) 
that should provide an encompassing answer to the treatment needs of particular 
target groups, e.g., substance abusers (Broekaert & Vanderplasschen, 2003).  
 
In the region of Ghent, this resulted in the development of a network of services, 
including all specialized drug abuse agencies and some social and health care 
agencies, that plans and monitors the organization of substance abuse treatment. 
Two interventions have been set up to improve co-ordination and continuity of 
care: (1) structural interagency care co-ordination and (2) intensive case 
management. The former condition includes tri-weekly meetings of caregivers 
from several specialized treatment agencies to discuss and monitor admissions 
and referrals of and services delivered to “shared clients.” This strategy should 
result in a coordinated approach and monitoring of multiple agency attendees to 
avoid these clients receiving episodic, non-continuous, and inadequate care (Cox 
et al., 1998). Intensive case management is characterized by a comprehensive, 
individualized, and continuous approach, assertive outreach, and the provision of 
direct services by one single case manager. This intervention is specifically 
targeted at the so-called revolving door clients, since some evidence is available 
that it is effective for reducing the use of expensive inpatient services, enhancing 
participation in community-based services, and stabilizing and improving 
clients’ situations (Kertesz et al., 2003; Okin et al., 2000; Thornquist et al., 2002; 
Witbeck, Hornfeld, & Dalack, 2000). 
 
Other authors have suggested establishing multidisciplinary working, 
particularly between specialist substance abuse agencies and emergency 
departments and mental health teams (Gossop, 2001). Common screening 
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instruments and multi-agency assessment procedures should be developed to 
enable different agencies and professionals to recognize common clients. In 
some places this has resulted in the organization of centralized intake units to 
improve initial treatment access and avoid multiple service utilization, but its 
influence on subsequent service utilization and treatment retention is limited 
(Scott, Sherman, Foss, Godley, & Hristova, 2002). Also, the development of 
common electronic client files may contribute to the provision of unfragmented 
and coordinated care in case of multiple service utilization.  
 
 
2.4.3.  Limitations of the study 
 
This study fills an important gap in our knowledge about overlapping 
populations in substance abuse agencies, but some limitations need to be 
reported. 
 
First, the cross-sectional snapshot design did not allow the monitoring of trends 
over time and only gives an indication about interagency overlap within a short 
period of time (i.e., six months). At best, this phenomenon is studied from a 
longitudinal perspective so the trajectories of clients can be studied over time 
and the organization of treatment can be adapted accordingly. 
 
Second, we solely focused on (a variety of) drug abuse agencies, while these 
clients also have many contacts with emergency wards, judicial agencies, 
homeless shelters, and other social services (Gossop, 2001; Weisner & Schmidt, 
1995). Since the role of drug and alcohol abusers in overlapping agency 
populations has already been studied by other authors, we looked in detail at 
drug abusers in specialized agencies. This specific population was addressed 
because multiple service utilization particularly occurs among drug abusers (who 
also abuse alcohol) and because alcohol and drug treatment are two clearly 
distinguished systems in Belgium. When developing multidisciplinary working, 
non-specialized agencies should also be involved. 
 
Thirdly, only a limited number of variables was registered. In order to 
distinguish single and multiple agency attendees, more in-depth information is 
required, e.g., concerning the mental health status, patterns of alcohol use, social 
support, treatment history, and judicial situation. Some predictors or facilitating 
factors of multiple agency attendance can be derived from this and previous 
studies, but the best way to recognize shared clients is to develop a common 
screening instrument and assessment protocol that will enable the identification 
of persons who contact other agencies, without violating their privacy and with 
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respect for the professional secrecy (e.g., by using an encrypted identifier). Early 
identification is necessary in order to offer them alternative services that better 
meet their specific conditions and prevent inadequate heavy use of expensive 
services (Roick et al., 2002). Moreover, a better understanding of those who 
engage in a persistent pattern of seeking services may assist in care planning that 
is better suited for clients’ needs (Montgomery & Kirkpatrick, 2002). 
 
Finally, the underlying reasons for multiple agency use remain unclear. It may be 
that clients are deliberately referred to other agencies, that more than one agency 
is required to meet clients’ complex problems, or that clients use the available 
services inefficiently. None of these hypotheses can be rejected since the logistic 
regression showed that multiple agency attendees go to treatment significantly 
more often on their own initiative (which indicates unplanned service 
utilization), but – on the other hand – they are more often referred by other 
specialized treatment agencies (which suggests a deliberate referral policy). 
These issues should be further explored through in-depth, qualitative interviews 
with multiple agency attendees about their treatment needs and argumentation 
for addressing various agencies within a short period of time. Up to now, 
available research has predominantly focused on issues related to treatment 
access and participation and client satisfaction (De Wilde & Hendriks, 2005), but 
to a lesser extent on patterns of treatment utilization and underlying motives for 
it (Copeland, 1997; Drumm et al., 2003). Finally, it is recommended to also 
assess characteristics of organizations and treatment systems – such as 
ownership, affiliation, organizational resources, leadership, professionalism, 
program philosophy, and connectedness between agencies – since these are 
clearly associated with service utilization (Friedmann, Alexander, & D’Aunno, 
1999; North, Pollio, Perron, Eyrich, & Spitznagel, 2005). For example, high 
levels of staff organization have been associated with less concurrent treatment 
contacts and more co-ordination of care (Sandell & Bertling, 1996). 
 
 
2.5.  Conclusion 
 
This study fills an important gap, because it provides some empirical data on 
multiple service utilization and overlapping populations in specialized drug 
abuse treatment. The extent of multiple agency attendance is relatively small, but 
this population is extremely resource-intensive for each specialist agency since – 
in the absence of co-ordination of care (e.g. good communication and 
multidisciplinary cooperation) – a lot of time is spent on repeated intake 
assessments and treatment planning. As compared with single agency attendees, 
multiple agency attendees are poly-substance abusers with greater problem 
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severity and more previous treatment contacts. Adequate screening and 
assessment procedures are necessary to identify this at-risk population and to 
better match the interventions from various agencies or to tailor services to the 
needs of this particular group. Multidisciplinary interagency meetings, intensive 
case management, and a common registration, tracking and documentation 
system across agencies all contribute to a better co-ordination of care, and 
consequently to improved quality of care.  
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Abstract 
 
 
Background: High comorbidity exists between alcohol and drug-related 
disorders. However, little information is available on characteristics of clients 
abusing both alcohol and illicit drugs (so-called dual substance abusers).  
Method: The proportion of dual substance abusers and their characteristics are 
examined in a sample of 1,626 clients seeking treatment in one of the 16 
participating centers in the province of Antwerp (Belgium).  
Results: More than a quarter of all clients were identified as dual substance 
abusers. Their characteristics correspond better to those of drug abusers than to 
those of alcohol abusers, but compared to the former, they are younger, more 
often male, use more types of illicit substances and more often use stimulating 
substances.  
Discussion: Alcohol is often underestimated in substance use patterns. Thorough 
alcohol assessment, early intervention but also preventive actions are needed 
within the drug treatment system and closer collaboration with the alcohol 
treatment system is absolutely essential.  
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3.1.  Introduction  
 
3.1.1.  Comorbidity between Alcohol- and Drug-Related Disorders in the 
General Population  
 
In large epidemiological studies among the general population, high levels of 
comorbidity between DSM-IV alcohol and drug disorders were found, which can 
be considered a specific type of homotypic (“occurrence of disorders within the 
same diagnostic class”) comorbidity (Angold, Costello & Erkanli, 1999; Stinson 
et al., 2005). Results from the cross-sectional 2001-2002 National Epidemiologic 
Survey on Alcohol and Related Conditions (NESARC) show that 55.2% of the 
persons who had a drug-related disorder in the past year also had an alcohol-
related disorder in that same period, and that 13.0% of those with an alcohol-
related disorder were also diagnosed with a drug-related disorder (Stinson et al., 
2005). Similar conclusions were drawn from the 1992 National Longitudinal 
Alcohol Epidemiologic Survey (NLAES) regarding lifetime prevalence figures: 
69.4% of the respondents with a lifetime drug use disorder were also diagnosed 
with an alcohol use disorder. Conversely, 23.1% of all respondents with a history 
of an alcohol use disorder had also suffered at some time from a drug use 
disorder (Grant & Pickering, 1996). In Australia, Canada, and Europe, 
conclusions regarding this form of homotypic comorbidity went in the same 
direction (Bijl, Ravelli & van Zessen, 1998; Burns & Teesson, 2002; Degenhardt 
& Hall, 2003; Ross, 1995). 
 
 
3.1.2.  Comorbidity between Alcohol- and Drug-Related Disorders in Substance 
Abuse Treatment Samples  
 
Studies carried out in clinical settings resulted in similar findings. First, various 
studies among drug treatment populations have demonstrated high rates of high-
risk drinking and alcohol dependence (Gossop, Marsden, Stewart & Rolfe, 2000; 
Miller, Klamen, Hoffman & Flaherty, 1996; Smart, Ogborne & Newton-Taylor, 
1990). Especially among clients in methadone treatment programs, heavy 
drinking has been identified as a substantial problem (Best et al., 1998; 
Hillebrand, Marsden, Finch & Strang, 2001). Second, research among alcohol 
treatment populations has pointed out that alcohol is often not the only substance 
that is being (mis)used (Caetano & Schafer, 1996; Caetano & Weisner, 1995). In 
a sample of 212 problem drinkers starting residential alcohol treatment, the 
majority (61%) had simultaneously used alcohol and illicit drugs during the 120 
days preceding their admission. The most commonly used substances were 
cocaine and marihuana (Martin et al., 1996). Similar findings were reported by 
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Staines and colleagues (2001): 68% of 248 clients starting treatment for alcohol 
problems had also used illicit substances (predominantly heroin, cocaine, and 
cannabis) in the 90 days preceding the start of treatment. 
 
 
3.1.3.  Characteristics of Persons with Both Alcohol and Drug Problems 
 
Although poly-drug use has become the rule rather than the exception (Byqvist, 
1999; Ives & Ghelani, 2006), most research projects and publications are 
conceptualized from a substance-specific point of view (e.g., focus on cocaine or 
amphetamine users) (Schensul, Convey & Burkholder, 2005). Furthermore, 
despite a large number of publications on non-substance-related homotypic 
comorbidity (e.g., between social phobia and specific phobia), the common 
knowledge on homotypic comorbidity between alcohol and drug-related 
disorders remains scarce. In this respect, the study of Stinson and colleagues 
(2005), deserves special mention since to the best of our knowledge, this is the 
only large-scale population study that has explicitly focused on the 
characteristics of persons with both alcohol and drug disorders. Compared to 
persons with alcohol or drug disorders only, the latter appeared to be more often 
male, younger, and never married. In addition, compared to the alcohol-only 
group they were less likely to be white and more likely to have a lower 
socioeconomic status and comorbid personality, mood, and anxiety disorders. 
The percentage of people having sought substance abuse treatment appeared 
highest among persons with both alcohol and drug disorders: 21.8% versus 6.1% 
(alcohol-only group) and 15.6% (drug-only group).  
 
In treatment outcome studies, it has been found that heavy drinking substantially 
increases the risk of overdose in drug users (Gossop, Stewart, Treacy & 
Marsden, 2002), has a negative influence on retention in outpatient drug-free 
treatment (Joe, Simpson & Broome, 1999), worsens treatment outcomes in 
substitution treatment (Chatham, Rowan-Szal, Joe & Simpson, 1997; Marsch et 
al., 2005), and increases the risk of cocaine relapse after drug treatment (McKay 
et al., 2005). The majority of drug treatment clients made no changes to their 
drinking patterns after having followed treatment for drug problems (Gossop et 
al., 2000). Some studies even carefully hypothesize an increase in alcohol use 
that replaces the reduction in drug use after having followed drug treatment 
(Slesnick, Bartle-Haring, Glebova & Glade, 2006).  
 
Although differences in substance use patterns affect treatment outcomes and 
may require specific treatment interventions, the number of treatment sample 
studies that have explicitly focused on comparing the characteristics of clients 
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entering treatment and having problems with both alcohol and illicit drugs to 
those of clients having problems with alcohol only on the one side and illicit 
drugs only on the other side is limited (Chaleby, 1986; Finkbiner & Wisdom, 
2000). In a number of other studies, two out of three groups were compared: 
alcohol-only with both alcohol and drugs (Tam, Weisner & Mertens, 2000) or 
drug-only with both alcohol and drugs (Gossop, Marsden & Stewart, 2002). An 
important study in this respect is that of Gossop and colleagues (2002) on “dual 
dependence”, based on the data of the National Treatment Outcome Research 
Study (NTORS) in England. Characteristics of drug-using clients who were 
concurrently high-dependent on alcohol were compared to those of clients who 
were not dependent or rather low-dependent. High-dependent drug users were 
less likely to use heroin or crack, but more likely to use benzodiazepines, 
cocaine, or amphetamines. They also had more often psychosocial or physical 
health problems and significantly more frequently reported one or more previous 
inpatient treatment admissions.  
 
 
3.1.4. The Belgian substance abuse policy and treatment context 
 
The old Belgian drug policy, dating back to the 1920’s, was thoroughly revised 
for the first time in 2001 when a – not legally binding - federal policy note on 
drugs was issued by the government. The main objective of the note is to prevent 
and reduce the associated risks for the drug users, his immediate surroundings 
and the society as a whole and to present an integrated drug policy plan. The 
strategies to achieve this were: prevention, treatment, harm minimization and as 
an “ultimum remedium” repression (Gelders & Van Mierlo, 2004). A so-called 
“third way” was sought between a more tolerant and a more repressive policy.  
 
Although this policy note covers in fact all legal and illegal substances, the 
discussion in the Belgian Parliament and in the media has often been reduced to 
the “cannabis debate”. At this point, the state of affairs is that a transitional 
common circular from the Ministry of Justice and the Board of Prosecutors-
General has been issued in January 2005 awaiting new legislation. In this 
circular, it is stipulated that: “In the case of personal use by a person of legal 
age, insofar as there is no disturbance of the public order or an aggravating 
circumstance, a simplified formal report has to be filed.” (Gelders & Vander 
Laenen, 2007, p. 106). In the circular the amount “for personal use” is set at 3 
grams or one plant. One of the “aggravating circumstances” mentioned in the 
circular is e.g. the use of cannabis in the presence of a minor. Although this type 
of possession is given the lowest priority for prosecution, it needs to be clearly 
mentioned that possession of cannabis still remains punishable.  
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In general the possession, import, transportation, selling and cultivation of 
cannabis and other illegal drugs are punishable, as well as the facilitation and 
stirring up to drug use and driving under the influence of alcohol or illegal drugs. 
The consumption of alcohol and nicotine is legal from 16 years onwards, except 
for strong alcoholic beverages, which are allowed from 18 years onwards. 
 
Belgium was first confronted with the (ab)use of illegal drugs on a larger scale in 
the seventies. At that time most services in the traditional mental health care 
system – who did treat alcohol addicts – were not eager to allow abusers of 
illegal drugs in their services. As a result a range of specific services for abusers 
of illegal drugs was developed, starting with therapeutic communities in the 
seventies, followed by day-care centers, crisis centers, and short-term therapeutic 
programs in the eighties and finally street corner work, needle exchange 
programs and medical-social centers for substitution treatment in the nineties. 
Although this separate treatment system for abusers of illegal substances (no 
exclusive alcohol abusers allowed) kept growing, the traditional mental health 
care system gradually also opened their doors for abusers of illegal substances 
(Vanderplasschen, De Bourdeaudhuij & Van Oost, 2002). Some of them did 
however define some exclusion criteria (e.g. no heroin addicts, no intravenous 
use) as opposed to the above-mentioned centers, which did not. 
 
Recently, a closer collaboration between the judicial and the treatment system 
was established, e.g. through the so-called “therapeutic advice”. Therapeutic 
advice is a measure through which youngsters who came into contact with the 
law because of drug-related offenses (possession or use of illicit drugs) are 
referred to substance abuse treatment in order to assess whether their use is 
problematic and whether or not treatment is indicated. This measure also has the 
objective for youngsters to become familiar with the treatment system. Secondly, 
on all levels of the judicial system abusers of illegal drugs can sometimes be 
referred to treatment as an alternative for further prosecution or punishment or as 
a condition for e.g. release on parole. For alcohol abusers on the other hand this 
is not common, as opposed to the United States where persons caught for driving 
under the influence of alcohol are obliged to follow treatment. 
  
 
3.1.5. Objectives of the Present Study 
 
The proportion of people having problems with both alcohol and illicit drugs 
appears to be quite high, as demonstrated in both population and treatment 
samples (Gossop et al., 2000; Miller et al., 1996; Smart et al., 1990; Stinson et 
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al., 2005). Overall, the limited research findings suggest that persons with both 
alcohol and illicit drug problems can indeed be considered a specific subgroup of 
substance abusers, with some specific own characteristics and therefore 
deserving special attention. Due to differences in sampling and data collection 
methodologies, results cannot always be compared and are therefore often 
inconsistent. Furthermore, although a number of studies have included variables 
related to previous treatment experiences in their interviews or surveys 
(Finkbiner et al., 2000; Stinson et al., 2005), information on the way persons 
with both alcohol and illicit drug problems make use of the existing treatment 
offer compared to those with alcohol or illicit drug problems only is virtually 
non-existent. Several studies have demonstrated that within substance abuse 
treatment agencies a small group of heavy users or revolving door clients can be 
identified (Colpaert, Vanderplasschen & Broekaert, 2007; Sandell & Bertling, 
1996), but it is unclear if clients with both alcohol and illicit drug problems 
belong to this group significantly more often.  
 
The purpose of the present study is threefold. First, we want to identify which 
proportion of clients demands substance abuse treatment in a clear-cut region in 
Belgium experience problems with both alcohol and illicit drugs. Following 
Gossop and colleagues (2002), who describe comorbidity between alcohol and 
drug dependence as “dual dependence”, we will further refer to the group of 
clients with both alcohol and drug problems as the “dual group” or “dual 
abusers”. Second, we want to gain more insight into socio-demographic and 
substance-related similarities and differences between the dual group (regular 
use of both alcohol and illicit drugs) on the one hand, and those solely abusing 
either alcohol or illicit substances on the other hand. Finally, we want to 
understand in what way dual abusers do or do not differ from the two other 
groups with regard to their utilization of the substance abuse treatment system, 
e.g., the number of treatment demands during a well-defined period.  
 
 
3.2.  Methods 
 
3.2.1.  Sample  
 
The study sample consisted of all persons (n=1,626) who had an initial intake 
interview in a substance abuse treatment center in the province of Antwerp 
(Belgium) between March 1, 2004, and August 31, 2004, due to problems with 
legal and/or illicit substances. The province of Antwerp is one of the ten Belgian 
provinces and currently has a population of 1.628.710 inhabitants. A province is 
an administrative policy level. In total, six outpatient and ten inpatient treatment 
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agencies or units for substance abusers participated in the study. Five of the 
centers are treatment centers where persons with exclusively alcohol problems 
cannot get help (=treatment centers for abusers of illegal drugs). In the remainder 
of the centers, persons with both alcohol and/or illegal drug problems can apply 
for treatment (=treatment centers for abusers of alcohol and/or illegal drugs). 
This current divide can be considered a result of the historical development of 
substance abuse treatment in Belgium (Vanderplasschen, De Bourdeaudhuij & 
Van Oost, 2002). A more detailed overview of the participating centers and their 
treatment offer can be found in table 3.1.  
 
Table 3.1.:  Overview of participating treatment centers (n=16) 
 
 
Treatment Centers for  
Illegal Drug Abusers 
Treatment Centers for   
Alcohol and/or 
Illegal Drug Abusers 
Total 
    
 
INPATIENT  
 
Crisis center (detox, motivation and 
orientation; abstinence-oriented): 
n=2 
 
 
 
Short-term therapeutic program (< 
6 months; abstinence-oriented): n=1 
 
 
OUTPATIENT  
 
Day-care center (medical 
assistance and psycho-social 
counseling + day program; 
methadone (detoxification) 
treatment; mainly abstinence-
oriented): n=1 
 
Medical-social center (low 
threshold medical care, e.g. 
methadone prescription, psycho-
social assistance; methadone 
maintenance treatment; mainly 
from a harm reduction perspective): 
n=1 
 
INPATIENT 
 
Substance abuse treatment units in 
psychiatric hospitals (short-term 
treatment < 6 months; abstinence-
oriented): n=5 
 
Detoxification unit in general 
hospital (detox, motivation and 
orientation; abstinence-oriented): 
n=2 
 
OUTPATIENT  
 
Mental health care centers (psycho-
social and psychiatric assistance, 
abstinence-oriented): n=4 
 
 
 
 
 
 
 
 
INPATIENT 
(n=10) 
 
 
 
 
 
 
 
 
 
 
 
OUTPATIENT 
(n=6) 
 
 
 
 
 
 
 
 
 
 
Total 5 11 16 
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The 16 treatment centers represent nearly the whole specialized treatment offer 
in this province. We decided not to include 5 psychiatric wards in general 
hospitals because in this type of treatment setting, people with various 
psychiatric disorders are admitted (e.g. anxiety, mood, substance-related 
disorders). Few of these patients have substance-related problems as their main 
reason of admission and no separate treatment program exists for people with 
this type of disorder. Private general practitioners, psychologists or psychiatrists 
were also excluded from the study because substance abuse agencies or units 
were targeted and not individual therapists. Efforts are made to increase 
collaboration between centers and to enhance coordination of care, e.g., through 
the organization of inter-agency care coordination meetings. 
 
 
3.2.2.  Procedure and Instrument 
 
Information on the treatment demanders’ characteristics was registered during 
the initial intake interview. An initial intake interview was defined as the first 
face-to-face contact between a person demanding treatment and a health care 
professional (e.g., psychologist, social worker, counselor) in order to bilaterally 
exchange information. After this initial intake interview, the health care 
professional decided together with the person if treatment was necessary, and in 
the latter case treatment was initiated. Since information was gathered and 
registered by practitioners, this contributed to the collection of high-quality data 
by persons specialized in this field, who have close contacts with clients (Simon 
et al., 1999). On the other hand, registration by practitioners includes the risk of 
so-called “registration fatigue”, while staff turnover and the involvement of 
various persons registering may hamper perfect standardization of registration 
procedures (Soldz, Panas & Rodriguez-Howard, 2002). These issues were 
addressed by limiting the registration to a six-month period, organizing several 
training sessions, giving financial incentives, elaborating an extended 
registration manual, and providing a helpdesk where practitioners could get 
prompt answers to their questions. Furthermore, after finishing the research 
project, individual feedback was provided to all participating treatment agencies 
regarding the number and characteristics of their respective client populations, 
which could serve future service planning and development. 
 
For data collection purposes, a secure on-line web application was developed 
which has considerable advantages compared to paper-based registration, e.g., 
improved data quality and communication between the practitioners and the 
researchers. A large majority of treatment centers made use of the application. 
Only two treatment centers filled out registration sheets and sent them in on a 
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monthly basis to the researchers due to the fact that Internet access was not 
readily available. All data were converted to or entered in SPSS, and a thorough 
data quality check was performed. If necessary, unclear or contradictory 
information was passed on to the person in the center responsible for the 
registration to be completed or corrected.  
 
Due to the lack of a common registration tool in Belgian substance abuse 
treatment (Colpaert & De Clercq, 2003), a specific instrument was developed. 
The variables included were largely derived from questions or variables in the 
“Treatment Demand Indicator” protocol, a common European standard manual 
on treatment demand registration developed by the Pompidou Group/European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Simon et al., 
1999) and from items in the European Addiction Severity Index (EuropASI), a 
semi-structured interview that offers the possibility to clinicians and researchers 
of mapping the severity of problems in various life areas of functioning 
(Kokkevi & Hartgers, 1995; McLellan, Luborsky, Woody & O’Brien, 1980). All 
treatment agencies were involved in the development and elaboration of the 
instrument and research design in order to enhance participation. Since this was 
an additional registration (besides the already-existing various administrative 
registration procedures in each agency), only a limited number of variables was 
collected: socio-demographic data (sex, age, place of residence, nationality, 
employment, and living situation); substance-related information (regular use of 
various types of substances); injecting behavior (ever, during the last 12 
months); previous treatment experiences, and type of treatment center (inpatient 
vs. outpatient and drug abuse treatment vs. substance abuse treatment).  
 
In order to explore the persons’ treatment demanding patterns without violating 
their privacy, a unique client identifier was introduced for this study, which 
permitted tracking of individuals across treatment demands and agencies. This 
identifier, in combination with other stable personal information (e.g., year of 
birth and sex), was also used for eliminating multiple counts when analyzing 
characteristics of unique treatment demanders. Although some double counts 
will not have been recognized as such, absolute perfection is neither possible nor 
required (Stauffacher & Kokkevi, 1999). After all, the main purpose was to 
reduce the probability of the number of multiple counts to a level that is a good 
estimation of the true number of unique treatment demanders (Simon et al., 
1999). Furthermore, this method is also advised by the EMCDDA in order to 
avoid distortion of research results.  
 
The distinction between the so-called “dual” group (n=417) and the two other 
“single” groups (regular use of alcohol only (n=692) or illicit drugs only 
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(n=432)) was made on the basis of the variable “regular use during the three 
months preceding the intake interview”, in which regular was operationalized as 
“more than three days a week or two consecutive days”. For alcohol a minimum 
amount of more than five glasses a day was set; for all other substances no 
minimum amount was set. Both these criteria were diverted from the EuropASI 
(Kokkevi & Hartgers, 1995).  
 
 
3.2.3.  Data Analysis 
 
Differences between the three groups were assessed depending upon the type of 
variable under consideration. For categorical variables chi-square tests were 
used, while for continuous variables analysis of variance (ANOVA) was used. 
Only results yielding a p-value < 0.05 were considered statistically significant. 
When the overall chi-square or F statistic was significant, post-hoc tests were 
used to evaluate the significance of the differences between pairs of groups. For 
categorical variables, the test for pairwise comparison of column proportions was 
used, adjusting the p-values for multiple comparisons through the Bonferroni 
method. For continuous variables, the Bonferroni post-hoc test was used. After 
the univariate comparisons, the variables that differed significantly between 
groups were entered in a logistic regression in order to assess their predictive 
value. Two logistic regressions were carried out to predict membership of the 
dual group, one in comparison with the alcohol group and one with the illicit 
drugs group. When comparing groups of clients, incomplete registration forms 
were excluded from the analysis. Unless mentioned otherwise, all percentages 
should be read as valid percentages.  
 
 
3.3.  Results  
 
3.3.1.  Sample Description 
 
During the six-month registration period, 1,935 treatment demands were 
registered, representing all treatment requests of persons demanding treatment in 
one of the 16 participating treatment agencies in the province of Antwerp. 
Almost two-thirds (63.0%) of all these intake interviews took place in residential 
facilities, 37.0% in outpatient agencies. After a careful analysis of possible 
multiple countings on the basis of the unique client identifier, it was concluded 
that these 1,935 treatment demands concerned 1,626 unique persons. The 
majority was thus registered only once (86.6%), while 9.6% were registered 
twice, and 3.8% three or more times. The majority (75.7%) already had a history 
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of substance abuse treatment in an inpatient or outpatient facility. The sample 
consisted of 26.4% women and 73.4% men. The mean age was 36.7 years old 
(SD=12.9).  
 
 
3.3.2.  Substance Use  
 
More than half (54.7%) of the 1,626 treatment demanders had regularly used at 
least one illicit substance in the course of the three months preceding the intake 
interview. The most commonly cited substances are cannabis (66.6%), cocaine 
(49.2%), amphetamines (35.6%), and opiates (31.0%). In this group of illicit 
drug users, the use of more than one substance was clearly the rule rather than 
the exception (78.8%). For more than a quarter (27.1%), cannabis was the 
substance that caused them the most problems, followed by opiates (13.9%), 
amphetamines (13.6%), and cocaine (11.5%). About half (47.3%) of the 878 
illicit drug users had also regularly (ab)used alcohol (at least five glasses a day) 
during that same period, and for 11.8% of them alcohol was even selected as 
their primary drug.  
 
Of 728 persons who had not used illicit substances, the majority had problems 
related to the use of alcohol (95.1%); the remaining 4.9% had problems due to 
the use of medicines (e.g. sedatives).  
 
For 49 persons, data on their use of substances were not sufficiently available; 
consequently, they were excluded from further analyses. The persons who 
demanded treatment for problems related to the use of medicines are also not 
further included in the study. Consequently, the three groups that will be studied 
in more detail are the dual group (regular use of both alcohol and illicit 
substances; n=417), the alcohol group (regular alcohol use only; n=692), and the 
illicit drugs group (regular illicit drug use only; n=432).  
 
 
3.3.3.  Dual Group Compared to the Alcohol Group 
 
Table 3.2. describes the study sample through a number of bivariate comparisons 
by substance use group. As shown in this table, the dual group is characterized 
by a remarkably low percentage of women (17.5%) compared to the alcohol 
group, where almost one-third of women were registered. There is a large age 
gap of almost 17 years between the older alcohol group (mean age of 46.2 years 
old, SD=10.1) and the younger dual group (mean age of 29.6 years old, SD=9.0). 
While only 5.8% of the alcohol group is younger than 30 years old, in the dual 
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group this is the case for more than 50% of the clients. Consequently, a 
significantly higher percentage of the latter treatment demanders are living with 
their parents (26.7%) and/or studying (11.5%). The alcohol group consists for 
the most part of persons who are living alone (43.8%) or with their partner 
and/or children (41.5%). Only a minority (5.5%) were not born in Belgium, 
while in the dual group this percentage is significantly higher (12.9%). In the 
latter group, persons are also more often homeless (12.1%) and/or unemployed, 
i.e., in more than one-third of the cases. By contrast, in the alcohol group 
significantly more clients are receiving health insurance benefits or pensions 
(38.2%) and a larger percentage of persons has a full-time or part-time job. If we 
compare the current judicial situation of the treatment demanders, we can 
observe that the dual group has significantly more legal problems than the 
alcohol group (28.5% vs. 9.9%). In the alcohol group, the most commonly cited 
judicial issues were compulsory admission to a treatment center (32.3%) and 
probation (30.9%). In the dual group these are probation (37.9%) and release on 
bail or other conditions while awaiting trial/sentencing (24.1%). Finally, the dual 
group appears to use sedatives significantly more often than the alcohol group 
(36.6% vs. 25.7%). 
 
Next to socio-demographic and substance-related variables, a number of 
treatment utilization indicators were also examined. During the six-month 
registration period, a significantly higher percentage of persons in the dual group 
were registered in more than one treatment center compared to those in the 
alcohol group (11.5% vs. 5.5%). Almost 80% of the persons in the latter group 
demanded treatment in a residential treatment setting (compared to 51.8% of the 
persons in the dual group).  
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Table 3.2.: Differences in socio-demographic, substance-related and treatment utilization variables by substance use group (n=1,541) 
 
  
Group 1 
Alcohol 
 
(n=692) 
Valid % 
 
Group 2 
Illicit drugs 
 
(n=432) 
Valid % 
 
Group 3 
Alcohol &  
Illicit drugs 
(n=417) 
Valid % 
 
 
Chi² (df=2) or 
F(df=2) statistic 
 
p-value 
 
Group differences 
** 
       
Gender    31.262  .000 a,b 
Male 67.9 77.1 82.5    
Female 32.1 22.9 17.5    
       
Age       
< 19 0.3 21.7 12.6 145.338 .000 a,b,c 
20 – 29 5.5 38.5 41.6 245.155 .000 a,b 
30 – 39 18.7 28.7 30.2 23.693 .000 a,b 
40 – 49 37.8 9.6 13.4 149.280 .000 a,b  
> 50 37.7 1.6 2.2 327.993 .000 a,b 
       
Mean age 46.2 28.0 29.6 632.039 .000 a,b,c 
       
Country of birth    66.518 .000 a,b,c 
Belgium 94.5 78.1 87.1    
       
Living situation       
Alone 43.8 24.8 33.5 42.518 .000 a,b,c 
With partner and/or children 41.5 24.8 16.5 83.849 .000 a,b,c 
With parents 5.0 32.3 26.7 153.977 .000 a,b 
Homeless 4.7 7.1 12.1 20.784 .000 b,c 
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Table 3.2. (continued): Differences in socio-demographic, substance-related and treatment utilization variables by substance use group (n=1,541) 
 
  
Group 1 
Alcohol 
 
(n=692) 
Valid % 
 
Group 2 
Illicit drugs 
 
(n=432) 
Valid % 
 
Group 3 
Alcohol &  
Illicit drugs 
(n=417) 
Valid % 
 
 
Chi² (df=2) or 
F(df=2) statistic 
 
p-value 
 
Group differences 
** 
       
Employment situation       
Employed 33.8 23.1 27.2 14.157 .001 a 
Student 0.6 22.8 11.5 135.273 .000 a,b,c 
Unemployed 22.9 34.2 36.4 25.895 .000 a,b 
Invalidity 29.3 14.8 17.7 35.388 .000 a,b 
       
Current legal problems 9.9 35.1 28.5 110.888 .000 a,b 
       
Regular use sedatives 25.7 22.9 36.6 22.433 .000 b,c 
       
Mean N° types illicit drugs* - 2.0 2.6 37.304 .000 c 
       
Regular use illicit drugs*       
Amphetamines - 28.1 43.5 21.628 .000 c 
Cannabis - 60.8 72.0 11.871 .001 c 
Cocaine - 40.7 57.3 23.160 .000 c 
Hallucinogens - 3.5 12.4 23.225 .000 c 
Ecstasy - 13.1 34.9 54.758 .000 c 
Heroin - 35.0 24.8 10.449 .001 c 
       
Injected during last year* - 22.6 15.8 5.377 .020 c 
       
Treatment history 82.2 61.9 77.9 59.196 .000 a,c 
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Table 3.2. (continued): Differences in socio-demographic, substance-related and treatment utilization variables by substance use group (n=1,541) 
 
  
Group 1 
Alcohol 
 
(n=692) 
Valid % 
 
Group 2 
Illicit drugs 
 
(n=432) 
Valid % 
 
Group 3 
Alcohol &  
Illicit drugs 
(n=417) 
Valid % 
 
 
Chi² (df=2) or 
F(df=2) statistic 
 
p-value 
 
Group differences 
** 
       
Number of registrations > 1  13.7 11.3 15.8 3.637 NS  
       
Registered in > 1 treatment center 5.5 7.6 11.5 13.237 .001 b 
       
Types of treatment centers       
Inpatient 79.5 31.0 51.8 267.376 .000 a, b, c 
Outpatient 18.5 65.0 42.9 249.730 .000 a, b, c 
Both 2.0 3.9 5.3 8.734 .013 b 
       
Types of treatment centers *       
Drug abuse treatment center - 41.9 30.5 12.018 .001 c 
Substance abuse treatment center - 55.1 64.7 8.231 .004 c 
Both - 3.0 4.8 1.814 NS  
       
*  Bivariate analyses carried out only between group 2 & 3 
**  a Significant difference between 1 & 2     b Significant difference between 1 & 3       c Significant difference between 2 & 3 
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All variables identified in these bivariate analyses as being significantly 
associated with being a regular user of both alcohol and illicit drugs were entered 
in a binary logistic regression. In the best fit model, data on 990 unique treatment 
demanders were included in the analysis. Seven variables were identified as 
significant determinants (cf. table 3.3.) and explained 59.2% of the variance in 
the outcome variable (Nagelkerke R square = 0.592). Most of the variance was 
explained by the variable “age”: the younger the client, the more likely to belong 
to the dual group. Men are 1.6 times more likely to belong to the dual group. 
Further, alcohol users who were registered in an outpatient treatment agency, are 
unemployed, and/or regularly use sedatives are more likely to also use illicit 
substances. Treatment demanders living alone or with their partner and/or 
children, on the other hand are more likely to belong to the alcohol-only group 
than those living in other conditions. 
 
Table 3.3.:  Binary logistic regression predicting membership of the dual group 
(compared to the alcohol group)  
 Β SE Wald Exp(β) 95% CI p 
Sex: male .495 .234 4.494 1.641 1.038-2.594 .034 
Age -.148 .011 188.393 .863 .845-.881 .000 
Living alone -.672 .225 8.923 .511 .329-.794 .003 
Living together with partner  
and/or children 
-1.138 .260 19.185 .320 .192-.533 .000 
Being unemployed .590 .200 8.724 1.804 1.220-2.668 .003 
Regular use of sedatives .790 .204 14.930 2.204 1.476-3.290 .000 
Treatment demand in an  
outpatient agency 
.823 .204 16.229 2.278 1.526-3.401 .000 
 
 
3.3.4.  Dual Group Compared to the Illicit Drugs Group 
 
The mean age of the dual group is in the same size order as that of the illicit 
drugs group (a mean age of 29.6 vs. 28.0 years old), but is still significantly 
higher. This is particularly due to a significantly lower percentage of persons 
who are under the age of 20 (12.6%). The proportion of women in the illicit drug 
group (22.9%) is lower than in the alcohol group, but is still – although not 
significantly - higher than in the dual group (17.5%). In the latter group, a 
significantly higher percentage of homeless people can be observed compared to 
the illicit drugs group. Treatment demanders regularly using both alcohol and 
drugs also more often live alone and less often together with a partner and/or 
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children. In the drug-only group, significantly more persons were not born in 
Belgium (21.9%). The proportion of persons having current legal problems is 
also higher in the drug-only group than in the dual group (35.1% vs. 28.5% 
respectively). The most frequent legal problems in the illicit drug group are 
therapeutic advice (36.1%) and release on bail or other conditions while awaiting 
trial/sentencing (24.5%). Regarding the use of illicit substances in both groups, 
we can observe that treatment demanders in the dual group have used 
significantly more types of illicit substances in the three months preceding the 
intake interview: a mean number of 2.6 (SD=1.6) vs. 2.0 (SD=1.1). All 
substances (amphetamines, cannabis, cocaine, hallucinogens, and ecstasy) were 
used more often by the dual group except for heroin, which was used 
significantly less often (24.8% vs. 35.0%). Persons in the dual group also had 
injected drugs significantly less often during the year preceding the interview. 
Finally, persons in the dual group used sedatives significantly more often. 
 
When treatment utilization patterns are considered, we can observe a number of 
differences between both groups. Compared to treatment demanders solely using 
illicit drugs, clients in the dual group more were more likely to have already had 
previous treatment experiences (77.9% vs. 61.9% respectively). Furthermore, 
during the six-month registration period they were registered more often in 
residential (51.8%) and/or treatment agencies for abusers of alcohol or illegal 
drugs (64.7%). No significant differences were found regarding the percentage of 
persons that were registered more than once during that period, although a 
tendency can be observed for this percentage to be higher in the dual group 
(11.5% vs. 7.6%).  
 
When all variables identified in these bivariate analyses as being significantly 
associated with being a regular user of both alcohol and illicit drugs were entered 
in a binary logistic regression, nine variables emerged in the best fit model as 
significant determinants for clients to belong to the dual group (cf. table 3.4.). In 
this model, data on 686 unique persons were included in the analysis. Being 
male, older, and born in Belgium were all associated with being more likely to 
have also regularly and excessively used alcohol next to the use of illicit drugs. 
Further, treatment demanders who regularly used ecstasy were 3.5 times more 
likely to belong to the dual group and users of cocaine were 1.8 times more 
likely. Two treatment utilization variables appeared to be significant predictors 
of belonging to the dual group: having previous treatment experiences 
(Exp(B)=2.0) and demanding treatment in a residential treatment agency 
(Exp(B)=1.6). Opiate users and those injecting drugs on the other hand, were 
significantly less likely to also abuse alcohol next to their drug use, resp. 1.8 
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times less likely. These nine variables accounted for 22.9% of the variability in 
the outcome variable (Nagelkerke R square = 0.229).  
 
Table 3.4.: Binary logistic regression predicting membership of the dual group 
(compared to the illicit drugs group)  
 Β SE Wald Exp(β) 95% CI p 
Sex: male .561 .212 6.990 1.752 1.156-2.656 .008 
Age .031 .011 8.523 1.032 1.010-1.053 .004 
Country of birth: Belgium .581 .238 5.977 1.787 1.122-2.847 .014 
Injected during the past year -.609 .241 6.397 .544 .339-.872 .011 
Regular use of heroin -.585 .215 7.426 .557 .365-.848 .006 
Regular use of ecstasy 1.254 .220 32.601 3.503 2.278-5.386 .000 
Regular use of cocaine .613 .186 10.907 1.846 1.283-2.657 .001 
Treatment history .706 .200 12.409 2.026 1.368-3.002 .000 
Treatment demand in  
an inpatient agency 
.452 .181 6.221 1.572 1.102-2.243 .013 
 
 
3.4.  Discussion  
 
3.4.1.  Extent of Poly-Drug Use, Including Alcohol Use 
 
In line with previous research (Conway, Kane, Ball, Poling & Rounsaville, 2005; 
Gossop et al., 1997), we found that the large majority of treatment demanders 
had regularly used multiple substances during the three months preceding the 
intake interview. Further, about half (47.3%) of all users of illicit drugs had 
regularly (more than three days or two consecutive days per week) drunk more 
than five glasses of alcohol in the period before their treatment demand. This 
corresponds to the findings of the Swedish Drug Abuse Treatment Evaluation 
(SWEDATE) study, where about 55% of the clients misused alcohol in addition 
to narcotic substances (Byqvist, 1999). Results from the NTORS study had 
shown that more than one-third of clients in drug treatment were also dependent 
on alcohol (Gossop et al., 2000). Although our findings do not inform us as to 
whether the criteria for DSM-IV alcohol abuse or dependence are met, the 
observed drinking pattern can – according to the criteria of Wechsler and 
colleagues (1994) – at least be referred to as “frequent binge drinking”. Several 
authors have argued that this type of excessive drinking may be a stronger 
predictor for alcohol-related problems than average measures of quantity or 
frequency of alcohol consumption (Bobak et al., 2004; Wechsler, Davenport, 
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Dowdall, Moeykens & Castillo, 1994). Our findings support Byqvists’ thesis 
(1999), stating that alcohol plays an important role within drug use patterns. 
Notwithstanding the fact that this particular type of drinking has been linked 
with severe health or other consequences and alcohol-related problems 
(Murgraff, Parrott & Bennett, 1999; Wechsler et al., 1994), several authors 
express their concern regarding the underestimation of alcohol problems in 
(illicit) substance abuse treatment. Thorough alcohol assessment at intake, early 
intervention and preventive as well as treatment actions are needed (Gossop et 
al., 2002; Room, Babor & Rehm, 2005). Also when developing evidence-based 
treatment guidelines, which are generally substance-specific, the reality of co-
existing alcohol and drug problems needs to be taken into account in order to 
increase treatment effectiveness.  
Based on our results, we also want to question the separate organization of 
alcohol and drug treatment that exists in several countries, including Belgium 
(Bergmark, 1999). Knowing that almost half of all users of illicit drugs appear to 
have at least some problems with their use of alcohol, further collaboration 
between and integration of both treatment systems is absolutely essential. Also 
exchange of expertise needs to be encouraged. In their article on recent trends in 
drug treatment in Europe, Kinnunen and Nilson (1999) already predicted the 
gradual evolution toward an implosion of the drug treatment system into the 
alcohol treatment system.  
 
 
3.4.2.  Characteristics of Dual Abusers 
 
In a number of studies, alcohol and drug abusers are compared for client 
characteristics or treatment outcomes. Often the primary drug of choice or 
primary problem substance is used to distinguish between the two groups 
(Gossop et al., 2001; Slesnick et al., 2006). However, by doing this the reality is 
not sufficiently acknowledged since primary drug users also regularly and/or 
excessively drink alcohol and primary alcohol users also use illicit substances to 
a certain degree (Gossop et al., 2000; Martin et al., 1996). We have tried to 
address this and make our analyses and results “cleaner” by creating groups on 
the basis of the variable “regular use” instead of “primary drug”. Consequently, 
it was also possible to focus on clients regularly (ab)using both alcohol and drugs 
in order to determine in what way they were different from clients solely using 
alcohol or illicit drugs.  
 
With regard to their age, sex, and other socio-demographic characteristics, dual 
abusers tend to display greater similarities with drug abusers than with alcohol 
abusers. Compared to alcohol abusers, they are significantly younger and more 
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often male, have more legal problems, and are more often unemployed. 
Conversely, alcohol abusers more often live alone or together with their partner 
and/or children. Overall, these findings are consistent with the differences that 
are generally found in the literature (Finkbiner & Wisdom, 2000; Gossop et al., 
2001; Rhee et al., 2006; Stinson et al., 2005; Tam et al., 2000). Only the higher 
prevalence of legal problems in dual abusers is not consistent with certain studies 
where the inverse was found (Finkbiner & Wisdom, 2002). This can possibly be 
attributed to contextual factors, e.g., differences between Europe and the United 
States regarding court-ordered drug treatment or measures taken by the criminal 
justice system regarding “driving under the influence (DUI)”. 
 
Although dual abusers show more similarities with drug abusers than with 
alcohol abusers, a number of variables do appear to differentiate between these 
two groups. Drug-abusing treatment demanders tend to be younger than dual 
abusers; more than one-fifth are younger than 19 years old, while this is the case 
for only 12.6% of the dual abusers. Further, dual abusers are more often male, 
born in Belgium, and homeless compared to drug abusers. The results of our 
study, indicating that predominantly amphetamine, cocaine, and ecstasy users 
regularly and excessively drink alcohol as opposed to opiate users and injecting 
drug users, confirm earlier international research (Gossop et al., 2002; Lowe & 
Shewan, 1999; Schmitz, Bordnick, Kearney, Fuller & Breckenridge, 1997). 
Although not maintained in the logistic regression analysis, dual abusers tend to 
use more different types of illicit substances (mean: 2.56) than drug abusers 
(mean: 1.98). Finally, it is important to note that in all three groups the use of 
sedatives is common. However, in the dual group more than one-third of the 
clients said they had regularly used sedatives in the three months preceding the 
intake interview, compared to 25.7% and 22.9% in the two other groups. 
Finally, when treatment utilization variables are concerned, a number of 
interesting findings need to be mentioned. Compared to the drug-only group, 
dual abusers more often already have a treatment history, even when controlled 
for age differences in the logistic regression analysis. This could indicate that 
they have a more severe disorder, that they experience more problems due to 
their substance use, and/or feel a greater need for treatment. This is in line with 
previous research (Finkbiner & Wisdom, 2000; Stinson et al., 2005) and 
confirmed by the fact that the dual clients in our sample more often demanded 
treatment in a residential facility (51.8% vs. 31.0%), which is generally 
considered a more intensive form of treatment and a higher step on the 
“treatment continuum”. The fact that more clients in the dual group were 
registered more than once and in more than one treatment agency – although not 
significantly – could indicate that they are more often floating around in search 
of the right treatment intervention. A more individualized, coordinated and 
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continuous form of care and treatment could therefore be recommended for this 
group, including an evolution towards the integration of treatment systems 
(Broekaert & Vanderplasschen, 2003; Vanderplasschen et al., 2002).  
 
 
3.4.3.  Limitations of the study 
 
Although this study has several strengths, including the large coverage of 
participating treatment centers and the conscientious organization of data 
collection (e.g., via online web application), several limitations need to be 
mentioned. As reported in the methodology section of this paper, we have 
chosen to keep the number of variables as limited as possible to ensure 
maximum participation of the treatment centers. As a result, we lack detailed 
information in certain areas, e.g., on substance use patterns (such as sequentiality 
or simultaneity of poly-drug use, DSM-IV abuse, or dependence diagnoses), 
treatment history, and psychiatric problems. Second, working with treatment 
demand data means that the generalizability to other samples is not self-evident. 
Each treatment system has its own characteristics (e.g., admission and referral 
policies or connections with the criminal justice system) which influence the 
vested results. Nevertheless, it is generally acknowledged that treatment sample 
studies can result in valuable information for further treatment planning and 
organization (Caetano & Schafer, 1996). Third, the cross-sectional snapshot 
design did not allow the monitoring of trends over time in order to test the 
substitution hypothesis (alcohol use increase after treatment for illicit drug-
related disorders) (Slesnick et al., 2006) or answer the question of whether or not 
poly-drug use is increasing (Yates, 1999). Another limitation could be that we 
relied on self-reported data and did not use biological testing. However, 
numerous studies have confirmed the validity and reliability of self-reported data 
regarding the use of licit and illicit substances (Del Boca & Noll, 2000; Vitale, 
van de Mheen, van de wiel & Garretsen, 2006). Finally, we have to mention the 
possibility of a categorization bias: several categorization methods exist to 
classify substance abusers (e.g. according to known health risks of the 
substances; the individual drugs and their combinations) of which we have 
selected one: alcohol versus illicit drugs. The main reason lies in the way the 
Belgian treatment system is organized and the historical division that has grown 
between treatment centers for abusers of illegal drugs and those for abusers of 
both alcohol and/or illegal drugs. Furthermore we believe that indeed – although 
alcohol is one of many psychotropic substances – alcohol has a special place in 
our society because of historical reasons, its legal status and the tolerance and 
acceptance by society (Cook & Reuter, 2007). 
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3.4.4. Further Research 
 
In this study we have identified a number of socio-demographic and substance-
related variables that were able to distinguish (to a certain degree) dual abusers 
from those who solely abuse alcohol or drugs. Future research should try to 
discover whether this dual group experiences more problems in various life areas 
(objective and subjective), especially with regard to psychiatric problems. Since 
only 22.9% of the variability in the outcome variable (dual group vs. illicit drugs 
group) was explained by the variables included in this study, it is crucial to 
explore more and other variables. In the other logistic regression (dual group vs. 
alcohol group), the percentage of variability explained was almost three times as 
high (59.2%).  
 
The link with the course and outcome of the treatment process also needs further 
investigation. Previous research already demonstrated that primary drug and 
alcohol abusers do indeed respond differently to the same treatment modalities 
(Slesnick et al., 2006), but what about dual abusers? In this respect it could also 
be useful to include the subjective assessment of clients regarding the 
substance(s) for which they feel that treatment is required and their motivation to 
change their specific substance-abusing behavior (alcohol, illicit drugs, both). A 
last but not unimportant finding in this study was the high percentage of 
treatment demanders who abused cannabis or had cannabis as their primary 
substance. It would be useful to further investigate what the underlying reasons 
are for these high figures, especially since also in the Netherlands and other 
European countries a rise in treatment demanders with cannabis as primary 
problem was seen (EMCDDA, 2006; LADIS, 2006).  
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Abstract 
 
 
Objective: Over the past two decades, an increased interest and awareness can be 
observed with regard to the potential adverse consequences of poly substance use 
problems in general and co-occurring alcohol and illicit drug use problems more 
in particular. This review intends to provide a systematic overview on 
similarities and differences between persons with co-occurring alcohol and drug 
problems versus those with either alcohol or drug use problems only with regard 
to socio-demographics, addiction severity and psychopathology.    
Methods: A comprehensive literature study was carried out, including database 
searches in the Web of Science and Pubmed. Studies were included if they were 
published in English, peer-reviewed journals between 1991 and 2011 and used 
statistical methods to analyse differences between persons with co-occurring 
alcohol and drug use disorders on the one hand and persons with either alcohol 
or drug problems on the other hand.  
Results: In total, 19 studies were selected. Across studies, consensus was found 
that persons with co-occurring alcohol and drug use problems have a different 
socio-demographic profile, a higher degree of psychopathology and a more 
severe addiction severity compared to persons with alcohol use problems only. 
When compared to persons with drug use problems only, findings were not 
univocal.   
Conclusion: Further research should particularly focus on differences between 
persons with co-occurring alcohol and drug use problems versus persons with 
drug use problems only as this review shows inconsistent findings. Future 
studies should always make the definitions, assessment instruments and time 
frames used clear and explicit.    
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4.1. Introduction 
 
 
Over the past decades an increased interest in the possible adverse consequences 
of poly drug use problems in general and co-occurring alcohol and drug 
problems in particular can be observed. It has been well-documented that the use 
of alcohol and drugs frequently co-occur (Ives & Ghelani, 2006; Falk, Yi & 
Hiller-Sturmhöfel, 2008). The joint use or misuse of alcohol and drugs can be 
considered a “double-bounded phenomenon” (Hakkarainen & Metso, 2009) : 
whereas heavy alcohol users also use other substances, illicit drug users also 
frequently use alcohol. Similarly, alcohol and drug use disorders appear to be 
highly comorbid (Caetano & Schafer, 1996; Grant & Pickering, 1996; Martin, 
Arria, Mezzich & Bukstein, 1993; Martin et al., 1996; Staines, Magura, Foote, 
Deluca & Kosanke, 2001; Stinson et al., 2005). Co-occurring alcohol and drug 
use disorders can be considered a specific type of homotypic (“occurrence of 
disorders within the same diagnostic class”) comorbidity (Angold, Costello & 
Erkanli, 1999; Stinson et al., 2005).  
 
Co-occurring alcohol and drug use problems have been studied in large-scale 
community samples (Stinson et al., 2005), clinical samples of individuals 
seeking alcohol or drug treatment (Gossop, Marsden, Stewart, & Rolfe, 2000; 
Martin et al., 1993; Miller, Klamen, Hoffmann & Flaherty, 1996) or psychiatric 
treatment (Charzynska et al., 2011), and in correctional settings (Velasquez, von 
Sternberg, Dolan Mullen, Carbonari & Kan, 2007). Overall, high levels of 
homotypic comorbidity between alcohol and drug use disorders are reported. 
After analysis of the data of the 2001-2002 National Epidemiologic Survey on 
Alcohol and Related Conditions (NESARC), Stinson and colleagues (2005) 
found that 55.2% of the individuals who had a drug use disorder in the past year 
also had an alcohol use disorder in that same period, and that 13.0% of those 
with an alcohol use disorder were also diagnosed with a drug use disorder. 
Within a lifetime perspective, prevalence figures are even higher (Grant & 
Pickering, 1996). In Australia, Canada, and Europe, conclusions regarding the 
lifetime and current prevalence of co-occurring alcohol and drug use disorders 
went in the same direction (Bijl, Ravelli & van Zessen, 1998; Burns & Teesson, 
2002; Degenhardt & Hall, 2003; Ross, 1995). Studies carried out in clinical 
settings resulted in similar conclusions. First, various studies among individuals 
in drug treatment have demonstrated high rates of drinking and alcohol 
dependence (Gossop, Marsden & Stewart, 2002; Gossop et al., 2000; Miller et 
al., 1996; Weisner, 1992). A large number of studies have identified heavy 
drinking and alcohol dependence as a substantial problem among clients in 
methadone treatment programs (Best et al., 1998; Hillebrand, Marsden, Finch & 
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Strang, 2001; Senbanjo, Wolff & Marshall, 2006; Stastny & Potter, 1991). 
Conversely, studies carried out in alcohol treatment populations have shown that 
alcohol is often not the only substance that is being (mis)used (Caetano & 
Schafer, 1996; Caetano & Weisner, 1995; Martin et al., 1993; Martin et al., 
1996; Staines et al., 2001).  
 
Despite its frequent co-occurrence, the number of studies focusing on the 
specific characteristics of this particular group of substance users, and more in 
particular on the prevalence of psychiatric disorders and overall psychological 
problems and distress, is rather limited, (Hakkarainen & Metso, 2009; Stinson et 
al., 2005). Recently, an increased attention towards persons with both alcohol 
and illicit drug problems and their specific characteristics and treatment needs 
can be observed in both science as well as policy (EMCDDA, 2006; Kranzler & 
Li, 2008), influenced by an increasing awareness that this group possibly could 
have a higher problem severity in many areas (Gossop et al., 2002) and benefit 
less of the existing treatment offer (Chatham, Rowan-Szal, Joe & Simpson, 
1997; McKay et al., 2005) as compared to individuals who have problems with 
either alcohol only or drugs only. The latter could partly be linked to the fact that 
a number of countries have a rather low degree of integration between alcohol 
and drug treatment systems (Bergmark, 1998).  
 
The overall objective of this paper is to provide a systematic review of the 
literature with regard to the socio-demographic, addiction severity and 
psychopathological profile of individuals with co-occurring alcohol and drug use 
problems. We hypothesize that individuals with co-occurring alcohol and drug 
use problems (A+D) have a distinct socio-demographic profile with regard to 
age, sex, ethnicity and socio-economic status as compared to individuals with 
either alcohol problems only (A) or drug problems only (D). We also expect a 
higher overall addiction severity, as operationalized in various measures such as 
abuse versus dependence; severity scores on various life domains, early age of 
onset; having a previous treatment history and severity of dependence. Also a 
more severe psychopathological profile (prevalence of mood, anxiety and 
personality disorders as well as overall psychological problems or distress) is 
expected in comparison with persons with either alcohol or drug problems only. 
In conclusion of this paper, we will also address some methodological 
difficulties and implications for future research. 
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4.2. Methods 
 
 
The studies that were included in this review were retrieved through keyword 
searches using the database Web of Science or were found in reference lists of 
selected articles. Only studies published in an English-language, peer-reviewed 
journal during the past two decades (between 1991 and 2011) were included. 
Keywords included (1) alcohol; (2) drug OR drugs; (3) combined, joint, dual, 
simultaneous, concurrent OR co-occurring; (4) use, abuse, misuse, dependence 
OR problem; (5) age, sex, gender, ethnicity, nationality, education, employment, 
SES, income, severity, mood, anxiety, personality, psychological OR distress. 
Only studies that used statistical methods to examine similarities and differences 
between individuals with co-occurring alcohol and drug use problems (A+D) in 
comparison with either individuals with alcohol problems only (A versus A+D) 
or drug problems only (D versus A+D) or both (A+D versus A and D) were 
included in the review. In this review, the term “co-occurring alcohol and drug 
use problems” refers to alcohol and drug problems in broad sense (not only as 
clinically diagnosed disorders) that occur at the same time. Both community 
sample studies as well as substance abuse treatment sample studies were 
included. 
 
 
4.3. Results 
 
The search resulted in 1,614 papers, published between 1991 and 2011. All titles 
and abstracts were carefully screened but only a limited number of studies 
specifically addressed co-occurring alcohol and drug use problems and made 
comparisons with persons having problems with either alcohol or drugs only on 
the basis of statistical methods. In total, 19 studies were included in our study 
(cf. table 4.1.). Eight studies were based on community samples; half of those 
(n=4) made use of the data gathered via the National Epidemiologic Study on 
Alcohol and Related Conditions (NESARC). Eleven studies were based on 
treatment samples: four took place in alcohol treatment settings, four in drug 
treatment settings and three in treatment settings that provide alcohol as well as 
drug treatment. Most studies were carried out in the US (n=13), next to studies in 
Germany (n=2), Great Britain (n=2), Belgium (n=1) and Spain (n=1). Overall, 
sample sizes varied from 212 to 43,093. Whereas in 11 studies, the 
characteristics of persons with co-occurring alcohol and drug use problems were 
compared to those of one other group only (either persons with alcohol or drug 
problems), eight studies included comparisons with both groups.  
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The results section consists of three parts: socio-demographic characteristics 
(age, sex, ethnicity/nationality/country of birth and socio-economic status), 
addiction severity measures and psychopathological profile (mood, anxiety and 
personality disorders, overall psychological problems or distress).  
 
 
4.3.1. Socio-demographic characteristics 
 
Sex. Results on sex differences are not equivocal. In a number of both 
community as well as treatment sample studies, individuals with co-occurring 
alcohol and drug use problems were found to be significantly more often male as 
compared to individuals with alcohol use problems only (Colpaert, 
Vanderplasschen, Van Hal & Broekaert, 2008, Martin et al., 1996; Midanik, Tam 
& Weisner, 2007; Tam, Weisner & Mertens, 2000) and also compared to 
individuals with drug use problems only (Backmund, Schütz, Meyer, Eichenlaub 
& Soyka, 2003; Campbell et al., 2006; Finkbiner & Wisdom, 2000; Senbanjo et 
al., 2006; Stinson et al., 2005). The prevalence of co-occurring alcohol and drug 
use problems is generally lower in females than in males (Falk et al., 2008). 
However, a number of other studies did not report any sex differences when 
comparing persons co-occurring alcohol and drug use problems to those with 
alcohol use problems only (Dick et al., 2007; Driessen et al., 2008; Echeburúa, 
De Medina & Aizpiri, 2009; Stinson et al., 2005) or to those with drug use 
problems only (Colpaert et al., 2008; Driessen et al., 2008; Gossop et al., 2002). 
In the various studies, the percentage of women among persons with co-
occurring alcohol and drug use problems is situated between 15.8% and 40.7%.  
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Table 4.1. : Overview of selected studies, including sample type and size, country and compared groups  
 
 Type of sample (country, size) Comparison between 
  A D A+D 
 
Backmund, M., Schütz, C. G., Meyer, K., 
Eichenlaub, D., & Soyka, M. (2003).  
 
Drug treatment  
(Germany, n=1,685) 
 
- 
 
Persons meeting the 
criteria for opioid or 
multiple addiction, 
admitted to inpatient 
detox treatment, without 
co-abuse of alcohol 
(>40g per day) 
 
Persons meeting the 
criteria for opioid or 
multiple addiction, 
admitted to inpatient 
detox treatment, with co-
abuse of alcohol (>40g 
per day) 
 
Caetano, R., & Schafer, J. (1996).  Alcohol treatment  
(US, n=731) 
Alcohol-dependent 
clients admitted to 
alcohol treatment 
programs who reported 
no drug use (other than 
alcohol) (5 times or 
more) in the 12 months 
preceding the interview 
- Alcohol-dependent 
clients admitted to 
alcohol treatment 
programs who reported 
drug use (other than 
alcohol) (5 times or 
more) in the 12 months 
preceding the interview 
 
Campbell, J. V., Hagan, H., Latka, M., 
Garfein, R. S., Golub, E. T., … Strathdee, S. 
A. (2006). 
Community sample of drug users  
(US, n=598) 
- HCV positive, HIV 
negative injection drug 
users in the community 
with an AUDIT        
score < 8 
HCV positive, HIV 
negative injection drug 
users in the community 
with an AUDIT       
score >= 8 
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Colpaert, K., Vanderplasschen, W., Van Hal, 
G., & Broekaert, E. (2008).  
 
Alcohol and drug treatment  
(Belgium, n=1,626) 
 
Persons in alcohol or 
drug treatment who have 
regularly (at least 2 or 3 
times a week) used 
alcohol (>= 5 glasses) 
during the 3 months 
preceding the intake 
interview. No regular use 
of other drugs.  
 
Persons in alcohol or 
drug treatment who have 
regularly (at least 2 or 3 
times a week) used an 
illicit drug during the 3 
months preceding the 
intake interview. No 
regular use of alcohol 
(>= 5 glasses). 
 
 
Persons in alcohol or 
drug treatment who have 
regularly (at least 2 or 3 
times a week) used both 
alcohol (>= 5 glasses) 
and at least one illicit 
drug during the 3 months 
preceding the intake 
interview.  
Compton, W. M., Thomas, Y. F., Stinson, F. S. 
& Grant, B. F. (2007). 
Community sample – NESARC 
study  
(US, n=43,093) 
- Persons who meet the 
criteria for DSM-IV past 
12-month drug use 
disorder only; separate 
figures availabe for 
abuse and dependence  
Persons who meet the 
criteria for DSM-IV past 
12-month alcohol and 
drug use disorder; 
separate figures availabe 
for abuse and 
dependence 
 
Dick, D. M., Agrawal, A., Wang, J. C., 
Hinrichs, A., Bertelsen, S., Bucholz, K. K., … 
Bierut, L. J. (2007). 
Community sample of persons with 
alcohol problems – COGA sample 
(US, n=910) 
Persons who meet the 
criteria for DSM-IV 
lifetime alcohol 
dependence only 
 
- Persons who meet the 
criteria for both DSM-IV 
alcohol as well as DSM-
IV drug dependence 
Driessen, M., Schulte, S., Luedecke, C., 
Schaefer, I., Sutmann, F., Ohlmeier, M., … the 
TRAUMAB-Study Group. (2008). 
Alcohol and drug treatment  
(Germany, n=459) 
Persons admitted to an 
addiction treatment 
center, meeting the 
criteria for DSM-IV 
alcohol dependence only 
Persons admitted to an 
addiction treatment 
center, meeting the 
criteria for DSM-IV drug 
dependence only 
Persons admitted to an 
addiction treatment 
center, meeting the 
criteria for both DSM-IV 
alcohol as well as drug 
dependence  
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Echeburúa, E., De Medina, R. B., & Aizpiri, J. 
(2009). 
 
Alcohol treatment  
(Spain, n=158) 
 
Alcohol-dependent 
outpatients who do not 
meet the DSM-IV 
criteria for cocaine abuse 
 
 
- 
 
Alcohol-dependent 
outpatients who meet the 
criteria for cocaine abuse 
Falk, D., Yi, H. – Y. & Hiller-Sturmhöfel, S. 
(2008). 
Community sample – NESARC 
study 
(US, n=43,093) 
Persons who meet the 
criteria for DSM-IV past 
12-month alcohol use 
disorder only 
 
Persons who meet the 
criteria for DSM-IV past 
12-month drug use 
disorder only 
Persons who meet the 
criteria for DSM-IV past 
12-month alcohol and 
drug use disorder 
Finkbiner & Wisdom 2000 Alcohol and drug treatment  
(US, n=4,411) 
Clients who entered 
treatment for alcohol 
problems only  
Clients who entered 
treatment for drug 
problems only 
Clients who entered 
treatment for both 
alcohol and drug 
problems  
Gossop, M., Marsden, J., & Stewart, D. (2002). Drug treatment  
(Great Britain, n=735) 
- Clients in drug misuse 
treatment, who are non 
(SDS score = 0) or low 
(SDS score between 1 
and 5) dependent on 
alcohol as measured with 
the Severity of 
Dependence Scale for 
Alcohol 
 
Clients in drug misuse 
treatment, who are high 
(SDS score is 6 or 
above) dependent on 
alcohol as measured with 
the Severity of 
Dependence Scale for 
Alcohol 
Hasin, D.S., Stinson, F.S., Ogburn, E. & Grant, 
B.F. (2007).  
Community sample – NESARC 
study  
(US, n=43,093) 
Persons who meet the 
criteria for DSM-IV past 
12-month alcohol use 
disorder only; separate 
figures availabe for 
abuse and dependence 
- Persons who meet the 
criteria for DSM-IV past 
12-month alcohol and 
drug use disorder; 
separate figures availabe 
for abuse and 
dependence 
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Kandel, D. B., Huang, F. Y., & Davies, M. 
(2001). 
 
Community sample – based on 
NHSDA surveys  
(US, 39,994) 
 
Persons who meet DSM-
IV criteria for past 12-
month alcohol 
dependence only (proxy 
measure; only 5 out of 7 
criteria included in the 
survey) 
 
 
Persons who meet DSM-
IV criteria for past 12-
month drug  dependence 
only (proxy measure; 
only 5 out of 7 criteria 
included in the survey) 
 
Persons  as who meet 
DSM-IV criteria for past 
12-month alcohol as well 
as  dependence (proxy 
measure; only 5 out of 7 
criteria included in the 
survey) 
Martin, C. S., Clifford, P. R., Maisto, S. A., 
Earleywine, M., Kirisci, L., & Longabaugh, R. 
(1996). 
Alcohol treatment  
(US, n=212) 
Problem drinkers in 
inpatient treatment who 
did not engage in 
simultaneous use of 
other drugs in the 120 
days before treatment 
 
- Problem drinkers in 
inpatient treatment who 
engaged in simultaneous 
use of other drugs in the 
120 days before 
treatment 
Midanik, L. T., Tam, T. W., & Weisner, C. 
(2007). 
Community  
(US, n=7,612) 
Current drinkers who 
reported no concurrent 
or simultaneous use of 
marijuna or other drugs 
in the past 12 months  
- Current drinkers who 
reported concurrent or 
simultaneous use of 
marijuana or other drugs 
in the past 12 months 
Miles, D.R., Svikis, D.S., Kulstad, J.L. & 
Haug, N.A. (2001) 
Drug treatment 
(US, n=170) 
- Pregnant women 
attending a 
comprehensive program 
for cocaine or opiate 
dependence, meeting the 
DSM-III-R criteria for 
drug dependence 
Pregnant women 
attending a 
comprehensive program 
for cocaine or opiate 
dependence, meeting the 
DSM-III-R criteria for 
both alcohol and drug 
dependence 
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Senbanjo, R., Wolff, K. & Marshall, J. (2006). 
 
Drug treatment 
(Great Britain, n=192) 
 
- 
 
Persons attending 
outpatient methadone 
clinics with a score on 
the AUDIT < 8 
 
Persons attending 
outpatient methadone 
clinics with a score on 
the AUDIT of >= 8 
 
Stinson, F. S., Grant, B. F., Dawson, D. A., 
Ruan, W. J., Huang, B., & Saha, T. (2005). 
Community sample – NESARC 
study  
(US, n=43,093) 
Persons who meet the 
criteria for DSM-IV past 
12-month alcohol use 
disorder only 
Persons who meet the 
criteria for DSM-IV past 
12-month any drug use 
disorder only 
Persons who meet the 
criteria for DSM-IV past 
12-month alcohol and 
any drug use disorder 
 
Tam, T. W., Weisner, C., & Mertens, J. (2000). Alcohol treatment  
(US, n=708) 
Clients in alcohol 
treatment  meeting the 
DSM-III-R criteria for 
alcohol dependence 
- Clients in alcohol 
treatment meeting the 
DSM-III-R criteria for 
both alcohol and drug 
dependence 
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Age. There is an overall agreement, both in community as well as in treatment 
sample studies, that individuals with both alcohol and drug use problems are 
significantly younger than individuals with alcohol use problems only (Colpaert 
et al., 2008; Driessen et al., 2008; Echeburúa et al., 2009; Falk et al., 2008, 
Finkbiner & Wisdom, 2000, Martin et al., 1996; Midanik et al., 2007; Stinson et 
al., 2005; Tam, Weisner & Mertens, 2000).  
There is less agreement on age differences between persons with drug problems 
only versus those with co-occurring alcohol and drug use problems. Based on the 
NESARC data, Stinson and colleagues (2005) concluded that among persons 
with co-occurring alcohol and drug use disorders, a larger proportion of “18-29 
years olds” can be found than among persons with drug use disorders only. In 
treatment sample studies, either the opposite or either no age differences were 
found. Drug users in treatment who are also highly dependent on alcohol 
(Gossop et al., 2002) or regularly and excessively use alcohol (Backmund et al., 
2003; Colpaert et al., 2008) were found to be older than those clients only having 
drug problems. In four studies (Driessen et al., 2008; Finkbiner & Wisdom, 
2000; Miles, Svikis, Kulstad & Haug, 2001; Senbanjo et al., 2006) no age 
differences were observed between groups. Also in a community sample of 
injection drug users no age difference were reported between persons with and 
without alcohol problems (Campbell et al., 2006). The mean age among persons 
with both alcohol and drug use problems was situated between 29.6 and 34.0 
years old.  
 
Ethnicity, nationality or country of birth. Most studies found that, compared to 
individuals with alcohol use problems only, individuals with co-occurring 
alcohol and drug use disorders were less likely to be White (Finkbiner & 
Wisdom, 2000; Midanik et al., 2007; Stinson et al., 2005; Tam et al., 2000) or to 
have been born in the country where the study took place, i.c. Belgium (Colpaert 
et al., 2008). Caetano and Schafer (1996) examined cross-ethnic differences in 
alcohol and drug dependence in a sample of Whites, Blacks and Mexican 
Americans admitted to alcohol treatment services. The percentage of Blacks and 
Mexican Americans reporting also other drug use was significantly higher than 
among Whites but no significant differences were found at the level of drug 
dependence. Three studies did not find any significant association between type 
of substance use problem (alcohol versus alcohol and drugs) and ethnicity (Dick 
et al., 2007; Driessen et al., 2008; Echeburúa et al., 2009).  
Next, comparing persons with drug problems only and persons with co-occurring 
alcohol and drug use problems, Stinson and colleagues (2005) found no 
differences in ethnicity. Also in three drug treatment sample studies, no 
differences were reported (Driessen et al., 2008; Gossop et al., 2002; Senbanjo et 
al., 2006). However, in the treatment sample study of Colpaert and colleagues 
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(2008), persons with drug problems only were significantly more often born in 
another country than Belgium and also in the study of Miles and colleagues 
(2001) higher percentages of African-Americans were registered among drug-
dependent pregnant women without co-occurring alcohol dependence. As 
compared to persons with drug problems only and in the study of Campbell and 
colleagues (2006), a score higher than 8 on the AUDIT screening instrument was 
associated with Hispanic ethnicity among injection drug users.  
 
Socio-economic status. There is overall agreement that individuals with alcohol 
use problems only have a higher educational level than persons with co-
occurring alcohol and drug use problems (Driessen et al., 2008; Echeburúa et al., 
2009; Finkbiner & Wisdom, 2000; Midanik et al., 2007; Stinson et al., 2005; 
Tam et al., 2000). Furthermore, compared to the alcohol-only group, persons 
with co-occurring alcohol and drug use problems are more likely to have a lower 
income, to be unemployed or to have a lower socioeconomic status (Colpaert et 
al., 2008; Driessen et al., 2008; Finkbiner & Wisdom, 2000; Midanik et al., 
2007; Stinson et al., 2005). Whereas one study found no significant differences 
with regard to the socio-economic status of alcoholics with and without cocaine 
abuse (Echeburúa et al., 2009), another study found significant differences for 
income, but not for employment status (Tam et al., 2000).  
No differences were observed between persons with drug use problems only and 
co-occurring alcohol and drug use problems (Campbell et al., 2006; Colpaert et 
al., 2008; Driessen et al., 2008; Finkbiner & Wisdom, 2000; Miles et al., 2001; 
Stinson et al., 2005) with regard to level of education, employment and income 
status except for one study in which methadone patients with problematic 
alcohol use problems were more often unemployed than those without (Senbanjo 
et al., 2006).  
 
 
4.3.2. Addiction severity measures 
 
Abuse and dependence. Whereas individuals meeting the criteria for current 
drug abuse are 6.4 times more likely to also meet the criteria for an alcohol use 
disorder, those meeting the criteria for current drug dependence are 15 times 
more likely to meet the criteria for a current alcohol use disorder, in comparison 
with individuals not meeting the criteria for drug abuse or dependence 
respectively (Compton, Thomas, Stinson & Grant, 2007). Conversely, 
individuals meeting the criteria for current alcohol abuse are 2.8 times more 
likely to also meet the criteria for a drug use disorder, those meeting the criteria 
for current alcohol dependence are 9.8 times more likely to meet the criteria for a 
current drug use disorder, in comparison with individuals not meeting the criteria 
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for current drug abuse or dependence respectively (Hasin, Stinson, Ogburn & 
Grant, 2007). However, Martin and colleagues (1996) reported no differences 
between problem drinkers with and without co-occurring illicit drug use in an 
inpatient treatment sample with regard to the scores on the Alcohol Dependence 
Scale and also Gossop and colleagues (2002) did not observe any differences in 
the mean severity of dependence scale (SDS) score for the main problem 
between drug users who are not, low or high dependent on alcohol. Dick and 
colleagues (2007) found persons with both alcohol and drug use disorders to 
meet a higher number of DSM alcohol dependence diagnostic criteria as 
compared to persons with alcohol use disorders only. Finally, in another study 
(Midanik et al., 2007), simultaneous use of alcohol and other drugs (but not 
concurrent use) appeared an important predictor for a diagnosis of alcohol 
dependence among current drinkers. 
  
ASI severity scores. In clinical settings, dual-dependent persons are found to 
have significantly higher scores on the Addiction Severity Index for the domains 
drug use, employment, legal situation, family and social situation and psychiatric 
status compared to alcohol-dependent persons. The latter have higher severity 
scores on the domain alcohol (Tam et al., 2000).  
 
Age of onset and duration of use. Persons with co-occurring alcohol and drug 
use problems also have a younger age of onset of (regular) use of alcohol or 
drugs, first drunkenness and dependence as well as significantly higher number 
of years of regular alcohol use compared to persons who are alcohol-dependent 
only (Dick et al., 2007; Tam et al., 2000). Among persons with drug problems, 
an earlier age of first injection (Campbell et al., 2006) and a longer duration of 
drug use (Backmund et al., 2006) were reported when co-occurring alcohol 
problems were present. In the study of Miles and colleagues (2001), no 
differences in age of first use of alcohol, cocaine and marihuana were reported 
between drug-dependent pregnant women with or without co-occurring alcohol 
dependence. Only for opiates, a younger age of onset was reported among drug-
dependent women without alcohol dependence.  
 
Previous treatment history. Across studies, clients who started treatment 
because of problems with both alcohol and drugs mostly had significantly higher 
rates of previous substance abuse treatment as compared to persons with drug 
problems only (Colpaert et al., 2008; Finkbiner & Wisdom, 2000; Gossop et al., 
2002). In the study of Campbell and colleagues (2006) higher rates were found 
for previous alcohol treatment not for previous drug treatment among clients 
with both alcohol and drug use problems as compared to drug problems only. In 
comparison with persons with alcohol problems only, three studies found higher 
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rates of previous treatment among persons with co-occurring alcohol and drug 
problems (Dick et al., 2007; Finkbiner & Wisdom, 2000; Stinson et al., 2005). 
whereas Colpaert and colleagues (2008) reported no significant differences.  
 
 
4.3.3. Psychopathological profile 
 
   Mood disorders 
 
Stinson and colleagues (2005) found that persons with both alcohol and drug use 
disorders were significantly more likely to have a comorbid past-year mood 
disorder (including major depressive episode, dysthymia, mania and/or 
hypomania) when compared to those with an alcohol use disorder only (35.3% 
vs. 16.4% respectively). For major depressive episode and mania this was 
confirmed in the study of Dick and colleagues (2007), who compared individuals 
with a lifetime alcohol dependence with a comorbid drug dependence to those 
without drug comorbidity in the framework of the COGA study. While 
controlling for a number of socio-demographical variables, Kandel and 
colleagues (2001) showed that for major depressive episode the adjusted OR 
doubled for persons concurrently dependent on both an illicit and licit drugs as 
compared to persons dependent on alcohol only (OR=3.7 versus OR=1.8) as 
measured by screening scales. Midanik and colleagues (2007) added an extra 
dimension to the studies already mentioned and examined two forms of 
combined drug and alcohol use in relation to depression: simultaneous and 
concurrent use. Simultaneous use was defined as using alcohol and drugs 
sometimes or always simultaneously and concurrent use was defined as using 
alcohol and drugs in the same time period but never simultaneously. In logistic 
regression analyses, both simultaneous as concurrent use of alcohol and drugs 
(marihuana or other) (versus alcohol only) were significant predictors for 
depression, as measured by the short version of the Center for Epidemiological 
Studies Depression Scale (CES-D), while controlling for socio-demographics 
and drinking patterns.  
Stinson and colleagues (2005) did not find any significant differences between 
individuals with drug use problems and those with co-occurring drug and alcohol 
use problems regarding the prevalence of past-year mood disorders (27.5% vs. 
35.3%). No significant differences regarding the AOR for major depressive 
episode were reported in the study of Kandel and colleagues (2001): AOR=1.8 
(alcohol only) versus AOR=3.7 (alcohol and illicit drugs). Campbell and 
colleagues (2006) on the other hand found a significant association between 
scores on the AUDIT and on the Beck Depression Inventory among injecting 
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drug users. Problem drinkers (score >= 8 on the AUDIT) were more likely to 
report depressive symptoms (score >= 19 on the BDI).  
 
 
   Anxiety disorders 
 
Stinson and colleagues (2005) found that persons with both alcohol and drug use 
disorders were significantly more likely to have a comorbid anxiety disorder 
(including panic disorder with(out) agoraphobia, social phobia, specific phobia 
and/or generalized anxiety) when compared to those with an alcohol use disorder 
only (26.5% vs. 15.6% respectively). Dick and colleagues (2007) also found 
higher rates of any anxiety disorder among individuals with a lifetime alcohol 
dependence and comorbid drug dependence as compared to those without. 
Kandel and colleagues (2001) found that, on the basis of a screening scale, the 
adjusted OR for any anxiety syndrome (including generalized anxiety disorder, 
panic attack and agoraphobia) doubled for persons concurrently dependent on 
both an illicit and licit drugs as compared to persons dependent on alcohol only 
(OR=4.7 versus OR=2.6). Driessen and colleagues (2011) examined the 
prevalence of Post Traumatic Stress Disorder (PTSD) in 459 treatment-seeking 
persons with substance use problems. PTSD was only diagnosed when 
confirmed by both the International Diagnostic Checklists (IDCL) and the Post-
traumatic Diagnostic Scale (PDS). When comparing the prevalence rates of 
alcohol-, drug- and dual-dependent patients, they found that alcohol-dependent 
patients had significantly lower PTSD prevalence rates as compared with dual-
dependent patients (15.4% vs. 34.1% respectively). 
Stinson and colleagues (2005) did not find any significant differences between 
individuals with drug use problems and those with co-occurring drug and alcohol 
use problems regarding the prevalence of past-year anxiety disorders (24.0 vs. 
26.5%). Also Driessen and colleagues (2006) did not find differences in PTSD 
prevalence rates between drug- and dual-dependent persons (29.9% vs. 34.1%). 
This was not the case in another study (Kandel, Huang & Davies, 2001), that 
observed significantly higher odds for any anxiety syndrome among persons 
dependent on alcohol and illicit drugs as compared to illicit drugs only. 
 
 
   Personality disorders 
 
Stinson and colleagues (2005) found that persons with both alcohol and drug use 
disorders were significantly more likely to have a comorbid personality disorder, 
including avoidant, dependent, obsessive-compulsive, paranoid, schizoid, 
histrionic and/or anti-social personality disorder, when compared to those with 
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an alcohol use disorder only (50.8% vs. 25.3% respectively). Significantly higher 
rates of antisocial personality disorder were also reported by Dick and colleagues 
(2007). Echeburúa and colleagues (2009) examined personality pathology in 
substance users and found no differences between the alcohol-only group 
(53.1%) and the dual (alcohol + cocaine) group (62.9%). However, on the level 
of the individual PDs the latter had significantly higher rates for anti-social, 
borderline and narcissistic PD and on a cluster level, they had higher rates of 
cluster B and lower rates of cluster A PDs as compared with the alcohol-only 
group. 
Only one large community sample study (Stinson et al., 2005) examined 
differences in personality pathology between persons with drug problems versus 
those with co-occurring alcohol and drug use problems and did not find any 
significant differences (44.0% vs. 50.8%).  
 
 
   Psychological distress or problems 
 
In a number of studies, no structured clinical assessment instruments for mood, 
anxiety or personality disorders were used. Rather, overall measures of 
psychological problems (such as the psychiatric section of the Addiction 
Severity Index), psychological distress (such as the Brief Symptom Inventory or 
the SCL-90) or perceived psychological problems were used. Overall, persons 
with co-occurring alcohol and drug use problems had higher rates of 
psychological problems and distress as compared to persons with alcohol or drug 
use problems only. Tam, Weisner and Mertens (2000) studied 491 alcohol-only 
and 217 alcohol-and-drug dependent patients, all admitted to the chemical 
dependence program of a health maintenance organization (HMO). They found 
that the alcohol-and-drug group had a significantly higher problem severity on 
the ASI psychiatric subdomain than the alcohol-only group. Higher rates of 
depression, hallucinations, trouble concentrating, violent behavior, suicidal 
thoughts and the use of prescribed medication for psychiatric problems but not 
severe anxiety or attempted suicide were reported. Also Echeburúa and 
colleagues (2009) found that alcohol-dependent persons also manifesting cocaine 
abuse had higher rates of psychological distress as measured with the SCL-90, 
both on the global severity index as on hostility, as compared to persons 
dependent on alcohol only (Echeburúa et al., 2009).  
Gossop and colleagues (2002) reported that drug users who were high-dependent 
on alcohol (based on a Severity of Dependence Scale score of >= 6 for alcohol) 
had significantly higher scores for total psychological health and for anxiety, 
depression and paranoid ideation, as measured with the Brief Symptom 
Inventory (BSI), in comparison with drug users who were not (SDS-A = 0) or 
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only low-dependent (SDS-A between 1 and 5) on alcohol. High alcohol-
dependent drug users also had significantly higher scores for psychoticism in 
comparison with the non-alcohol-dependent, but not with the low alcohol-
dependent drug users. Senbanjo and colleagues (2006) reported that methadone 
patients who obtained an AUDIT score >= 8 experienced significantly more 
often one or more psychological health problems, anxiety or panic attacks, and 
fits or seizures, than patients with lower AUDIT scores. No differences were 
found for low mood nor for self-harm or suicide attempts. Among pregnant 
women in a comprehensive treatment program for cocaine or opiate dependence, 
higher levels of psychopathology were observed among women with a co-
occurring alcohol dependence as measured with the Minnesota Multiphasic 
Personality Inventory–Revised (MMPI-2). Higher scores were reported on the 
scales Depression, Psychopathic Deviance, Schizophrenia and Social 
Introversion (Miles et al., 2001).  
 
 
 
4.4. Discussion 
 
 
The objective of this review was to examine the available literature on 
similarities and differences between persons with co-occurring alcohol and drug 
use problems versus alcohol or drug use problems only with regard to socio-
demographics, addiction severity and psychopathology. First, the overall 
findings are discussed, next some methodological and terminological issues are 
raised. Implications for future research are discussed wherever appropriate.  
 
 
4.4.1. Overall findings 
 
As Byqvist stated in 1999, alcohol plays an important role in poly drug use 
patterns which are found to be the rule rather than the exception (Byqvist, 1999). 
This was confirmed in our review: high prevalence rates of alcohol use problems 
among individuals with drug use problems were found and vice versa, this in 
both community as well as treatment sample studies. However, our search of the 
literature resulted in 19 studies that contained information on one or more 
characteristics of persons with co-occurring alcohol and drug use problems, of 
which 10 studies contained information on persons’ psychopathological status. 
One could therefore say that, over a period of 20 years (1991-2011), the 
scientific attention for the issue of co-occurring alcohol and drug use problems 
has stayed rather modest. Although this implies that solid conclusions are 
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difficult to draw, the findings of the present review clearly emphasize the need to 
continue the study of co-occurring alcohol and drug use problems. The joint 
(ab)use of illicit drugs and alcohol and associated problems are for many 
substance users a daily reality, but the world of alcohol research on the one hand 
and drug research on the other hand appear to have each developed an own 
“discursive reality” (Hakkarainen & Metso, 2009, p.114) in which the number of 
so-called “cross-over studies” remains limited. Researchers are likely to focus on 
either alcohol or illicit drugs, and either assume that primary alcohol users do not 
use other substances, exclude persons who also use other substances to get a 
more pure sample, forget to include information on the use of other substances or 
believe that the (ab)use of additional substances, next to alcohol, is not relevant 
for their study objectives. In reviews on alcohol treatment outcome studies 
(Breslin, Sobell, Sobell & Sobell, 1997) and drug treatment outcome studies 
(Ellingstad, Sobell, Sobell & Planthara, 2002), the influence of several 
pretreatment variables on treatment outcome was reviewed. Surprisingly, in the 
review on alcohol treatment outcome studies the use of secondary substances of 
abuse was not reviewed (Breslin et al.; 1997) and in the review on drug treatment 
outcomes studies it was concluded that the use of secondary substances was 
reported only in 25% of the cases. This way, the reality of poly drug use and its 
possible implications is insufficiently acknowledged; certain associations could 
have been confounded and the (un)observed effects may have been due to co-
occurring use of or dependence upon other substances (Barrett, Darredeau & 
Pihl, 2006; Byqvist, 2006; Parrott, 2001). Although it is not easy to adequately 
define and measure poly drug use (Schensul, Convey & Burkholder, 2005), we 
cannot hesitate to take on this challenge. When poly drug use is the rule rather 
than the exception, it is indispensable to adopt a multiple drug focus in substance 
abuse clinical trials (Rounsaville, Petry & Carroll, 2003) and other community or 
treatment sample studies.  
 
Our review of the literature also demonstrates that individuals with alcohol 
problems and those with co-occurring alcohol and drug use problems clearly 
have a different socio-demographic profile and are two distinct subgroups. 
Individuals who also have problems with drugs are younger, have a lower socio-
economic status and are less often White or born in the country where their study 
took place. Only with regard to sex differences, results are not equivocal. 
Whereas some studies found a higher proportion of males among those who also 
have problems with drugs, other studies did not find any differences.  
Our review also shows that the profile of individuals with co-occurring alcohol 
and drug use disorders is not so clear-cut when compared to that of individuals 
with drug problems only. For most of the socio-demographic variables, divergent 
findings are reported. Only for socio-economic status, all but one of the studies 
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found no differences between persons with drug problems on the one hand and 
persons with both alcohol and drug problems on the other hand. Analyses of the 
available evidence also showed that, with a few exceptions, most studies agreed 
that persons with co-occurring alcohol and drug use problems have a higher 
addiction severity than persons with alcohol use problems only but when 
compared to persons with illicit drug problems only, results are indecisive.   
 
Also regarding mood, anxiety and personality disorders on the one hand and 
overall psychological problems or distress on the other hand, similar conclusions 
can be formulated. There is overall consensus that persons with co-occurring 
alcohol and drug use problems have a more severe psychopathological profile 
compared to persons with alcohol use problems only. These findings are in line 
with the various typologies of alcoholism that have been developed over the 
years, such as the type I/II typology of Cloninger (1987) and the type A/B 
typology of Babor and colleagues (1992). The latter identified type A and type B 
alcoholics in which type A are alcoholics with a later onset, less severe 
dependence and less psychopathology whereas type B alcoholics are 
characterized by familial alcoholism, early onset, greater severity of dependence, 
a more chronic treatment history and poly drug use. 
 
The findings of studies examining the psychopathological similarities and 
differences between persons with drug use problems and persons with co-
occurring drug and alcohol use problems are very divergent. Whereas for mood 
and personality disorders no consensus between studies was found, for anxiety 
disorders, there was an overall consensus that there were no differences between 
groups. However, at the level of psychological problems and distress, the results 
of all available studies went in the same direction, reporting higher scores on 
measures of (perceived) psychological problems or distress among persons with 
co-occurring drug and alcohol use problems compared with persons with drug 
problems only.  
 
 
4.4.2. Terminological and methodological issues 
 
The studies that were included in this review all focused on “co-occurring 
alcohol and drug use problems” but various terms were used in the different 
studies, depending on the alcohol and drug measures that were used: joint use of 
drugs and alcohol (Hakkarainen & Metso, 2009), concurrent and simultaneous 
drug and alcohol use (Midanik et al., 2007), dual dependence (Gossop et al., 
2002), concurrent drug and alcohol dependency (Johnson, 2006) or co-occurring 
alcohol and other drug use disorders (Kranzler & Li, 2008).  
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A wide array of screening and assessment methods was used to distinguish 
between persons with alcohol/drug problems with and without co-occurring 
drug/alcohol problems such as the AUDIT (Campbell et al., 2006), grams of 
alcohol per day (Backmund et al., 2003), the Severity of Dependence Scale for 
Alcohol (Gossop et al., 2002), the self-defined reason for entering treatment 
(Finkbiner & Wisdom, 2000), regular use according to the alcohol and drugs 
section of the ASI (Colpaert et al., 2008) and abuse or dependence according to 
the DSM-IV (Driessen et al., 2008; Stinson et al., 2005; Tam et al., 2000). In 
most studies only two out of three groups (alcohol, drugs or alcohol + drugs) 
were compared. While focusing on problem drinkers, individuals with current 
alcohol dependence, illicit drug users, injecting drug users, methadone clients, 
etc … the prevalence of co-occurring problematic use, abuse or dependence of 
the other category of substances (either alcohol or drugs) is assessed. However, 
in order to get a more comprehensive overview, comparisons between all three 
groups (A, D, A+D) are particularly useful in order to cover the whole spectrum 
of substance use problems.  
A third observation in this respect is that the time frames in which the “co-
occurrence” took place were very different across studies: having regularly used 
a substance during the past 3 months (Colpaert et al., 2008), current dependence 
(Driessen et al., 2008), dependence during the past year (Stinson et al., 2005) or 
lifetime dependence (Dick et al., 2007). Although we believe that the use of 
lifetime measures can be adequate to study certain (e.g. etiological) research 
questions on co-occurring alcohol and drug use problems, overall we agree with 
Falk and colleagues (2008) that current measures are more appropriate to study 
the relation between co-occurring alcohol and drug use problems. After all, the 
idea is that alcohol and drug problems are present more or less 
contemporaneously and when problematic use, abuse or dependence is assessed 
on a lifetime basis, it is possible that the problems have occurred in very 
different time periods of a persons’ life, with many years in between and 
therefore have not both been present at the same time. 
 
To enhance communication and comparison between studies, future studies 
should use reliable and validated clinical assessment instruments (e.g. based on 
the DSM-IV or future DSM-5) on the one hand, but should also incorporate the 
subjective perception of clients. Research has shown that there is often a large 
discrepancy between traditional or socially desirable (outcome) measures and 
individuals’ subjective perspectives (Donovan, Mattson, Cisler, Longabaugh & 
Zweben, 2005; Foster, Peters & Marshall, 2000). Also in the present review, this 
difference was observed. Whereas persons with co-occurring alcohol and drug 
problems had consistently higher rates on (perceived) psychological problems or 
distress than persons with drug problems only, the results of the studies that used 
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structured clinical assessment instruments based on the DSM-IV were diverging. 
Attention for person-centered outcomes (e.g. QoL), starting from the personal 
perspectives of substance dependent individuals can be useful to gain insight into 
the aspects that differentiate between persons with alcohol and drug use 
problems and persons with alcohol or drug use problems only. Especially in view 
of the chronic nature of substance dependence, it is more and more 
acknowledged that Quality of Life (QoL) can be applied as a useful assessment 
and outcome measure in substance abuse treatment (Foster, Powell, Marshall & 
Peters, 1999; Foster et al., 2000). 
 
 
4.4.3. In conclusion 
 
The strength of the present review was that for the first time all available studies 
were gathered in order to get an overview of existing descriptive studies on co-
occurring alcohol and drug problems. Despite large differences between studies 
with regard to terminology, screening and assessment methods and time frames, 
our findings showed that persons with co-occurring alcohol and drug use 
problems clearly have different profiles as compared to persons with alcohol use 
problems. Compared to persons with drug problems only, findings are not as 
clear-cut and our hypothesis of a higher overall problem severity could not be 
confirmed. This could possibly be explained by methodological differences 
between studies with regard to the use of different assessment instruments and 
time frames.  
 
Further studying co-occurring alcohol and drug use problems is important, all the 
more since a number of countries, such as Canada, Japan and Belgium, have 
alcohol and drug treatment systems with a rather low level of integration 
(Bergmark, 1998), which raises questions on the attention to drug problems 
within alcohol treatment settings and vice versa. In future studies on the subject, 
both reliable and validated clinical assessment instruments as well as instruments 
capturing the subjective perception of clients should be used. Further, not only 
descriptive studies but also studies focusing on the underlying etiological 
mechanisms or on the effectiveness of treatment modalities could provide 
interesting insights. 
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Abstract 
 
 
The present study compares the prevalence rates of twelve DSM-IV Personality 
Disorders (PDs) in patients with an alcohol, drug and dual dependence through 
chi-square tests and analyses of variance and investigates the socio-demographic 
and substance-related variables (nature and severity) as possible predictors of 
these twelve PDs through multiple linear regression analyses. Data were 
gathered in 2007 and 2008 among 274 patients admitted to intensive, residential 
substance abuse treatment programs in Belgium, using the ADP-IV 
questionnaire (Assessment of DSM Personality Disorders IV), the European 
Addiction Severity Index (EuropASI) and the Mini International 
Neuropsychiatric Interview (M.I.N.I.).  
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5.1.  Introduction 
 
5.1.1. Comorbidity between substance-related disorders and personality 
disorders  
 
Various studies have demonstrated a high level of comorbidity between 
personality and substance use disorders. Based on an extensive literature review, 
Verheul (2001) concluded that prevalence rates of personality disorders among 
substance abusers are about four times higher than among the general 
population, but that prevalence rates vary widely. Based on the available 
literature, persons in substance abuse treatment programs appeared to meet the 
criteria for at least one personality disorder in 34.8% to 73.0% of the cases 
(median: 56.5%) (Verheul, 2001). In particular, the association between 
substance use disorders and cluster B personality disorders (especially borderline 
and anti-social personality disorders) appears to be very robust (Moran, Coffey, 
Mann, Carlin & Patton, 2006; Rounsaville et al., 1998; Skodol, Oldham & 
Gallaher, 1999). 
 
Since the presence of personality pathology is associated with greater 
impairment (Skodol et al., 1999), stronger problem severity at treatment intake 
(Ross, Dermatis, Levounis & Galanter, 2003) and a lower quality of life 
(Fassino, Daga, Delsedime, Rogna & Boggio, 2004), it is important to timely 
detect personality disorders in substance abusers. Moreover, the presence of one 
or more personality disorders can seriously influence the course, prognosis and 
treatment outcome of substance use disorders. In most treatment outcome 
studies, higher rates of attrition and lower compliance have been observed in 
substance abusers with comorbid personality disorders than in those without 
(Kokkevi, Stefanis, Anastasopoulou & Kostogianni, 1998; Ross et al., 2003; 
Siqueland et al., 1998), as well as poorer outcomes for a number of alcohol-
related measures one year after treatment (Rounsaville, Dolinsky, Babor & 
Meyer, 1987). However, some of these studies did not control for pretreatment 
functioning and when pretreatment characteristics are controlled for, substance 
abusers with axis II comorbidity appear to benefit equally from treatment as 
those without. However, clients’ personality problems do have a strong influence 
on the course of addiction problems after discharge (e.g. time to relapse) 
(Verheul, 2001). 
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5.1.2.  Substance-specific comorbidity between substance-related and 
personality disorders  
 
Regardless of differences in sampling procedures and diagnostic instruments 
(Coid, Yang, Tyrer, Roberts & Ullrich, 2006), one of the elements that clearly 
explains the different prevalence rates and the results of the treatment outcome 
studies is the primary substance of abuse (Verheul, 2001). 
 
Within the framework of the National Epidemiologic Survey on Alcohol and 
Related Conditions (NESARC), the co-occurrence of 12-month alcohol and drug 
use disorders and personality disorders was assessed. The authors found that 
personality disorder prevalence figures were significantly higher among 
individuals with a current drug use disorder (47.7%) than among those with a 
current alcohol use disorder (28.6%) (Grant et al., 2004). When re-analyzing the 
NESARC data, Trull and colleagues (Trull, Jahng, Tomko, Wood & Sher, 2010) 
found that, when examining the comorbidity between PDs and lifetime 
substance-related dependence, people with a PD diagnosis were 5.01 times as 
likely as those without to have a lifetime alcohol dependence and 12.24 times as 
likely to have a drug dependence. Similar conclusions have been found in studies 
among clinical samples (Conway, Kane, Ball, Poling & Rounsaville, 2003; De 
Jong, Van den Brink, Harteveld & van der Wielen, 1993; Landheim, Bakken & 
Vaglum, 2003; Verheul, Van den Brink & Hartgers, 1995). Most of the 
aforementioned studies categorized substance abusers into two groups: (illicit) 
drug abusers on the one hand and alcoholics on the other. However, this 
dichotomy ignores the reality that many alcohol-dependent individuals are also 
dependent on other (illicit) drugs and that many drug-dependent individuals are 
also dependent on alcohol (Burns & Teesson, 2002; Caetano & Schafer, 1996; 
Degenhardt & Hall, 2003; Falk, Yi & Hiller-Sturmhöfel, 2008; Gossop, 
Marsden, Stewart & Rolfe, 2000; Grant & Pickering, 1996; Miller, Klamen, 
Hoffman & Flaherty, 1996; Ross, 1995; Smart, Ogborne & Newton-Taylor, 
1990; Regier et al., 1990; Stinson et al., 2005).  
 
Meeting the criteria for both DSM-IV alcohol dependence and drug dependence 
can be considered as an example of homotypic comorbidity, i.e. the co-
occurrence of disorders within a diagnostic section of the DSM (Angold, 
Costello & Erkanli, 1999), in this case the diagnostic section of substance-related 
disorders. Gossop and colleagues (Gossop, Marsden & Stewart, 2002) referred to 
this specific type of homotypic comorbidity of alcohol and drug dependence as 
“dual dependence”. Thus far, relatively little is known about the homotypic 
comorbidity of alcohol and drug use disorders (Falk et al., 2008). In particular, 
the psychopathological correlates of the homotypic comorbidity of alcohol and 
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drug use disorders have been understudied (Stinson et al., 2005). The limited 
number of studies that has been carried out thus far show that individuals with a 
dual dependence generally have more psychosocial problems or comorbid 
psychiatric disorders and a more extensive treatment history, suggesting a more 
severe treatment profile at baseline, than those who are merely dependent on 
alcohol or illicit drugs only (Colpaert, Vanderplasschen & Broekaert, 2008; Dick 
et al., 2007; Gossop et al., 2002; Miles, Svikis, Kulstad & Haug, 2001; Stinson et 
al., 2005; Tam, Weisner & Mertens, 2000). However, inconsistent findings have 
been reported concerning the prevalence of personality disorders. Whereas 
Stinson and colleagues (2005) found that people in the dual group (50.8%) were 
significantly more likely to have personality disorders as compared to the 
alcohol-only group (25.3%), other studies found no significant differences, for 
example between an alcohol-only group (53.1%) and dual (alcohol + cocaine) 
group (62.9%) (Echeburúa, de Medina & Aizpiri, 2009). When comparing the 
prevalence rates of personality disorders among people in the drug-only group 
(44.0%) and the dual group (50.8%), no significant differences were observed 
(Stinson et al., 2005). Whether or not dual dependence increases the likelihood 
of personality disorders among individuals with alcohol use disorders on the one 
hand and (illicit) drug use disorders on the other needs replication and further 
study (Stinson et al., 2005), since disentangling the concurrent epidemiology of 
substance abuse and personality disorders is essential for determining the course, 
prognosis and treatment outcomes of these disorders. 
 
 
5.1.3. Objectives of the present study 
 
Since the psychopathological correlates of the homotypic comorbidity of alcohol 
and drug use disorders have been understudied, this study sought to determine 
the prevalence of personality disorders among a clinical sample of individuals 
seeking residential substance abuse treatment and to compare prevalence rates 
and patterns of personality disorders between patients dependent on alcohol only 
(A), drugs only (D) and alcohol and drugs, the so-called dual-dependent (A+D) 
patients. Based on the limited number of available studies, it was hypothesized 
that patients in the A+D group would have significantly higher PD prevalence 
rates compared to patients in the A group, but that they would not significantly 
differ from patients in the D group. Furthermore, we wanted to examine 
substance-related predictors of personality disorders (nature and severity of 
substance abuse problems) while controlling for socio-demographic variables. It 
was hypothesized that an illicit drug profile (nature) and a more severe substance 
abuse profile (severity) would be associated with higher scores on personality 
pathology.  
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5.2. Material and methods 
 
5.2.1. Design and setting 
 
This study was set up as a multi-center, cross-sectional study. Data were 
collected between July 1st 2007 and October 31th 2008 in 11 units for substance 
abuse treatment, each situated within a psychiatric hospital in two specific 
regions in Belgium (East- and West-Flanders). In order to be included in the 
study, the psychiatric hospitals had to have a unit specializing in the intensive 
residential treatment of alcohol and/or drug abuse problems following an initial 
detoxification phase. The 11 psychiatric hospitals that were selected on the basis 
of this criterion agreed to participate in the study. In all participating units, data 
were collected during a period of four months. 
 
 
5.2.2. Participants 
 
In total, 274 patients were interviewed. All individuals who were consecutively 
admitted to one of the 11 participating units and who met the inclusion criteria 
were invited to participate in the study. In order to be eligible for the study, 
patients had to (a) have started a new residential treatment episode, (b) be older 
than 18 and (c) be able to speak and read Dutch. Individuals were excluded if (a) 
they had started day- or night-care treatment only, (b) had Korsakoff syndrome 
or very limited cognitive abilities, (c) suffered from acute psychotic symptoms, 
(d) had already participated in the study or (e) left the hospital before the seventh 
day after admission. After being informed in detail about the objectives of the 
study and their specific contribution, patients gave their informed written 
consent. The study was approved by the Ethics Committees of all participating 
psychiatric hospitals. 
 
During the data collection period, 682 individuals were admitted to one of the 
participating treatment units. About one third of the patients (n=248; 36.3%) did 
not meet the inclusion criteria, and 154 patients (22.6%) refused to participate in 
the study. Of the remaining 280 interviews that were conducted, six were not 
fully completed. In total, the data on 274 patients were included in the database. 
Comparisons between patients who were interviewed (n=280) and those who 
refused to participate (n=154) showed no significant differences with regard to 
age, gender or type of dependence (none, alcohol only, drugs only or dual 
dependence).  
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5.2.3. Procedure and interview instruments  
 
Data were collected using the EuropASI (Kokkevi & Hartgers, 1995), the 
M.I.N.I. (Sheehan et al., 1998) and the ADP-IV (Schotte, de Doncker, 
Vankerckhoven, Vertommen & Cosyns, 1998). One interview took an average of 
97.28 minutes (SD=22.31). All participants were interviewed between the 7th 
and 21st day after admission.  
 
The “Assessment of DSM-IV Personality Disorders (ADP-IV)” is a self-report 
instrument that assesses DSM-IV personality disorders (Schotte et al., 1998). It 
consists of 94 items, representing the 80 criteria of the 10 DSM-IV personality 
disorders and the 14 research criteria representing depressive and passive-
aggressive personality disorders in a randomized order. Each item needs to be 
scored on a trait (T) and on a distress (D) scale. The trait scale is a 7-point scale 
ranging from “totally disagree” (1) to “totally agree” (7). When an individual 
indicates agreement with the item (scores 5, 6 or 7), he/she needs to indicate the 
level of distress on a 3-point scale ranging from “totally not” (1) to “most 
certainly” (3). This instrument has the substantial advantage of allowing both a 
dimensional and a categorical personality disorder assessment. Both approaches 
were used in this paper. A dimensional assessment is obtained by adding up the 
ADP-IV trait scores for the 12 personality disorders, for the three clusters and for 
a total score. In the categorical evaluation, the trait and distress scores are 
combined in scoring algorithms (T>4 & D>1 and T>5 & D>2). The first 
algorithm (T>4 & D>1) is most frequently used in clinical practice and for 
research purposes (Schotte & De Doncker, 2000) and was also used in this study: 
an item is considered to be pathological and represents a DSM-IV criterion if a 
trait score of 5, 6 or 7 and a distress score of 2 or 3 are simultaneously obtained. 
In this respect, we followed a similar diagnostic rule as for example, Trull and 
colleagues (2010), who reanalyzed the two waves of the NESARC data and 
diagnosed PD only if all symptoms (and not merely just one) that were linked to 
a certain diagnosis were associated with distress or impairment. Next, categorical 
personality disorder diagnoses are obtained according to the DSM-IV cut-off 
scores. Research demonstrates that the ADP-IV shows satisfying psychometric 
properties with regard to test-retest reliability and construct validity (Schotte, de 
Doncker & Courjaret, 2007). The ADP-IV is considered to be one of the most 
valid Dutch language self-report instruments for measuring personality disorders 
(Verheul, Van den Brink, Spinhoven & Haringsma, 2000). The internal 
consistency of the ADP-IV trait scales in our sample of substance abusers was 
adequate. Cronbach’s Alpha values ranged from 0.706 to 0.839. For two trait 
scales, the Cronbach’s Alpha values were below 0.70: the schizoid PD 
(Cronbach’s Alpha = 0.552) and the obsessive-compulsive PD (Cronbach’s 
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Alpha = 0.618). Research indicates that these two scales generally obtain the 
lowest internal consistency scores (Schotte et al., 1998).  
 
The “Mini-International Neuropsychiatric Interview (M.I.N.I.)” is a short, 
structured diagnostic interview for DSM-IV and ICD-10 psychiatric disorders 
(Sheehan et al., 1998).The M.I.N.I. has been validated in the United States as 
well as in Europe and is available in several languages, including Dutch. In this 
study, the M.I.N.I. was used to assess substance dependence according to the 
DSM-IV criteria. The M.I.N.I. was administered by trained researchers. 
Research demonstrates that the M.I.N.I. reaches sufficiently high validity and 
reliability scores in comparison with the “Structured Clinical Interview for DSM 
Disorders (SCID)”, but it can be administered in a much shorter time period 
(Jones et al., 2005; Sheehan et al., 1997).  
 
Finally, the European version of the “Addiction Severity Index (EuropASI)” was 
administered (Kokkevi & Hartgers, 1995; McLellan, Luborsky, Woody & 
O'Brien, 1980). The EuropASI is a semi-structured interview that uses a 
multidimensional approach to map the nature and severity of diverse problems in 
seven life areas of functioning: physical health; education and employment; 
alcohol use; drug use; legal problems; family and social relationships and 
psychological/emotional health. For each of these life areas a problem inventory 
is compiled. The EuropASI is used for both clinical and research purposes and is 
a validated and widely-used instrument (McLellan, Cacciola, Alterman, Rikoon 
& Carise, 2006). In this study, the EuropASI was used to gather socio-
demographical and substance use severity information based on the EuropASI 
interviewer severity rating scales for each life domain ranging from 0 (no 
treatment needed) to 9 (treatment needed to intervene in life-threatening 
situation).  
 
 
5.2.4.  Data-analyses 
 
In this article, we first compare the socio-demographic characteristics and 
personality pathology of patients dependent on alcohol only (A) (n=191) and 
drugs only (D) (n=33) with those who are dual-dependent (A+D) (n=34) 
according to the DSM-IV criteria as measured by the M.I.N.I. Those who did not 
meet the criteria for current substance dependence or did not fill out the ADP-IV 
were excluded from the analyses (n=16). Differences between the three groups 
were assessed depending upon the type of variable under consideration. For 
categorical variables chi-square tests were used, whereas for continuous 
variables analyses of variance (ANOVA) were used. Only results yielding a p-
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value < 0.05 were considered statistically significant. When the overall chi-
square or F statistic was significant, post-hoc tests were used to evaluate the 
significance of differences between pairs of groups. For categorical variables, the 
test for pairwise comparisons of column proportions was used, adjusting the p-
values for multiple comparisons through the Bonferroni method. For continuous 
variables, the Bonferroni post-hoc test was used. Unless mentioned otherwise, all 
percentages should be read as valid percentages.  
 
Secondly, in order to examine the independent contribution of socio-
demographic and substance-related predictors to personality pathology, 12 
multiple linear regression analyses were carried out using the dimensional score 
on each of the 12 PDs as dependent variables. Three groups of predictors were 
included in the analysis: 1) socio-demographics: gender, age, highest educational 
level, civil state, living situation and employment situation 2) nature of 
substance-related problems: DSM-IV current alcohol dependence, DSM-IV 
current amphetamine dependence, DSM-IV current opioid dependence, DSM-IV 
current cocaine dependence, DSM-IV current cannabis dependence, DSM-IV 
current sedatives dependence, type of dependence (alcohol; drugs; dual 
dependence) 3) severity of substance-related problems: EuropASI severity score 
for physical health, EuropASI severity score for education and employment, 
EuropASI severity score for legal status, EuropASI alcohol severity score, 
EuropASI drug severity score, EuropASI severity score for 
psychological/emotional health, EuropASI severity score for family and social 
relationships. No significant multicollinearity was found between the predictors 
included in the regression analyses. 
 
 
5.3.  Results 
 
5.3.1.  Sample description 
 
The mean age of the patients in our sample was 41.5 years (SD=11.407) and 
more than two thirds were male (n=180; 69.8%). In the month preceding their 
admission to the treatment unit, half of the patients had lived together with a 
partner, children, family and/or friends, whereas 27.9% had lived alone and 
19.4% had lived in a controlled environment (hospital, treatment center, prison, 
for example). About 70% of the sample had achieved secondary school 
education at least. In the month preceding their admission, only 27.5% of the 
sample were in part-time or full-time employment. The majority of the sample 
met the criteria for alcohol dependence only (A) (n=191; 74.0%), whereas 12.8% 
(n=33) of the sample met the criteria for drug dependence only (D), and 13.2% 
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(n=34) of the sample could be described as patients with a dual dependence 
(A+D): a dependence on both alcohol and drugs. Among those with a drug 
dependence (n=67), the most common types of dependence were opioid 
dependence (62.7%), cocaine dependence (62.7%), cannabis dependence 
(47.8%) and amphetamine dependence (35.8%). Most drug-dependent patients 
were dependent on more than one substance (86.6%).  
 
 
5.3.2. Prevalence of personality disorders in the sample  
 
In our clinical sample of substance abusers, 42.6% met the criteria for at least 
one personality disorder according to the ADP-IV. More than half (n=63; 57.3%) 
of these 110 patients met the criteria for more than one PD; the mean number of 
PDs among those with at least one PD was 2.15 (SD=1.473). The total ADP-IV 
dimensional score ranged from 89 to 435 with a mean of 234.65 and a standard 
deviation of 61.50. Cluster B personality disorders were most common (31.8%), 
followed by cluster C PDs (22.9%) and cluster A PDs (14.3%). Where individual 
PDs were concerned, the most prevalent disorders were borderline PD (26.7%), 
avoidant PD (14.7%), anti-social PD (10.1%), obsessive-compulsive PD (10.1%) 
and paranoid PD (10.1%).  
 
 
5.3.3. Differences between patients with an alcohol, drug or dual dependence  
 
The alcohol-dependent patients were significantly older, had a higher educational 
level and were significantly more frequently dependent on health insurance 
benefits compared to drug-dependent patients with or without alcohol 
dependence. Furthermore, they lived significantly more often with a partner 
and/or children and were at the time of the interview more likely to be either 
married or divorced (cf. Table 5.1.).  
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Table 5.1.: Differences in socio-demographic characteristics by substance use group (n=258) 
  
Group A 
Alcohol 
 
(n=191) 
Valid % 
 
Group D 
Illicit drugs 
 
(n=33) 
Valid % 
 
Group A+D 
Alcohol &  
illicit drugs 
(n=34) 
Valid % 
 
 
Chi² (df=2) or 
F(df=2) statistic 
 
p-value 
 
Group differences  
       
Gender: male 67.5 72.7 79.4 2.086 NS  
Mean age in years [SD] 
Civil state:  
Married 
Never married 
Divorced 
46.2 [8.81] 
 
29.3 
25.7 
44.0 
27.4 [5.45] 
 
0.0 
90.9 
9.1 
29.0 [7.18] 
 
5.9 
88.2 
5.9 
117.432 
 
20.071 
83.051 
29.347 
.000 
 
.000 
.000 
.000 
a, b 
 
a, b 
a, b 
a, b 
Living situation:  
Alone 
With partner and/or children 
With parents 
In a controlled environment 
Employment situation :  
Employed 
Unemployed 
Invalidity 
 
29.8 
48.2 
2.6 
16.2 
 
31.4 
16.8 
40.8 
 
15.2 
9.1 
30.3 
33.3 
 
15.2 
45.5 
18.2 
 
29.4 
11.8 
23.5 
23.5 
 
17.6 
41.2 
29.4 
 
3.063 
29.893 
36.862 
5.700 
 
5.644 
19.507 
7.070 
 
NS 
.000 
.000 
NS 
 
NS 
.000 
.029 
 
 
a, b 
a, b 
 
 
 
a, b 
a 
Highest educational level :  
Primary education or none 
Secondary education 
Higher education  
 
21.5 
51.8 
26.7 
 
60.6 
39.4 
0.0 
 
47.1 
50.0 
2.9 
 
26.130 
1.741 
19.677 
 
.000 
NS 
.000 
 
a, b 
 
a, b 
Note :  a : Significant difference between group A & D; b:  Significant difference between group A & A+D; c:  Significant difference between group D & A+D 
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Whereas about one third (34.0%) of the alcohol-dependent patients showed at 
least one PD, this was the case for about two thirds of the drug-dependent and 
dual-dependent patients (66.7% and 67.6% respectively). A comparison between 
groups showed a statistically significant lower prevalence rate for the alcohol-
dependent patients compared with the patients in the other two groups (cf. Table 
5.2.). Among the three groups, cluster B PDs were most frequently diagnosed 
but both drug-dependent and dual-dependent patients showed these disorders 
significantly more frequently than alcohol-dependent patients: 54.5% (drug-
dependent) and 58.8% (dual-dependent) versus 23.0% (alcohol-dependent). In 
the three groups, cluster B PDs were followed first by cluster C and then by 
cluster A PDs. Compared to alcohol-dependent patients, drug-dependent patients 
showed significantly more cluster A PDs (30.3% vs. 12.0%). No statistically 
significant differences were found regarding the various clusters between drug-
dependent and dual-dependent patients. Statistically significant differences 
between the three groups were found for: paranoid PD, antisocial PD, borderline 
PD and passive-aggressive PD. Post-hoc tests demonstrated that drug-dependent 
patients were significantly more frequently diagnosed with paranoid (24.2% vs. 
7.3%), anti-social (30.3% vs. 3.1%) and passive-aggressive PD (12.1% vs. 2.6%) 
compared to alcohol-dependent patients, and that dual-dependent patients were 
significantly more frequently diagnosed with anti-social (29.4% vs. 3.1%) and 
borderline PD (44.1% vs. 22.0%), compared to alcohol-dependent patients. Post-
hoc tests did not show any statistically significant differences between the drug-
dependent and dual-dependent patients.  
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Table 5.2.: Differences in personality disorders by substance use group following categorical personality disorder assessment (n=258) 
  
Group A 
Alcohol 
 
(n=191) 
Valid % 
 
Group D 
Illicit drugs 
 
(n=33) 
Valid % 
 
Group A+D 
Alcohol &  
illicit drugs 
(n=34) 
Valid % 
 
 
Chi² (df=2) statistic 
 
p-value 
 
Group differences 
       
Personality Disorder : yes 34.0 66.7 67.6 22.270 .000 a, b 
 
Cluster A PD : yes 
Cluster B PD : yes 
Cluster C PD : yes 
 
12.0 
23.0 
20.4 
 
30.3 
54.5 
33.3 
 
11.8 
58.8 
26.5 
 
7.850 
26.091 
2.949 
 
.020 
.000 
NS 
 
a 
a,b 
 
 
Paranoid PD 
Schizoid PD 
Schizotypical PD 
Antisocial PD 
Borderline PD 
Histrionic PD 
Narcissistic PD 
Avoidant PD 
Dependent PD 
Obsessive-compulsive PD 
Depressive 
Passive-aggressive 
 
7.3 
5.2 
3.7 
3.1 
22.0 
1.0 
2.1 
12.6 
5.2 
11.0 
7.3 
2.6 
 
24.2 
12.1 
9.1 
30.3 
36.4 
6.1 
3.0 
18.2 
12.1 
9.1 
9.1 
12.1 
 
11.8 
0.0 
2.9 
29.4 
44.1 
0.0 
2.9 
23.5 
8.8 
5.9 
11.8 
5.9 
 
7.317 
5.979 
1.777 
33.605 
9.001 
3.966 
.165 
2.869 
2.195 
.974 
.805 
6.477 
 
.026 
NS 
NS 
.000 
.011 
NS 
NS 
NS 
NS 
NS 
NS 
.039 
 
a 
 
 
a, b 
b 
 
 
 
 
 
 
a 
Note :  a : Significant difference between group A & D; b:  Significant difference between group A & A+D; c:  Significant difference between group D & A+D 
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When considering the dimensional ADP-IV trait scales (cf. Table 5.3.), we 
observed that the overall total dimensional ADP-IV score was highest among 
patients with a dual dependence (M=264.68). This total score was significantly 
higher compared with alcohol-dependent patients, whose mean total score was 
the lowest (M= 227.46). Furthermore, the drug-dependent patients scored 
significantly higher on the anti-social PD scale (M=25.97 vs. M=16.57) than 
alcohol-dependent patients, whereas dual-dependent patients scored higher on 
the schizotypical (M=29.79 vs. M=24.03), anti-social (M=25.68 vs. M=25.97), 
borderline (M=42.44 vs. M=34.45), avoidant (M=26.35 vs. M=20.80) and 
passive-aggressive PD scales (M=21.41 vs. M=17.62) compared to alcohol-
dependent patients.  
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Table 5.3.  Differences in personality disorders by substance use group following dimensional personality disorder assessment (n=258) 
  
Group A 
Alcohol 
 
(n=191) 
Mean  
[sd] 
 
Group D 
Illicit drugs 
 
(n=33) 
Mean 
[sd] 
 
Group A+D 
Alcohol &  
illicit drugs 
(n=34) 
Mean 
[sd] 
 
F(df=2) statistic 
 
p-value 
 
Group differences 
       
Total dimensional ADP-IV score  
 
 
Cluster A PD  
 
 
Cluster B PD  
 
 
Cluster C PD  
227.46  
[58.93] 
 
64.82 
[18.70] 
 
93.87 
[27.32] 
 
68.76 
[21.63] 
245.36  
[71.53] 
 
69.30 
[24.06] 
 
108.85 
[33.84] 
 
67.21 
[20.04] 
264.68  
[56.14] 
 
74.26 
[20.11] 
 
114.68 
[25.48] 
 
75.74 
[20.21] 
6.092 
 
 
3.692 
 
 
10.536 
 
 
1.768 
.003 
 
 
.026 
 
 
.000 
 
 
NS 
 
b 
 
 
b 
 
a, b 
 
Paranoid PD 
 
 
Schizoid PD 
 
 
Schizotypical PD 
 
 
20.64 
[7.62] 
 
20.15 
[6.42] 
 
24.03 
[8.38] 
 
23.30 
[8.91] 
 
20.73 
[7.69] 
 
25.27 
[9.46] 
 
24.03 
[7.44] 
 
20.44 
[7.11] 
 
29.79 
[10.38] 
 
3.838 
 
 
.121 
 
 
6.221 
 
 
.023 
 
 
NS 
 
 
.002 
 
 
 
 
 
 
 
 
b 
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Antisocial PD 
 
 
Borderline PD 
 
 
Histrionic PD 
 
 
Narcissistic PD 
 
 
Avoidant PD 
 
 
Dependent PD 
 
 
Obsessive-compulsive PD 
 
 
Depressive PD 
 
 
Passive-aggressive PD 
 
16.57 
[7.05] 
 
34.45 
[11.21] 
 
21.76 
[7.35] 
 
21.09 
[7.80] 
 
20.80 
[8.95] 
 
23.03 
[8.65] 
 
24.94 
[7.91] 
 
21.70 
[8.61] 
 
17.62 
[6.08] 
 
25.97 
[8.62] 
 
37.42 
[12.87] 
 
22.61 
[8.59] 
 
22.85 
[9.67] 
 
21.48 
[8.29] 
 
22.45 
[9.41] 
 
23.27 
[7.11] 
 
21.48 
[8.98] 
 
20.33 
[8.44] 
 
25.68 
[9.18] 
 
42.44 
[10.18] 
 
24.32 
[6.79] 
 
22.24 
[8.77] 
 
26.35 
[10.52] 
 
24.88 
[8.72] 
 
24.50 
[7.62] 
 
24.68 
[9.11] 
 
21.41 
[7.73] 
 
37.105 
 
 
7.565 
 
 
1.756 
 
 
.818 
 
 
5.400 
 
 
.783 
 
 
.654 
 
 
1.766 
 
 
6.177 
 
.000 
 
 
.001 
 
 
NS 
 
 
NS 
 
 
.005 
 
 
NS 
 
 
NS 
 
 
NS 
 
 
.002 
 
a,b 
 
 
b 
 
 
 
 
 
 
 
 
b 
 
 
 
 
 
 
 
 
 
 
 
b 
 
Note :  a : Significant difference between group A & D; b:  Significant difference between group A & A+D; c:  Significant difference between group D & A+D 
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5.3.4.  Socio-demographic and substance-related variables predicting 
personality disorders  
 
In order to further evaluate the relationship between the nature and severity of 
substance abuse problems and personality pathology, we used linear regression 
modeling (cf. Table 5.4.). After controlling for gender, age, highest educational 
level, civil state, and living and employment situation, several addiction severity 
indicators (EuropASI) remained significant predictors of personality pathology, 
as measured by the 12 PD scales of the ADP-IV. In particular, higher interviewer 
severity ratings on the EuropASI domains “alcohol” and 
“psychological/emotional health” were significantly associated with higher 
scores on various PD scales. The independent variables related to the nature of 
the substance abuse problems (cf. type of dependence) did not appear to be 
significant predictors of personality pathology after controlling for the socio-
demographic variables.  
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Table 5.4. : Associations among personality pathology, socio-demographic and substance-related variables  
 CLUSTER A CLUSTER B CLUSTER C  
 PAR SZ ST AS BDL HIS NAR AV DEP OC DE PA 
R² .233 .110 .242 .471 .418 .173 .086 .208 .254 .124 .286 .270 
Adjusted R² .163 .029 .173 .423 .365 .098 .002 .135 .186 .044 .221 .203 
F (df=21) value 3.326** 1.358 3.496** 9.747** 7.875** 2.293** 1.025 2.870** 3.726** 1.556 4.397** 4.049** 
 
SOCIO-DEMOGRAPHICS (standardized beta coefficients) 
 Gender: male .110 -.006 .043 -.049 .086 .025 -.120 .093 .167** -.052 .105 .060 
Age -.103 .085 -.111 -.288** -.334** -.260** -104 -.214* -.300** .018 -.087 -.098 
Educational level: higher education -.189** -.071 -.084 -.055 -.079 -.077 -114 -.070 -.162** -.083 -.057 -.088 
Civil state : married .177* .105 .118 .006 .029 -.026 .007 .017 .100 .153* .053 .077 
Living situation: living together -.106 -.026 -.159* -.032 .019 -.086 -.097 -.046 -.038 -.068 -.091 -.174* 
Employment situation: employed .036 -.102 -.011 -.034 -.038 .079 -.028 -.069 -.063 -.140 -.053 -.007 
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Table 5.4. (continued): Associations among personality pathology, socio-demographic and substance-related variables  
 CLUSTER A CLUSTER B CLUSTER C  
 PAR SZ ST AS BDL HIS NAR AV DEP OC DE PA 
SEVERITY OF SUBSTANCE ABUSE PROBLEMS (standardized beta coefficients) 
EuropASI physical health .043 .101 .133* .019 .122* .034 .011 .108 .037 .093 .118* .044 
EuropASI education and employment .035 -.042 .016 .065 -.038 -.001 -.061 -.159* -.133 -.078 -.078 .076 
EuropASI alcohol  .228* .203* .230* .142 .153 .132 .077 .280** .348** .030 .252** .266** 
EuropASI drug -.013 -.036 .099 .047 .065 .146 .023 .091 .244 -.081 .091 .089 
EuropASI legal status .217** .110 .127 .358** .141* .047 .010 .021 -.033 .055 -.018 .158* 
EuropASI family and social 
relationships 
.020 -.080 .115 .073 .119* .050 .009 .060 .143 .102 .139* .080 
EuropASI psychological/emotional 
health 
.191** .096 .148* .092 .374** .189** .133 .208** .164* .172* .335** .177* 
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Table 5.4. (continued): Associations among personality pathology, socio-demographic and substance-related variables  
 CLUSTER A CLUSTER B CLUSTER C  
 PAR SZ ST AS BDL HIS NAR AV DEP OC DE PA 
NATURE OF SUBSTANCE ABUSE PROBLEMS (standardized beta coefficients) 
DSM-IV current alcohol dependence -.107 .118 -.108 -.067 -.105 .017 -.071 -.189 .078 -.016 -.039 -.071 
DSM-IV current amphetamine 
dependence 
-.031 -.104 .007 -.100 .016 -.011 .032 .069 .086 -.104 .000 
-.081 
DSM-IV current opioid dependence .144 .149 .158 .132 .122 .073 .073 .121 .027 .145 .180* .162 
DSM-IV current cocaine dependence .119 -.045 .034 .025 .024 .059 .127 -.074 .040 .014 .066 .190* 
DSM-IV current cannabis dependence -.012 .004 .077 .015 .038 .092 -.056 -.051 .050 .027 -.049 -.011 
DSM-IV current sedatives dependence -.056 .025 -.067 .020 .044 -.036 -.050 -.050 -.087 .015 -.048 -.041 
Type of dependence : Illicit Drugs -.043 .211 -.196 -.030 -.181 -.014 -.017 -.224 .154 -.078 -.055 -.042 
Type of dependence : Alcohol .101 -.088 .065 .039 .173 .330* .182 -.102 .334* .027 .055 .175 
Note : * significant on the .05 level; **significant on the .01 level. PAR : Paranoid PD; SZ : Schizoid PD; ST : Schizotypical PD; AS : Antisocial PD; BDL : Borderline PD; 
HIS : Histrionic PD; NAR : Narcissistic PD; AV : Avoidant PD; DEP : Dependent PD; OC : Obsessive-compulsive PD; DE : Depressive PD; PA : Passive-aggressive PD.  
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5.4. Discussion 
 
5.4.1. Personality disorders in a clinical sample of substance abusers  
 
The aim of our study was threefold: (1) to determine the prevalence of PDs 
among a clinical sample of substance abusers, (2) to examine whether or not 
patients with an alcohol, drug or dual dependence had a different personality 
pathology profile and (3) to assess the impact of substance-related predictors 
(nature and severity of dependence) on personality disorders. 
 
 
   Prevalence of personality disorders  
 
Overall, personality disorders were highly prevalent in our clinical sample of 274 
substance dependent patients; almost half (42.6%) of the patients met the criteria 
for at least one personality disorder. This figure can be situated within the range 
of the overall estimates of axis II comorbidity among substance abusers in 
treatment (from 34.8% to 73.0%), as reported in the review by Verheul (2001) 
and other, more recent studies (Echeburúa, de Medina & Aizpiri, 2007; Fassino 
et al., 2004; Preuss et al., 2009; Zikos, Gill & Charney, 2010). Differences 
between the various studies, including the present study, could possibly be 
attributed to the sample setting, the use of different assessment tools, the use of a 
self-report instrument and the specific characteristics of the samples in terms of 
type of substance dependence. Our cross-sectional study did not allow to address 
questions related to the temporal order and causality of the disorders, but the 
high comorbidity between substance use and personality disorders suggests 
certain causal relationships between the two conditions (Verheul & Van den 
Brink, 2005) or might indicate a common vulnerability or cause, which should 
be the focus of future research. Furthermore, it was demonstrated that most 
patients did not fit into one single personality disorder: more than half (n=63; 
57.3%) of all patients who met the criteria for at least one PD suffered from 
additional personality pathology. The co-occurrence of personality disorders is 
considered to be one of the main limitations of the current DSM categorical 
conceptualization of PDs (Skodol, Bender, Morey, Clark, Oldham, Alarcon et 
al., 2011). In the process of developing the fifth version of the DSM, these and 
other limitations will be addressed.  
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   Differences between alcohol-, drug- and dual-dependent patients  
 
When comparing the PD prevalence rates of patients with an alcohol, drug or 
dual dependence, our results were unequivocal and confirmed our initial 
hypotheses. First, the prevalence rates of PDs among patients with a dual 
dependence were significantly higher than among patients with alcohol 
dependence only (67.6% vs. 34.0%). This supports the findings of several other 
studies (Conway et al., 2003; Landheim et al., 2003). In addition, Dick and 
colleagues (2007) provided specific genetic evidence suggesting that dual-
dependent individuals appear to display a more severe form of the disorder, 
including higher rates of anti-social PD, than alcohol-dependent individuals 
without comorbid illicit drug dependence.  
 
Second, the prevalence rates of PDs among patients with a dual dependence did 
not differ significantly from those of patients with a drug dependence only 
(67.6% vs. 66.7%). Also, at the level of the individual PDs, no significant 
differences were found between patients with a drug versus a dual dependence. 
Although it was demonstrated in various studies that overall, people with a dual 
dependence demonstrate more psychological health problems and a greater 
psychopathology compared to people with a drug dependence only (Gossop et 
al., 2002; Miles et al., 2001), the results of the present study do not support this 
general observation for the prevalence of personality disorders, being one 
particular manifestation of psychopathology. Whether or not a drug-dependent 
patient is also dependent on alcohol does not seem to increase the overall PD 
prevalence figures. Clearly, the association between PDs and drug use disorders 
is stronger compared with alcohol use disorders (Verheul et al., 1995), 
illustrating that alcohol dependent patients have a different psychiatric profile 
compared with dual and drug dependent persons.  
 
 
   Impact of substance-related predictors on personality disorders  
 
Through the use of 12 linear regression analyses, we found that the severity 
rather than the nature of the dependence is an important predictor of personality 
pathology among substance-dependent patients, when controlling for socio-
demographic variables. In particular, higher scores on the domains alcohol and 
psychological/emotional problems were associated with significantly higher 
scores on several of the 12 PD scales. 
 
The association between a higher problem severity on the EuropASI life domain 
“alcohol” and higher scores on several of the 12 PD scales (PAR, SZ, ST, AV, 
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DEP, DE & PA) confirms the findings of Preuss and colleagues (2009), who 
demonstrated an association between PDs and alcohol dependence severity. In 
their study, alcohol dependence severity was operationalized in terms of the age 
of first alcohol consumption and the number of DSM-IV alcohol dependence 
criteria, whereas in the present study, the EuropASI severity ratings for the 
various life domains were used as operationalizations of addiction severity. 
Despite the use of different operational definitions of “severity”, the results of 
both studies reached the same overall conclusion. The high correlation between 
the EuropASI domain “psychological/emotional problems” and several of the 12 
PD scales (PAR, ST, BDL, HIS, AV, DEP, OC, DE & PA) supports the overall 
scientific evidence of substantial comorbidity between PDs (Axis II) and clinical 
disorders (Axis I) in the general population as well as among clinical samples 
(Roysamb et al., 2011).  
 
 
5.4.2. Clinical implications 
 
Given the high PD prevalence rates among substance-dependent patients and the 
large impact of personality pathology on the course of addiction problems after 
discharge (van den bosch & Verheul, 2007), it is highly important to pay 
adequate attention to this form of comorbidity in substance abuse treatment 
programs. In any case, treating patients with PDs is often described as 
challenging since the presence of PDs appears to make it more difficult to 
establish a therapeutic alliance between therapist and patient (Dimaggio & 
Norcross, 2008). Furthermore, the therapist's ability to intervene helpfully is 
hampered, partly because maladaptive patterns can influence the therapeutic 
relationship itself (Critchfield & Benjamin, 2006). Also, personality disorder 
features undeniably have an impact on staff members’ emotional reactions 
towards patients (Thylstrup & Hesse, 2008). A thorough personality disorder 
screening and assessment should therefore be part of the intake and assessment 
phase of substance abuse treatment, especially among drug- and dual-dependent 
patients. 
 
 
   Screening and assessment of personality disorders among substance 
abusers  
 
The shift from the long-standing DSM-IV, a categorical classification system, to 
the new DSM-5 (to be published in 2013), incorporating a dimensional 
personality trait model, contains important opportunities for screening and 
assessment, as one of the predominant goals of the revision is to maximize the 
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models’ utility for clinicians. Instead of merely describing a patient in terms of 
one or more disorders, the DSM-5 applies a full trait personality profile on five 
higher order traits (antagonism, impulsivity, emotional dysregulation, 
introversion and psychoticism) and 25 lower order traits (Krueger & Eaton, 
2010; Hopwood, Thomas, Markon, Wright & Krueger, in press). Such 
personality trait profiles provide the clinician with more comprehensive 
diagnostic information and will equip the clinician with valuable tools for 
establishing a therapeutic relation and developing an individual treatment 
program. The new model will not make a radical shift from a categorical to a 
dimensional model: in the most recent DSM-5 proposal, six prototypes (closely 
related to the PDs included in the DSM-IV), will remain in conjunction to the 
five trait dimensions and the 25 traits in order to ensure some continuity with the 
DSM-IV. The Personality Inventory for DSM-5 (PID-5) is a new questionnaire 
developed for measuring DSM-5 traits and therefore incorporating the 
dimensional shift and clinical advantages of the DSM-5 (Hopwood et al., in 
press). Since many programs have limited resources, patients have multiple 
comorbidities and thorough assessment can be time-consuming, the PID-5 could 
be used as a second step in a two-step screening and assessment procedure for 
patients who were identified via a screening instrument, e.g. the Standardised 
Assessment of Personality: Abbreviated Scale (SAPAS) (Hesse & Moran, 2010), 
as individuals in need of a more detailed personality assessment.  
 
 
   Addressing comorbid personality pathology in substance abuse 
treatment  
 
In a reality where one third of the alcohol-dependent and approximately two 
thirds of the drug- and dual-dependent patients in our sample have one or more 
PDs, it would be indispensable to tailor standard interventions to the specific 
needs and oddities of individuals (Verheul, 2001), for example, to increase 
intensive individual counseling focusing on the establishment of a working 
alliance or to match interventions to the personality traits of the patients. For 
reward-sensitive people, one could, for example, consider looking for an 
alternative source of reward to increase their retention in the program (as a short-
term goal) via contingency management (Staiger, Kambouropoulos & Dawe, 
2007). Also, the possibilities of two psychotherapies specifically adapted to meet 
the needs of patients with both a substance-related and a personality disorder 
should be further explored: Dual Focus Schema Therapy (DFST) (Ball, 1998) 
and Dialectical Behavioural Therapy targeting Substance abuse (DBT-S) 
(Linehan, Schmidt & Dimeff, 1999). These treatment approaches seem to be 
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encouraging but further clinical trials in larger populations are needed to 
demonstrate their effectiveness (van den bosch & Verheul, 2007).  
 
In order to improve the overall quality of substance abuse treatment, evidence-
based guidelines should be applied where possible, always taking into account 
the specific needs of individual patients (e.g. personality pathology) (Broekaert 
et al., 2010; Sackett, Rosenberg, Gray, Haynes & Richardson, 1996).  
 
On a more structural or system level, adjustments need to be made to address the 
high level of comorbid personality pathology among patients in substance abuse 
treatment. Given the complex and multidimensional nature of substance abuse 
problems, mutual and intensified co-operation and networking among alcohol 
and drug services is indispensable (Vanderplasschen, De Bourdeaudhuij & Van 
Oost, 2002). Cooperation between specialized substance abuse and mental health 
services (e.g. specialized in treatment of personality disorders) needs to be 
encouraged given the large proportion of mental health problems. This should 
result in an increased overall expertise and competence of professionals and in 
improved service delivery to patients with substance-related as well as 
personality disorders. Intensified networking between agencies can encourage 
specific initiatives such as the organization of a basic training on personality 
disorders, case reviews or supervisions. Finally, in the pre-service training of 
addiction professionals, modules on the assessment and treatment of co-morbid 
mental health problems should be included in the curriculum (Graham, 2004; 
Walters, Matson, Baer & Ziedonis, 2005). 
 
 
5.4.3. Limitations of the study 
 
The present study is one of the first to have compared the prevalence rates of the 
full range of DSM-IV PDs between people with alcohol, drug and dual 
dependence within the same clinical sample. Although the joint (ab)use of illicit 
drugs and alcohol is for many substance users a daily reality, the world of 
alcohol research on the one hand and (illicit) drug research on the other hand 
have each developed an own “discursive reality” (Hakkarainen & Metso, 2009, 
p.114). Researchers, especially those studying the issue of supply control, are 
likely to focus on either alcohol or illicit drugs. Also in research funding, 
different rules apply for alcohol and drug research (Cook & Reuter, 2007). With 
this study, we have attempted to bridge the gap between both worlds since 
previous studies which examined personality disorders in persons with 
substance-related disorders mostly ignored the reality of dual dependence and 
merely compared alcohol with drug users. 
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However, it is important that the findings of our study are read in light of their 
methodological limitations. First, in our study we used the ADP-IV, a self-report 
instrument, to assess personality disorders among our clinical sample of 
substance abusers. Although self-report questionnaires have numerous 
advantages (e.g. easier and more cost-effective administration) (Oldham, Skodol 
& Bender, 2005), they are associated with various weaknesses. Several studies 
indicated that self-report instruments are characterized by a high number of so-
called false-positives and tend to overdiagnose (Hersen, Hilsenroth & Segal, 
2004). However, due to the fact that the ADP-IV not only measures personality 
traits but also measures the impairment and distress associated with the traits, 
this risk of overdiagnosis is limited (Schotte et al., 1998). Still, when using a 
self-report instrument for the assessment of PDs, questions can be raised about 
the patients' motivation to communicate frankly and about their ability to make 
accurate judgments about axis II symptoms (Meyer et al., 2001; Oldham et al., 
2005). In our study we addressed these issues by stressing the anonymous 
character of the study. Ideally, a multi-method assessment battery should have 
been used for the assessment of PDs, including information from informants 
other than the patient (Meyer et al., 2001; Perry, 1992), but due to a lack of time 
and resources we were unable to include this in the present study. Furthermore, 
we want to stress that the participants represented substance-dependent people in 
inpatient treatment. Therefore, our results do not reflect the prevalence of PDs 
among substance-dependent people in the community. We refer to a subgroup 
with severe problems in an intensive form of residential treatment. Since the 
patients did not receive financial or any other compensation for their 
participation in the study, and since participation in the study implied an 
additional effort on top of their regular treatment schedule, about one fifth 
(22.6%) of the patients chose not to participate in this study. However, when 
comparing the patients who refused and those who were interviewed with regard 
to age, gender and type of dependence, we found no significant differences. 
Finally, in this paper we presented patients with an alcohol, drug or dual 
dependence as three distinct categories. However, substantial diversity and 
heterogeneity is hidden within each of the three categories and within each 
patient that participated in the study. 
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Glossary 
 
Substance dependence :  
An individual can be diagnosed with substance dependence when (s)he persists 
in use of alcohol or other drugs despite problems related to the use of the 
substance. Compulsive and repetitive use may result in tolerance to the effect of 
the drug and withdrawal symptoms when the use is reduced or stopped. 
 
Dual dependence :  
Dependence on both alcohol and (one or more types of) illicit drugs.  
 
Personality disorder :  
A personality disorder is an enduring pattern of inner experience and behavior 
that deviates markedly from the expectation of the individual's culture, is 
pervasive and inflexible, has an onset in adolescence or early adulthood, is stable 
over time, and leads to distress or impairment. Because these disorders are 
chronic and pervasive, they can lead to serious impairments in daily life and 
functioning. 
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Abstract 
 
 
Background: Substance users’ Quality of Life (QoL) is influenced by several 
variables, including psychiatric comorbidity and addiction severity. Thus far, the 
impact of the type of dependence (alcohol, drugs, both alcohol and drugs) 
remains unclear. Therefore, the objectives of the study are to evaluate QoL in a 
clinical sample of alcohol- drug- and dual-dependent patients and to assess the 
independent impact of psychiatric comorbidity, addiction severity and type of 
dependence on QoL.  
Methods: Face-to-face interviews with 274 patients admitted to residential 
substance abuse treatment were held using the European Addiction Severity 
Index, the Mini International Neuropsychiatric Interview (M.I.N.I.) and the 
Assessment of Personality Disorders self-report questionnaire.  
Results: Multivariate analyses showed that anxiety, mood or personality 
disorder, employment status and the EuropASI severity rating on the domain 
“alcohol use” were associated with overall QoL. Gender, anxiety disorder and 
the EuropASI severity ratings on the domains “alcohol use”, “drug use”, 
“physical health” and “emotional and psychological health” were associated with 
overall perception of health.  
Conclusion: Addiction severity and psychiatric comorbidity explained the 
greatest amount of QoL variance whereas the type of dependence did not play a 
central role.  
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6.1.  Introduction 
 
6.1.1. Poly substance use and dual dependence  
 
Substance dependence is a complex and multidimensional phenomenon that can 
be described as a maladaptive pattern of drinking or using other substances, 
leading to clinically significant impairment or distress (APA, 2000). It is 
characterized by a chronic and relapsing nature (McLellan, Lewis, O’Brien & 
Kleber, 2000) and problems in various life domains such as employment, 
physical health, social relationships and psychopathology (EMCDDA, 2008). 
Although, it is increasingly recognized that among substance users, poly 
substance use is the rule rather than the exception, scientific interest in the 
potentially adverse health, and other consequences, remained limited. This 
inspired the European Monitoring Centre on Drugs and Drug Addiction 
(EMCDDA) to declare poly substance use a “priority for investigation” 
(EMCDDA, 2009). So called “dual dependence” can be considered to be one 
particular form of poly substance use where a person is dependent on both 
alcohol and (one or more) illicit drugs (Colpaert, Vanderplasschen, Van Hal & 
Broekaert, 2008; Gossop, Marsden & Stewart, 2002). Both population and 
treatment sample studies have demonstrated that the number of people 
experiencing problems with both alcohol and illicit drugs is high (Colpaert et al., 
2008; Gossop, Marsden, Stewart & Rolfe, 2000; Smart, Ogborne & Newton-
Taylor, 1990; Stinson et al., 2005). The available research findings suggest that, 
compared to persons dependent on either alcohol or drugs only, persons with a 
dual dependence make up a subgroup of substance, users with specific 
characteristics and treatment needs (Falk, Yi & Hiller-Sturmhöfel, 2008; Stinson 
et al., 2005). 
 
 
6.1.2. Quality of life of substance users 
 
Given the chronic nature of substance dependence and the various life domains it 
affects, there is a growing recognition that Quality of Life (QoL) can be a useful 
assessment tool and outcome measure in alcohol and drug treatment (Foster, 
Powell, Marshall & Peters, 1999; Foster, Peters & Marchall, 2000). Currently, 
substance abuse research is characterized by a dominant focus on traditional, 
socially desirable outcomes (e.g. abstinence from alcohol and other drugs) and 
direct symptoms of a disease (e.g. health-related aspects), with limited attention 
to outcomes important to the clients themselves (e.g. QoL) (Donovan, Mattson, 
Cisler, Longabaugh & Zweben, 2005). Furthermore, research with alcohol- and 
drug-dependent individuals, shows that there is limited resemblance between 
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socially desirable outcomes and individuals’ subjective well-being, illustrating 
the need to adopt a subjective and person-centered approach (Schalock et al., 
2002).  
Since the nineties, several studies have investigated QoL among alcohol-
dependent persons (Zubaran & Foresti, 2009), by use of various instruments, 
such as the Short-Form-36 (SF-36), the Nottingham Health Profile (NHP), the 
Life Situation Survey (LSS), the EQ-5D and more recently the WHO-QoL and 
WHO-QoL-BREF (Barros da Silva Lima da et al., 2005; Foster, Marshall, 
Hooper & Peters, 1998; Günther, Roick, Angermeyer & König, 2007). The 
number of studies that have investigated the relationship between the use of 
various illicit drugs and QoL is smaller and, in general, those studies are of more 
recent date (Costenbader, Zule & Coome, 2007; De Maeyer et al., 2011; 
Senbanjo, Wolff & Marshall, 2006; Zubaran & Foresti, 2009). Overall, the QoL 
of substance dependent persons is found to be poor compared to that of the 
general population (Foster, Peters & Kind, 2002; Foster et al., 1999; Smith & 
Larson, 2003) and is most comparable to the QoL of individuals with other 
psychiatric illnesses (e.g. schizophrenia) (Akvardar et al., 2006; De Maeyer, 
Vanderplasschen & Broekaert, 2010). Treatment participation (Braucht, 
Reichardt, Geissler & Kwiatowski, 1995; Ginieri-Coccossis, Liappas, Tzavellas, 
Triantafillou & Soldatos, 2007) and abstinence or minimal/controlled drinking 
(Rather & Sherman, 1989; Gillet et al., 1991) clearly lead to improved QoL 
among people with substance-related problems.  
 
 
6.1.3. Addiction severity, type of dependence and psychiatric comorbidity in 
relation to Quality of Life  
 
Most authors agree that addiction severity has a significant impact on the QoL of 
substance users. Volk and colleagues (1997) demonstrated significantly lower 
QoL scores for individuals with a diagnosis of alcohol dependence compared 
with those with a diagnosis of alcohol abuse and individuals who did not meet 
the criteria for a DSM-IV alcohol-related disorder, and also found a moderate 
impact of consumption patterns (quantity and frequency) on QoL. Also, in other 
studies (Daeppen, Krieg, Burnand & Yersin, 1998; Evren et al., 2010; Lahmek et 
al., 2009) greater severity of alcohol-related problems was associated with lower 
QoL. In a study among young, out-of-treatment, regular cocaine users, Lozano 
and colleagues (2010) found that greater severity of cocaine dependence was 
associated with a more impaired QoL and that severity of cocaine dependence 
explained the greatest amount of QoL variation in multivariate analyses.  
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However, only a few studies have examined the impact of the type of substance 
dependence (alcohol, drug or dual dependence) on QoL and conclusions on this 
particular relationship are not univocal. In the study of Lahmek and colleagues 
(1998), the presence of abuse or dependence on another legal or illegal substance 
did not affect the QoL of alcohol-dependent patients. Romeis and colleagues 
(1999) on the other hand, examined which parameters explained the difference in 
QoL between alcohol-dependent twins and alcohol-dependent twins abstinent 
from alcohol for more than five years, and found that the existence of an 
associated dependence on nicotine or drugs was a significant parameter for QoL. 
Also, in the study of Hambley and colleagues (2010), patients dependent on 
multiple substances showed lower QoL scores and had more emotional 
impairment than patients dependent on alcohol alone. To our knowledge, only 
one study has focused explicitly on dual dependence and compared the QoL of 
alcohol-, drug- and dual-dependent patients within the same sample (Garg, 
Yates, Jones, Zhou & Williams, 1999). In this study, no differences were found 
in overall QoL (based on the SF-36) between patients dependent on alcohol only, 
drugs only or both alcohol and other drugs. 
 
In addition to addiction severity and type of dependence, the presence of 
comorbid psychopathology among individuals with alcohol or other substance 
use disorders has clearly been shown to affect QoL scores negatively (Bizzarri et 
al., 2005; Lahmek et al., 2009; Smith & Larson, 2003; Romeis et al., 1999). 
Personality disorders are highly prevalent among people with substance use 
disorders (Colpaert, De Maeyer, Vanderplasschen, De Fruyt & Broekaert, 2012; 
Grant et al., 2004) and the presence of a comorbid personality pathology is 
clearly associated with lower QoL results in opiate-dependent persons (Fassino, 
Daga, Delsedime, Rogna & Boggio, 2004; Karow, Verthein, Krausz & Schäfer, 
2008). Similar conclusions were found for mood, anxiety and post-traumatic 
stress disorders among alcohol-dependent persons (Evren et al., 2011; 
Saatcioglu, Yapici & Cakmak, 2008; Volk et al., 1995). 
  
 
6.1.4. Objectives of the present study  
 
Substance users’ QoL is clearly influenced by several variables, including 
psychiatric comorbidity, addiction severity and type of dependence. Thus far, the 
impact of the type of dependence (alcohol only, drugs only, both alcohol and 
drugs) on QoL remains unclear and to our knowledge, no studies have examined 
psychiatric comorbidity, addiction severity and type of dependence 
simultaneously, in conjunction with use of multivariate analyses to determine the 
relative contribution of each factor. Therefore, the objectives of the study were 
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(1) to evaluate QoL in a clinical sample of alcohol-, drug- and dual-dependent 
patients, and (2) to assess the independent impact of psychiatric comorbidity, 
addiction severity and type of dependence on QoL, while controlling for a 
number of socio-demographic variables.  
 
 
6.2. Methods 
 
6.2.1.  Design and setting  
 
This study was set up as a multi-center, cross-sectional study. Data were 
collected between July 1st 2007 and October 31th 2008 in 11 units for the 
intensive residential treatment of alcohol and/or drug abuse problems, each 
situated within a psychiatric hospital in two specific regions in Belgium (East- 
and West-Flanders). In all participating units, data were collected over a four-
month period.  
 
6.2.2.  Participants 
 
In total, 274 patients were interviewed. All individuals who were consecutively 
admitted to one of the 11 participating units and who met the following inclusion 
criteria were invited to participate in the study: (a) older than 18 years, (b) new 
residential treatment episode, and (c) able to speak and read Dutch. Individuals 
were excluded if (a) they had started day- or night-care treatment only, (b) had 
Korsakoff syndrome or very limited cognitive abilities, (c) suffered from acute 
psychotic symptoms, (d) had already participated in the study or (e) left the 
hospital before the seventh day after admission. After being informed in detail of 
the objectives and concrete modalities of the study, patients gave their written, 
informed consent to participate. The study was approved by the Ethics 
Committees of Ghent University and all participating psychiatric hospitals. 
 
During the data collection period, 682 individuals were admitted to one of the 
participating treatment units. About one third of the patients (n = 248; 36.3 %) 
did not meet the inclusion criteria, predominantly because they left the hospital 
after a few days admission. About one fifth of the patients (n = 154; 22.6 %) 
refused to participate in the study. Of the remaining 280 interviews that were 
conducted, six were not fully completed. In total, the data on 274 patients was 
included in the database. Comparisons between patients who were interviewed (n 
= 280) and those who refused to participate (n = 154) showed no significant 
differences with regard to age, gender or type of dependence (none, alcohol only, 
drugs only or dual dependence).  
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6.2.3.  Procedure and interview instruments  
 
Data were collected via a semi-structured interview (EuropASI), a structured 
interview (M.I.N.I.) and two self-report questionnaires (ADP-IV and WHOQoL-
BREF). One interview took on average 97.28 minutes (SD = 22.31). All 
participants were interviewed between the 7th and 21st day following admission.  
The “European version of the Addiction Severity Index (EuropASI)” is a semi-
structured interview that uses a multidimensional approach to map the nature and 
severity of substance-related problems in seven life areas of functioning: 
physical health; education and employment; alcohol use; drug use; legal 
problems; family and social relationships, and psychological/emotional health 
(Kokkevi & Hartgers, 1995; McLellan, Luborsky, Woody & O'Brien, 1980). The 
EuropASI is a validated and widely-used instrument and can be used for both 
clinical and research purposes (McLellan, Cacciola, Alterman, Rikoon & Carise, 
2006). In this study, the EuropASI interviewer severity rating scales for each life 
domain were used to operationalize addiction severity. These scales range from 0 
(no treatment needed) to 9 (treatment needed to intervene in a life-threatening 
situation).  
 
The “Mini-International Neuropsychiatric Interview (M.I.N.I.)” is a short, 
structured diagnostic interview for DSM-IV and ICD-10 psychiatric disorders 
(Sheehan et al., 1998). In this study, the M.I.N.I. was administered by trained 
researchers and was used to assess current substance dependence, mood and 
anxiety disorders according to the DSM-IV criteria. Research demonstrates that 
the M.I.N.I. reaches sufficiently high validity and reliability scores in 
comparison with the “Structured Clinical Interview for DSM Disorders (SCID)”, 
but it can be administered in a much shorter time period (Jones et al., 2005; 
Sheehan et al., 1997).  
 
The “Assessment of DSM-IV Personality Disorders (ADP-IV)” is a self-
reporting, Dutch language instrument that assesses DSM-IV personality 
disorders (Schotte, de Doncker, Vankerckhoven, Vertommen & Cosyns, 1998). 
Research shows that the ADP-IV has satisfying psychometric properties with 
regard to test-retest reliability and construct validity (Schotte, de Doncker & 
Courjaret, 2007). It consists of 94 items, representing the 80 criteria of the 10 
DSM-IV personality disorders and the 14 research criteria representing 
depressive and passive-aggressive personality disorders.  
 
The “World Health Organization Quality of Life BREF instrument (WHOQoL-
BREF)” is a short version of the WHOQOL-100 assessment and is a person-
centered self-reported instrument for the subjective assessment of QoL. The 
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WHOQoL-BREF consists of 26 items: two “benchmark” items measuring 
overall QoL and perception of health and 24 items measuring four domains of 
QoL: physical, psychological, social and environment. The instrument makes use 
of 5-point Likert scales to check “how satisfied”, “how often”, “how good”, … 
the respondent had felt in the past two weeks. The WHOQoL-BREF has good to 
excellent psychometric properties (Skevington, Lofty & O’Connell, 2004; The 
WHOQoL Group, 1998).  
 
 
6.2.4.  Data-analyses 
 
In this article, we first evaluate the QoL in our sample, making use of the two 
benchmark items of the WHOQoL-BREF (range: 1 - 5 with 1 being “very bad” 
and 5 being “very good”) and the four domains of QoL (range: 0 - 100, higher 
scores indicating better QoL). Secondly, through analyses of variance 
(ANOVA), we compare the mean scores on the two benchmark items and the 
four domains between patients with an alcohol, drug and dual dependence and 
between patients with and without current personality disorder(s), with and 
without current mood disorder(s) and with and without current anxiety 
disorder(s). Thirdly, a Pearson correlation matrix was computed in order to 
measure the association between addiction severity, as measured by the 
EuropASI severity ratings for the seven life areas, and the scores on the two 
benchmark items and the four domains of the WHOQoL-BREF. Overall, only 
results yielding a p-value < 0.05 were considered statistically significant. 
 
Finally, in order to assess the independent impact of substance-related problems 
(type of dependence and addiction severity) and psychiatric comorbidity 
(personality disorders, mood disorders, anxiety disorders) on QoL, while 
controlling for a number of socio-demographic variables (age, gender, 
educational level, civil and employment status), two stepwise linear regression 
analyses were carried out using the score on the benchmark items of the 
WHOQoL-BREF on ‘overall QoL’ and ‘overall perception of health’ as 
dependent variables. Independent variables were selected on the basis of 
theoretical relevance and the results of the bivariate analyses. Each of the two 
models was constructed using stepwise linear regression analysis, with a p value 
below 0.05 required to be included in the model and a p value below 0.10 
required to be kept in the model. No significant multicollinearity was found 
between the variables included in the regression analyses. Unless mentioned 
otherwise, all percentages should be read as valid percentages. Patients who did 
not meet the criteria for current substance dependence or did not (completely) fill 
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out the ADP-IV or the WHOQoL-BREF were excluded from all analyses (n = 
16).  
 
 
6.3.  Results 
 
6.3.1.  Sample description 
 
Patients were predominantly male (69.8 %) and were on average of 41.5 years 
old (SD = 11.407) (see Table 6.1.). Substances that were most often used in the 
30 days preceding admission were: alcohol (81.0 %), prescription drugs such as 
benzodiazepines (45.0 %) and antidepressants (37.6 %), and cannabis (18.6 %).  
 
Table 6.1. : Characteristics of the study sample (n=258) 
 
Variable N % 
   
Gender   
 Male 180 69.8 
 Female 78 30.2 
   
Mean age [SD] 41.5 [11.407]  
   
Civil state   
 Married 58 22.5 
 Never married 109 42.2 
 Divorced 89 34.5 
 Widower 2 0.8 
   
Highest educational level   
 Primary education or none 77 29.8 
 Secondary education 129 50.0 
 Higher education 52 20.2 
   
Current employment situation   
 Employed 71 27.5 
 Unemployed 61 23.6 
 Incapacity benefits 94 36.4 
 Other 32 12.5 
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Table 6.1. (continued): Characteristics of the study sample (n=258) 
 
Variable N % 
Substance use in the past 30 days   
 Alcohol (>= 5 glasses/day) 209 81.0 
 Cannabis 48 18.6 
 Cocaine 34 13.2 
 Amphetamines 16 6.2 
 Heroin 28 10.9 
 Methadone 17 6.6 
 Other opiates 12 4.7 
 Benzodiazepines 116 45.0 
 Anti-depressants 97 37.6 
   
Type of current dependence   
 Alcohol (A) 191 74.0 
 Illicit drugs (D) 33 12.8 
 Alcohol and illicit drugs (A+D) 34 13.2 
   
At least one personality disorder 110 42.6 
   
At least one mood disorder 104 40.3 
   
At least one anxiety disorder 95 36.8 
   
 
 
6.3.2.  Patients’ psychiatric and substance use profile in relation to their current 
quality of life  
 
About one third of the sample (34.5 %) rate their overall QoL as poor or very 
poor and almost 40 % of the sample was dissatisfied or very dissatisfied with 
their overall health status. On the other hand, about 30 % rated their overall QoL 
as good or very good and about one third of the patients (34.1 %) were satisfied 
or very satisfied with their overall health status (see Table 6.2.).  
 
Respondents indicated that they were most satisfied with the domains 
“environment” (M = 61.82) and “physical health” (M = 57.30) and were least 
satisfied with the domains “social relationships” (M = 53.46) and “psychological 
health” (M = 50.86) (see Table 6.3.).  
 
The presence of a comorbid mood, anxiety or personality disorder was 
significantly associated with lower scores on both of the two benchmark items as 
well as the four WHO-QoL-BREF domains (see Table 6.3.).  
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Table 6.2. : Scores on the two benchmark items of the WHOQoL-BREF 
 
 N (%) 
  
Overall perception of QoL  
Very poor 22 (8.5) 
Poor 67 (26.0) 
Neither good, neither poor  93 (36.0) 
Good 66 (25.6) 
Very good 10 (3.9) 
  
Overall perception of health  
Very dissatisfied 17 (6.6) 
Dissatisfied 87 (33.7) 
Neither satisfied, neither dissatisfied 66 (25.6) 
Satisfied 77 (29.8) 
Very satisfied 11 (4.3) 
  
 
The type of dependence was significantly associated with the scores on both 
benchmark items: people with a dual dependence had significantly lower scores 
on overall QoL and perception of health as compared to people with a drug or 
alcohol dependence only (see Table 6.3.). Overall, the associations between 
addiction severity ratings and QoL measures were small to moderate (see Table 
6.4.). The severity rating on the EuropASI domains “family and social 
relationships” as well as on the domain “psychological/emotional health” were 
negatively correlated with all QoL measures. Severity ratings on other domains 
were correlated with some of the measures, such as the rating on the domain 
“physical health”, which was negatively correlated with the overall perception of 
health and the WHO-QoL-BREF physical domain, and the severity ratings for 
alcohol and drug use which were both negatively correlated with individuals’ 
overall QoL and perception of health. The rating on the domain “drug use” was 
further significantly associated with the WHO-QoL-BREF environment domain 
and the rating on the domain “alcohol use” with the WHO-QoL-BREF physical 
and psychological domain.  
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Table 6.3. : Mean scores on overall and domain-specific QoL in relation to type of dependence and psychiatric comorbidity  
 
 
Overall perception 
of QoL 
Overall perception 
of health 
Physical 
domain 
Psychological 
domain 
Social relations 
domain 
Environment 
domain 
       
Study population mean scores [SD] 2.90 [1.00] 2.91 [1.03] 57.30 [17.33] 50.86 [16.76] 53.46 [22.30] 61.82 [15.92] 
       
Current mood disorder       
No 3.12** 3.13** 62.34** 55.90** 56.93** 64.69** 
Yes 2.59 2.60 49.83 43.39 48.24 57.57 
       
Current anxiety disorder       
No 3.17** 3.15** 61.35** 55.34** 56.34** 65.91** 
Yes 2.44 2.52 50.34 43.16 48.07 54.80 
       
Current personality disorder       
No 3.13** 3.11** 62.11** 56.25** 56.98** 66.45** 
Yes 2.59 2.64 50.81 43.60 48.64 55.60 
       
Type of dependence        
Alcohol 2.95** 2.97** 57.22 50.94 53.71 63.38* 
Illicit Drugs 3.12 3.18 59.09 54.42 55.56 57.96 
Dual dependence 2.41 2.35 55.99 46.94 49.76 56.80 
       
Note : * p<0.05, ** p<0.01       
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Table 6.4. : Pearsons’ correlation coefficients between addiction severity ratings and quality of life measures  
 
 
Overall 
perception of 
QoL 
Overall 
perception of 
health 
Physical  
domain 
Psychological 
domain 
Social relations 
domain 
Environment 
domain 
       
Addiction severity ratings       
Physical health -.006 -.292** -.255** -.056 -.031 -.049 
Education & employment -.140* -.140* -.159* -.089 -.045 -.387** 
Alcohol use -.155* -.157* -.144* -.140* -.045 .002 
Drug use -.135* -.131* -.063 -.072 -.069 -.220** 
Legal problems -.047 -.076 .010 .101 -.040 -.221** 
Family en social relationships -.183** -.149* -.207** -.272** -.352** -.284** 
Psychological/emotional health -.222** -.248** -.403** -.448** -.339** -.333** 
       
Note : * p<0.05, ** p<0.01       
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6.3.3. Determinants of Quality of Life  
 
In the first linear regression model, five variables emerged as significant 
determinants of the benchmark item “overall quality of life” of the WHO-QoL-
BREF: being unemployed, having a mood, anxiety or personality disorder and 
lower scores on the EuropASI life domain “alcohol” were all independently 
associated with having a poorer quality of life (see Table 6.5.). The amount of 
variance explained by this first model was 22 %.  
 
 
Table 6.5.: Linear regression model predicting the overall perception of quality of life  
 
 Β SE Beta t p 
(constant) 3.954 .199  19.893 .000 
Current anxiety disorder: yes -.492 .127 -.239 -3.877 .000 
Unemployed: yes -.394 .134 -.170 -2.949 .003 
EuropASI severity score domain 
alcohol use 
-.091 .031 -.168 -2.937 .004 
Personality disorder: yes -.311 .125 -.155 -2.485 .014 
Current mood disorder: yes -.278 .124 -.138 -2.245 .026 
R² =  .220; Adjusted R² =  .205; F(df=5) =  13.913 
 
In the second linear regression model with the benchmark item “overall 
perception of health” of the WHO-QoL-BREF as dependent variable, six 
variables emerged as independent, significant determinants: being female, having 
a current anxiety disorder and lower scores on the EuropASI life domains 
“alcohol use”, “drug use”, “physical health” and “emotional and psychological 
health” were all associated with being less satisfied with one’s overall health 
status (see Table 6.6.). The overall R² value for this second model was 27.5 %.  
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Table 6.6.: Linear regression model predicting the overall perception of health 
 
 Β SE Beta t p 
(constant) 4.612 .277  16.645 .000 
Gender : male .292 .127 .131 2.292 .023 
EuropASI severity score domain       
alcohol use 
-.165 .036 -.295 -4.526 .000 
EuropASI severity score domain            
drug use 
-.090 .024 -.258 -3.832 .000 
EuropASI severity score domain       
physical health  
-.134 .025 -.300 -5.432 .000 
EuropASI severity score domain    
emotional and psychological health 
-.051 .026 -.116 -1.938 .054 
Current anxiety disorder : yes -.347 .127 -.163 -2.735 .007 
R² =  .275; Adjusted R² = .257 ; F(df=6) =15.477  
 
6.4.  Discussion 
 
6.4.1. Quality of life among alcohol-, drug- and dual-dependent patients 
 
In this paper, the QoL of alcohol-, drug- and dual-dependent patients and the 
independent impact of psychiatric comorbidity, addiction severity and type of 
dependence on persons’ overall QoL and perception of health was examined. 
The results of this study show that dual-dependent patients have a significantly 
poorer QoL as compared to patients with an alcohol or drug dependence only: a 
mean score of 2.41 (compared with 2.95 and 3.12 respectively) on overall 
perception of QoL and a mean score of 2.35 (compared with 2.97 and 3.18 
respectively) on overall perception of health, as measured by the WHO-QoL-
BREF. These results support the converging evidence that, compared to persons 
dependent on alcohol or drugs only, persons with a dual dependence make up an 
extra vulnerable subgroup of substance users within treatment settings (Falk et 
al., 2008; Stinson et al., 2005). However, in the linear regression models, the 
type of dependence (alcohol, drugs, dual) did not appear to have any explanatory 
value when other variables (psychopathology, addiction severity and a number of 
socio-demographic variables) were included in the model, which indicates that 
dual dependence does not play a central role in affecting QoL, as opposed to 
addiction severity and psychopathology.  
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6.4.2.  Addiction severity and Quality of Life  
 
We can observe that the severity of the substance problem is negatively 
correlated with QoL: the higher the addiction severity, the lower the QoL. In the 
multivariate analyses, particularly the EuropASI domains ‘alcohol use’ (in 
relation to overall QoL) and ‘alcohol use’, ‘drug use’, ‘physical health’ and 
‘emotional and psychological health’ (in relation to overall perception of health), 
were found to be important determinants, even when type of dependence and 
psychiatric comorbidity were also taken into account. These results are 
consistent with the findings of Gonzales and colleagues (2011) who found that 
the severity of the substance use profile (history, frequency of drug use and route 
of administration) among treatment seeking metamphetamine-dependent patients 
was significantly associated with QoL and health status. In other studies, similar 
associations between addiction severity and QoL were found (Costenbader et al., 
2007; Lozano et al., 2008). The fact that addiction severity is closely linked to 
QoL not only implies that treatment interventions are needed to reduce the 
severity of the problem, but also that early intervention programs are a crucial 
element in alcohol and drug policy planning in avoiding that small or moderate 
problem progresses into a more serious problem and further impairs a person’s 
QoL.  
 
 
6.4.3.  Psychiatric comorbidity and Quality of Life  
 
Psychiatric comorbidity in our clinical sample of substance users is high: in 
particular personality (42.6 %), mood (40.3 %) and anxiety disorders (36.8 %) 
were frequently observed. Moreover, when evaluating patients’ quality of life, 
our findings show that overall, respondents are least satisfied with the WHO-
QoL-BREF domain “psychological health” and that the presence of a comorbid 
mood, anxiety or personality disorder is significantly associated with lower 
scores on both benchmark items as well as on the four WHO-QoL-BREF 
domains. These results are in line with the conclusions of review articles in 
which a strong relationship between QoL and mental health problems was 
demonstrated (De Maeyer et al., 2011; Mendlowicz & Stein, 2000). However, 
Garg and colleagues (1999) found no association between comorbidity and 
quality of life among inpatient substance users. This discrepancy might reflect an 
important difference in the methodological approach to measure psychiatric 
comorbidity: clinician-based diagnoses in the study of Garg and colleagues 
(1999), versus structured interviews and self-report questionnaires in the present 
study. Overall, agreement exists that diagnostic accuracy can be enhanced by 
using structured interview methods (Miller, Dasher & Collins, 2001).  
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The high prevalence of mood, anxiety and personality disorders in our clinical 
sample of substance users and the large impact of psychiatric comorbidity on 
their current QoL not only induces the need for thorough psychiatric screening 
and assessment of persons presenting for substance abuse treatment (McGovern, 
Xie, Segal, Siembab & Drake, 2006), but also for an integrated mental health and 
substance abuse treatment approach. Since, in the linear regression analyses of 
the present study, the presence of an anxiety disorder appeared to have the 
largest impact on patients’ overall QoL, it is crucial to set up more targeted 
psychological interventions and to engage in more research on underlying 
mechanisms (Baillie et al., 2010). Several studies report better treatment 
outcomes when patients with comorbid psychiatric problems are treated in 
programs with a stronger dual diagnosis focus (Moggi, Hirsbrunner, Brodbeck & 
Bachmann, 1999).  
 
 
6.4.4.  Limitations of the study 
 
The present study is one of the first to have compared the QoL scores of people 
with an alcohol, drug or dual dependence within the same clinical sample and to 
have simultaneously assessed the independent impact of psychiatric comorbidity, 
addiction severity and type of dependence on quality of life, while controlling for 
a number of socio-demographic variables. An additional strength of this study is 
the inclusion of psychiatric disorders on both axis I (mood and anxiety disorders) 
and axis II (personality disorders), and within axis II, the whole range of 
disorders, and not only anti-social personality disorder. However, it is important 
that certain methodological limitations are discussed.  
 
Firstly, the ADP-IV, a self-report instrument, was used to assess personality 
disorders. Although self-report questionnaires have numerous advantages, they 
are associated with a number of weaknesses. Elsewhere, we have discussed at 
length these advantages and weaknesses and the measures we have taken in this 
study to address potential risks (Colpaert et al., 2012). Secondly, we want to 
stress that the participants represent severely impaired, substance-dependent 
people in the first phase of intensive, inpatient treatment. Therefore, our results 
do not reflect the QoL of substance-dependent people in the community or in 
other treatment modalities. Previous research has demonstrated that QoL of 
persons can vary according to treatment setting (e.g. outpatient, inpatient, 
therapeutic community) (Garg et al., 1999; Zimmer, 1993). Finally, we recognize 
that the overall R² values of our two regression models are relatively small (22 % 
and 27.5 % respectively), which indicates that variables other than psychiatric 
comorbidity, addiction severity and type of dependence also affect the QoL in 
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our study population. An example based on literature findings is the presence of 
a lifetime history of emotional, physical or sexual abuse, which has been 
demonstrated to affect people’s QoL (Millson et al., 2006). Nonetheless, the two 
models were designed specifically to simultaneously assess the independent 
effects of psychiatric comorbidity (mood, anxiety and personality disorders), 
addiction severity and type of dependence on overall QoL and perception of 
health and therefore other possible explanatory variables were deliberately 
omitted. 
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Abstract 
 
 
In this final chapter, we present the main findings of this dissertation and discuss 
some of the most important implications for policy, research and clinical 
practice. We also address the strengths as well as the limitations of our studies 
and make some recommendations for further research.  
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7.1.  Introduction  
 
 
In this dissertation, we have portrayed the socio-demographic, substance-related 
and treatment utilization characteristics as well as the psychopathological profile 
and the Quality of Life of substance users who started alcohol or drug treatment. 
This dissertation arose from a genuine interest in understanding the complex 
situation and treatment needs of individuals with substance use problems at the 
moment they are in touch with a center for substance abuse treatment, whether or 
not for the first time. A particular focus was placed on the situation of persons 
with co-occurring alcohol and drug use problems as various studies have shown 
that these persons might have different characteristics, psychopathological 
profiles and treatment needs as compared to persons who have problems with 
either alcohol only or illicit drugs only. In this final chapter, the main findings, 
strengths and limitations of the various studies are discussed and 
recommendations for further research are made. Also the implications of our 
findings for policy, research and clinical practice are thoroughly discussed, 
providing several opportunities for improving the provision and organization of 
substance abuse treatment which can result in an immediate improvement of the 
overall situation of individuals having multiple and complex problems due to the 
use of licit and/or illicit substances. 
 
 
7.2. Main findings 
 
7.2.1. Treatment utilization patterns of illicit drug users 
 
In the first study of this dissertation, we aimed at getting more insight in the 
treatment utilization patterns of illicit drug users seeking treatment in a wide 
variety of treatment agencies and modalities, with a particular focus on so-called 
“multiple agency attenders” or “shared clients” (cf. Chapter 2). In total, 18 
treatment centers situated in the province of East-Flanders participated in the 
study. Practitioners registered a limited number of variables for each client with 
an illicit drug problem with whom they had an initial intake interview during the 
six-month registration period. 
 
In total, 1,500 intake interviews with 1,139 unique clients took place. The overall 
majority (80.8%) only had one intake interview during this period, but 219 
clients (19.2%) were registered more than once. About three-quarter (n=164) of 
the latter group had an intake interview in more than one treatment agency 
within the 6-month registration period. As already demonstrated in literature, 
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both the chronic and relapsing nature and high degree of accompanying 
problems in various life areas are responsible for high service utilization across 
various services, such as substance abuse treatment, health and social welfare 
services (Keene & Bailey, 2000; McLellan, Lewis, O’Brien & Kleber, 2000). 
Our study demonstrates that also within one particular sector, notably the sector 
of substance abuse treatment, about 15% of all clients registered within a well-
defined period of time are in fact “shared clients”. We also found multiple 
agency attenders to be more likely to regularly use cocaine, opiates and sedative 
drugs, to have ever injected drugs and to use various substances without one 
substance being more important than the other (category “multiple substance 
use” indicated as primary drug). Furthermore, they more frequently also had a 
previous treatment history and were registered more often in residential 
treatment centers. Single agency attenders on the other hand more often had 
cannabis as their primary drug, were more often registered in outpatient 
treatment centers and were either self-referred or by their family, friends or GP. 
In conclusion, single and multiple agency attenders appear to differ in addiction 
severity and can be situated at different stages of their treatment careers. This 
study also revealed that a large proportion of illicit drug users (56.4%) regularly 
uses alcohol (>= 5 glasses). In view of the fact that other studies (Gossop, 
Marsden & Stewart, 2002; Stinson et al., 2005) have found that alcohol-
dependent drug users have a different profile and a higher problem severity as 
compared to non-alcohol-dependent drug users, our observation gave rise to 
important questions on the overall prevalence and correlates of co-occurring 
alcohol and drug use problems in Belgian substance abuse treatment centers. 
 
 
7.2.2. Prevalence of co-occurring alcohol and drug use problems among 
individuals who have started substance abuse treatment 
 
In a number of countries, high prevalence rates of co-occurring alcohol and drug 
use problems have been reported in both large-scale community samples (Bijl, 
Ravelli & van Zessen, 1998; Burns & Teesson, 2002; Stinson et al., 2005) as 
well as in clinical samples of individuals seeking alcohol and/or drug treatment 
(Gossop, Marsden, Stewart & Rolfe, 2000; Martin, Arria, Mezzich & Bukstein, 
2003; Miller, Klamen, Hoffmann & Flaherty, 1996). Until recently, Belgium had 
no uniform treatment demand registration system (Colpaert & De Clercq, 2003; 
Lamkaddem & Roelands, 2010) that we could rely on to estimate the proportion 
of clients having problems due to the use of both alcohol and illicit drugs within 
the Belgian context of substance abuse treatment and to map their characteristics 
and treatment needs. Therefore, a second study was set up that would allow us to 
get some first insights in this phenomenon (cf. Chapter 3). This study followed a 
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similar methodological design as the first study but it took place in another 
Belgian province, notably Antwerp. Furthermore, practitioners were instructed to 
not only register data on individuals with illicit drug problems (as was the case in 
the first study) but also on individuals with alcohol use problems. All specialized 
substance abuse treatment centers, both inpatient as well as outpatient, in a clear-
cut region in Belgium were asked to take part in the study. Not only centers with 
a strong focus on illicit drug use problems but also centers with a strong or 
predominant focus on alcohol use problems were invited to participate. This 
way, the prevalence of co-occurring alcohol and drug use problems could be 
estimated against the background of the total alcohol and drug treatment-seeking 
population. During the six-month registration period, a limited number of 
variables on 1,626 unique clients was registered. Whereas about 45% of the 
clients were regular (at least two consecutive or three days non-consecutive days 
a week) users of alcohol (>= 5 glasses) only, 28% were regular users of illicit 
drugs only and 27% were regular users of both alcohol (>= 5 glasses) and illicit 
drugs (the so-called “dual group”). In this study, regular alcohol (>= 5 glasses) 
use was used as a measure for alcohol use problems, which can be considered as 
“frequent binge drinking” (Wechsler, Davenport, Dowdall, Moeykens & 
Castillo, 1994) and thus as a form of alcohol misuse. 
 
In order to also have information on the DSM-IV diagnoses of substance abuse 
and dependence, a more in-depth study on the prevalence and correlates of co-
occurring alcohol and drug use disorders was set up in 11 units that provide 
intensive, long-term residential treatment, situated in psychiatric hospitals (cf. 
Chapters 5 and 6). Traditionally, substance abuse treatment situated within the 
more generic mental health care had a strong focus on the treatment of alcohol 
use problems. However, it is generally acknowledged that over the past few 
decades this sector has broadened its focus and now also welcomes persons with 
illicit drug problems (Vanderplasschen, De Bourdeaudhuij & Van Oost, 2002). 
Therefore, we felt this sector to be the most appropriate sector to carry out this 
in-depth study. This way, we were able to include persons with alcohol 
problems, persons with illicit drug problems and persons with co-occurring 
alcohol and illicit drug problems in our study who all started treatment within the 
same type of treatment modality. After all, in the categorical treatment centers 
(such as the therapeutic communities and the day-care centers with 
RIZIV/INAMI conventions), persons with alcohol use problems rarely present 
for treatment. Furthermore, it would allow us to evaluate if this generally 
assumed diversity in substance use problems could indeed be confirmed. In total, 
274 persons were interviewed. Using an internationally recognized and validated 
instrument, the M.I.N.I., our findings revealed that the large majority (74.0%) 
was currently dependent on alcohol only whereas 12.8% was only dependent on 
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one or more illicit drugs and 13.2% was dual-dependent (both alcohol and one or 
more illicit drugs) (cf. Chapter 5). When a less stringent measure for substance 
use problems is considered 9
 
, notably “having used alcohol (>= 5 glasses) and/or 
illicit drugs at least 1 or 2 times a week during the past year”, proportions shift to 
65.9% for alcohol only, 12.8% for illicit drugs only and to 21.3% for alcohol and 
illicit drugs. 
Although different alcohol measures were used in the first (regular use) and 
second study (DSM-IV current substance dependence), our findings confirm that 
among all persons with illicit drug use problems registered in treatment settings, 
about half also have alcohol use problems, which is in line with the international 
literature (Byqvist, 1999). On the other hand, among persons with alcohol use 
problems, the proportion of persons also having problems due to the use of illicit 
drugs is somewhat lower than what is generally reported in other studies 
(Caetano & Schafer, 1996; Martin et al., 1996; Staines, Magura, Foote, Deluca & 
Kosanke, 2001). Whereas in the first study about one third (37.6%) of all regular 
alcohol users had also regularly used illicit substances in the three months 
preceding the intake interview, the second study showed that only 15.1% of all 
alcohol-dependent persons were also dependent on one or more illicit drugs. This 
rate increased to 24.4% when the less stringent measure “having used one or 
more illicit drugs at least 1 or 2 times a week during the past year” was used. 
Since most other studies were carried out in the US, a country where high rates 
of current illicit drug use are observed among older age cohorts, this can (partly) 
explain the lower prevalence rates found in our two Belgian samples. After all, 
since a so-called “long lag time” can generally be observed between the onset of 
the symptoms of an alcohol use disorder and treatment seeking (Cohen, Feinn, 
Arias & Kranzler, 2007; Kessler et al., 2001; Simpson & Tucker, 2002), clients 
in treatment for alcohol use problems generally belong to those older age cohorts 
(Colpaert, Vanderplasschen, Van Hal & Broekaert, 2005a; Laudens, 2006). In 
Belgium, the last year prevalence rates of marijuana and other illicit drug use 
among the age group “55-64 year olds” are 1.0% and 0.2% respectively (Gisle et 
al., 2010) whereas in the US, the last year prevalence rate of any illicit drug use 
(including marijuana use) among 50 to 59 year olds is found to be 9.7% (Han, 
Gfroerer & Colliver, 2009) and has increased significantly during the past 
decade.  
 
 
 
 
                                                          
9 New analysis ; not included in chapter 4.  
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7.2.3. Socio-demographic characteristics of persons with co-occurring alcohol 
and drug use problems who have started substance abuse treatment 
 
In the literature review (cf. Chapter 4), we analyzed the available evidence with 
regard to similarities and differences in socio-demographic variables (age, sex, 
ethnicity and socio-economic status) between persons with co-occurring alcohol 
and drug use problems on the one hand and persons with either alcohol or drug 
use problems on the other hand. We concluded that the former clearly have a 
different socio-demographic profile when compared to persons with alcohol use 
problems only. They are younger, more often male, less often White and have a 
lower socio-economic status. Also in our study in the province of Antwerp (cf. 
Chapter 3) and in the in-depth study (cf. Chapter 5), this overall picture was 
largely confirmed. In both studies, persons with co-occurring alcohol and drug 
use problems were younger (46.2 versus 29.6 years and 46.2% vs. 29.0 years 
respectively), more often male – although not significant in the second study - 
(32.1% vs. 17.5% and 32.5% vs. 20.6%), have higher rates of unemployment 
(36.4% vs. 22.9% and 41.2% vs. 16.8%) and live together with their partner 
and/or children less often (16.5% vs. 41.5% and 11.8% vs. 48.2%). Furthermore, 
the results of the Antwerp study show that they are more often born in a country 
other than Belgium (12.9% vs. 5.5%) and have higher rates of legal problems 
(28.5% vs. 9.9%) whereas the in-depth study confirms the rather low level of 
education among persons with co-occurring alcohol and drug use problems as 
compared to those with alcohol use problems only. For 47.1% in the dual group, 
the highest educational level is primary education (as opposed to 21.5% in the 
alcohol-only group). 
 
The socio-demographic differences between persons with co-occurring alcohol 
and drug use problems and those with drug problems only are found to be not so 
straightforward. The literature review (cf. Chapter 4) reveals that the findings of 
the selected studies vary to a considerable extent. Only with regard to the socio-
economic status, all studies (including our own study) agree that there are no 
significant differences between groups. With regard to age, sex and ethnicity 
there is no consensus across studies. Clearly, differences are less pronounced and 
are probably to a greater extent subject to sampling and methodological issues. 
Also between our own two studies, differences can be observed. Whereas in both 
studies, persons in the dual group are found to be significantly more often male 
(82.5% vs. 77.1% and 79.4% vs. 72.7%), older (29.6 vs. 28.0 years and 29.0 vs. 
27.4 years) and living alone (33.5% vs. 24.8% and 29.4% vs. 15.2%) compared 
to persons with drug problems, only in the first of the two studies the differences 
between groups were statistically significant.  
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In conclusion, both the literature review as well as our own studies show that 
individuals with co-occurring alcohol and illicit drug use problems (the dual 
group) are clearly distinct from persons with alcohol use problems only. In 
comparison with persons with drug use problems only, findings are less 
straightforward and overall, the socio-demographic situation of persons with co-
occurring alcohol and drug use problems bears much stronger resemblance to the 
situation of persons with drug problems only than to those of persons with 
alcohol problems only.  
 
 
7.2.4. Substance-related characteristics and addiction severity of persons with 
co-occurring alcohol and drug use problems starting substance abuse 
treatment 
 
When comparing the illicit substance use patterns of persons with drug problems 
only with those of persons with co-occurring alcohol and drug use problems, we 
observed higher rates of regular cannabis (72.0% vs. 60.8%), amphetamine 
(43.5% vs. 28.1%), cocaine (57.3% vs. 40.7%), hallucinogens (12.4% vs. 3.5%) 
and ecstasy (34.9% vs. 13.1%) use among the dual group and lower rates of 
regular heroin (24.8% vs. 35.0%) and injecting drug use (15.8% vs. 22.6%) (cf. 
Chapter 3). As was also demonstrated in other studies, multivariate analyses 
confirmed that the regular and excessive use of alcohol among drug users is 
much more associated with the regular use of stimulants or so-called “uppers” 
(e.g. cocaine) than with the use of depressants or so-called “downers” (e.g. 
heroin) (Gossop et al., 2002; Schmitz, Bordnick, Kearney, Fuller & 
Breckenridge, 1997). 
 
Although the use and misuse of prescription drugs was not the main focus of this 
Ph.D. dissertation, the study provided us with some insights in the use of 
sedatives (predominantly benzodiazepines) among clients in substance abuse 
treatment within the month preceding the start of treatment. Between-group 
comparisons revealed that the regular use of sedatives before the start of 
treatment was highest in the dual group (36.6%) as compared to the alcohol-only 
(25.7%) and illicit drug-only group (22.9%). In multivariate analyses, the regular 
use of sedatives significantly increased the odds of belonging to the dual group 
as compared to the alcohol-only group but not as compared to the drug-only 
group. As benzodiazepines are often prescribed to assist persons during the 
detoxification phase or are prescribed to treat co-occurring anxiety disorders, it is 
expected that as the residential treatment period advances these prevalence rates 
can become even higher. However, it is well-known that individuals not always 
use prescription drugs for legitimate medical purposes and that prescription 
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drugs can also be misused, bringing along important risks for developing 
addiction (Compton & Volkow, 2006).  
 
As shown in the literature review (cf. Chapter 4), studies have used various 
measures to operationalize and better understand addiction severity such as age 
at first onset of use or dependence, duration of use, presence of the DSM-IV 
diagnoses of abuse versus dependence, number of substance dependence criteria 
and multidimensional instruments such as the Addiction Severity Index. 
Analyses of the available evidence showed that, with a few exceptions, the 
selected studies agreed that persons with co-occurring alcohol and drug use 
problems have a higher addiction severity than persons with alcohol use 
problems only. When compared to persons with illicit drug problems only, 
results are indecisive. Overall, addiction severity is found to be a strong 
determinant of high psychiatric co-morbidity and low quality of life (Evren et al., 
2010; Preuss et al., 2009; Volk, Cantor, Steinbauer & Cass, 1997). 
 
 
7.2.5. Treatment utilization of persons with co-occurring alcohol and drug use 
problems starting substance abuse treatment 
 
Our second study (cf. Chapter 3) which covered the whole specialized alcohol 
and drug treatment sector in the province of Antwerp showed that during the 6-
month registration period, half (51.8%) of all persons with co-occurring alcohol 
and drug use problems were registered only in (a) center(s) providing residential 
treatment, whereas 42.9% was registered only in (a) center(s) providing 
outpatient treatment and 5.3% was registered in centers providing inpatient as 
well as outpatient treatment. Compared with persons with alcohol use problems 
only, persons with co-occurring alcohol and drug use problems were 
significantly more often registered in treatment centers providing outpatient 
treatment, as the overall majority (79.5%) of the former was registered in 
residential treatment centers. Compared with persons with illicit drug use 
problems only, persons with co-occurring alcohol and drug use problems were 
registered more often in residential treatment agencies only, as about two thirds 
(65.0%) the former was registered only in centers for outpatient treatment.  
 
The second study also showed that whereas all persons with alcohol use 
problems only were registered in the generic (mental) health care treatment 
centers, 41.9% of the persons with illicit drug problems only were registered in a 
categorical treatment center only and 55.1% in a generic treatment center. 
During the short registration period of 6 months, 3.0% was registered in both 
sectors. Compared to the latter, persons with co-occurring alcohol and drug use 
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problems were more often registered in the generic treatment centers (64.7% 
versus 55.1%). In general, they also had higher rates of previous treatment 
history upon admission (77.9% vs. 61.9%). 
The overall picture that arose from our in-depth study (cf. Chapter 4) was that in 
the units for intensive, long-term residential substance abuse treatment, situated 
in psychiatric hospitals in East- and West-Flanders, the large majority consisted 
of persons who met the criteria for a current DSM-IV alcohol dependence only 
(74.0%). A quarter of all persons was dependent on one or more illicit drugs, 
with (13.2%) or without (12.8%) a co-occurring alcohol dependence.  
 
However, in this concluding chapter, it is also important to refer to the 
differences between units 10
 
. Although all 11 units are situated within the generic 
mental health care and provide intensive, long-term residential treatment after an 
initial detoxification phase. Although traditionally the generic centers had a 
predominant focus on alcohol use problems, important differences can be 
observed between units. Table 7.1. shows indeed that in 6 out of 11 units, 
between 90 and 100% of all patients are only dependent on alcohol whereas in 4 
out of 11 units, this percentage is situated between 50 and 75%. In one unit, the 
situation is reversed: the overall majority of the admitted persons is dependent on 
one or more illicit drugs, either with (31.0%) or without (55.2%) co-occurring 
alcohol dependence. The table also shows that although in 5 out of 11 units dual-
dependent persons were registered, no persons dependent on illicit drugs only 
were registered. This could possibly be linked to the units’ strong historical focus 
on alcohol use problems and to a deliberate treatment admission policy (e.g. 
persons with illicit drug problems are only admitted when also an alcohol use 
problems is present).  
 
 
 
                                                          
10 New analysis ; not included in chapters 4 or 5. 
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Table 7.1.:  Prevalence rates of current alcohol-, drug- and dual-dependence in the participating treatment units  
 Unit 
1 
(n=29) 
Unit 
2 
(n=19) 
Unit 
3 
(n=25) 
Unit 
4 
(n=29) 
Unit 
5 
(n=14) 
Unit 
6 
(n=14) 
Unit 
7 
(n=56) 
Unit 
8 
(n=29) 
Unit 
9 
(n=16) 
Unit 
10 
(n=7) 
Unit 
11 
(n=20) 
Currently DSM-IV dependent on             
* alcohol only 58.6 100.0 68.0 13.8 92.9 100.0 96.4 51.7 93.8 71.4 90.0 
* illicit drugs only 34.5 0.0 8.0 55.2 0.0 0.0 0.0 17.2 0.0 0.0 0.0 
* both alcohol and illicit drugs 6.9 0.0 24.0 31.0 7.1 0.0 3.6 31.0 6.2 28.6 10.0 
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7.2.6. Personality pathology among persons with co-occurring alcohol and 
drug use starting substance abuse treatment 
 
The aim of the fourth study was to estimate the prevalence of personality 
disorders among substance abusers starting treatment and to look for similarities 
and differences between individuals with an alcohol, drug or dual dependence.  
(cf. Chapter 5). We also wanted to assess the impact of the type of dependence 
(alcohol, drugs or dual) on personality pathology when also addiction severity 
and a number of socio-demographic variables would be included in multivariate 
analysis. In total, 274 persons were interviewed between the 7th and 21st day 
after admission, using the EuropASI (Kokkevi & Hartgers, 1995), the M.I.N.I. 
(Sheehan et al., 1998), the ADP-IV (Schotte, de Doncker, Vankerckhoven, 
Vertommen & Cosyns, 1998) and the WHO-QOL-BREF (Skevington, Lofty & 
O'Connell, 2004). 
 
Personality disorders were highly prevalent in the sample. Almost half (42.6%) 
of all clients met the criteria for at least one DSM-IV personality disorder, which 
is in accordance with what is generally reported (Echeburúa, de Medina & 
Aizpiri, 2007; Fassino, Daga, Delsedime, Rogna & Boggio, 2004; Preuss et al., 
2009; Verheul, 2001; Zikos, Gill & Charney, 2010). The most prevalent 
personality disorders were borderline, avoidant, anti-social, obsessive-
compulsive and paranoid personality disorders. Our study also demonstrates that 
more than half (n=63; 57.3%) of all persons meeting the criteria for at least one 
personality disorder, in fact meet the criteria for two or more personality 
disorders. Furthermore, prevalence rates of personality disorders among 
individuals with a drug (66.7%) or dual dependence (67.6%) were significantly 
higher than among patients with alcohol dependence only (34.0%). This 
confirms the overall conclusion of our systematic review (cf. Chapter 4) in 
which persons with co-occurring alcohol and drug use problems were found to 
have higher levels of mood, anxiety and personality disorders and higher levels 
of overall psychological distress as compared to persons with alcohol use 
problems only.    
 
Although a number of studies have stated that overall, dual-dependent persons 
have a greater psychopathology and more psychological problems as compared 
to drug-dependent persons (Gossop et al., 2002; Miles, Svikis, Kulstad & Haug, 
2001), our systematic literature review (cf. Chapter 4) shows diverging findings 
for mood, anxiety and personality disorders. Only for overall psychological 
problems or distress, a consensus across studies was found with higher levels of 
problems and distress among persons with co-occurring alcohol and drug use 
problems as compared to persons with drug problems only. Meanwhile, our 
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study on the prevalence of personality disorders among clients starting alcohol or 
drug treatment, found no significant differences between drug-dependent persons 
with and without co-occurring alcohol dependence. Clearly, the connection 
between personality disorders and drug use disorders is clearly stronger as 
compared with alcohol use disorders (Verheul, Van den Brink & Hartgers, 
1995). However, multiple regression analyses showed that, when socio-
demographic variables and addiction severity are taken into account, the type of 
dependence (alcohol, drug- or dual dependence) is not an independent 
determinant of personality pathology, as measured by the continuous scores for 
the 12 personality disorders included in the ADP-IV. 
 
 
7.2.7. Quality of Life among persons with co-occurring alcohol and drug use 
starting substance abuse treatment 
 
In the fifth study, we focused on the Quality of Life and subjective perspectives 
of individuals starting substance abuse treatment (cf. Chapter 6). In view of the 
increasing recognition that substance use disorders are chronic, relapsing 
conditions that require a long-term, continuing care perspective (McLellan, 
McKay, Forman, Cacciola & Kemp, 2005), Quality of Life is increasingly being 
put forward as a useful instrument for overall assessment and for measuring 
treatment outcome within substance abuse treatment (Foster, Peters & Marshall, 
2000; Foster, Powell, Marshall & Peters, 1999). In this fifth study, we aimed at 
assessing persons’ QoL with specific attention for similarities and differences in 
QoL between alcohol-, drug- and dual-dependent patients. Furthermore, we 
wanted to investigate the independent impact of type of dependence (alcohol, 
drugs or dual), addiction severity and psychiatric comorbidity on overall Quality 
of Life and perception of health. To answer our research questions, we relied on 
the database of the fourth study.  
Results show that dual-dependent individuals have the lowest WHO-QoL-BREF 
scores on overall QoL (mean score of 2.41) and perception of health (mean score 
of 2.35), when compared to individuals dependent on alcohol only (mean scores 
of 2.95 and 2.97 respectively) and drugs only (mean scores of 3.12 and 3.18 
respectively). However, in multivariate analyses the type of dependence (alcohol, 
drugs, dual) appeared no significant determinant of QoL when addiction 
severity, psychiatric comorbidity and some socio-demographic variables are 
included in the models. The presence of an anxiety, mood or personality 
disorder, being unemployed and a higher severity rating on the EuropASI 
domain “alcohol use” were associated with a lower, overall QoL. Being male, 
the presence of an anxiety disorder and lower severity ratings on the EuropASI 
domains “alcohol use”, “drug use”, “physical health” and “emotional and 
General Conclusion and Discussion 
 
205 
psychological health” were associated with a lower, overall perception of health. 
Whereas addiction severity and psychiatric comorbidity were independently 
associated with overall QoL and perception of health, the type of dependence 
was not. 
  
 
7.3. Implications for policy, research and clinical practice 
 
7.3.1. Adopt comprehensive policy plans and strategies including both alcohol 
and other drugs 
 
Across studies (Chapter 2, 3 and 5), high levels of poly drug use were observed 
among clients in substance abuse treatment. This is consistent with the findings 
of a recently finished research project on poly drug use and mental health, 
financed by the Belgian Science Policy Office (Vanderplasschen et al., 2012) 
and a number of other studies, stating that poly drug use is now the rule rather 
than the exception (e.g. Byqvist, 2006; Ives & Ghelani, 2006). Users experiment 
with new substances and combinations (Klee, Faugier, Hayes, Boulton & Morris, 
1990), continue to not only use one but multiple substances and possibly develop 
problems that are related to the use of those different substances. As 
demonstrated throughout this dissertation, not only illicit drugs but also alcohol 
and prescription drugs are involved in these poly drug use patterns. 
 
Therefore, it is important to adopt comprehensive policy plans including all 
substances, rather than the adoption of separate plans for alcohol and illicit 
drugs. Although we fully agree that it is necessary to target certain policy actions 
towards people using one particular substance or group of substances, it is 
recommended to always keep the larger picture and the interconnectedness 
between all substances in mind. It is important to realize that actions targeted at 
one particular substance can have intended effects on the use of that one 
substance, but also unintended effects on the use of other substances.  
 
Both at the federal as well as at the Flemish policy level, an explicit choice was 
made for such an integrated approach of all substances, as outlined in the 
communal declaration of the inter-ministerial conference on drugs “A global and 
integrated drug policy for Belgium”, issued in January 2010 and in the “Flemish 
Action Plan Tobacco, Alcohol and Drugs 2009-2015” (Crement, De Ruyver, 
Vander Laenen & Lievens, 2012).  
The communal declaration can be seen as a confirmation and actualization of the 
federal drug policy note of 2001 (Interministeriële Conferentie Drugs, 2010). 
Both this policy note as well as the declaration is clearly oriented on the whole of 
Chapter 7 
 
206 
tobacco, alcohol, illicit drugs and psycho-active medication. However, in order 
to refer to these four categories of substances the word “drugs” is used whereas 
we feel that the term “substances” (or “middelen” in Dutch) would have been 
more appropriate and perhaps less misleading for the general public as the term 
“drugs” (both in English and Dutch) still has a strong “illicit drug” connotation 
(see infra). Also in the federal research program on drugs that was established to 
support the federal drug policy note of 2001, this comprehensive approach 
towards all licit and illicit substances was adopted (BELSPO, 2012).    
In their action plan, the Flemish Community aims at reducing health-related 
harm caused by the use of tobacco, alcohol and drugs. The overall objective is 
not only to reduce the use of these various substances at population level but also 
on a more individual level several objectives are formulated for the whole of all 
substances, e.g. postponing the first use of substances and assisting regular users 
in quitting their use. The concrete elaboration of these objectives can differ from 
one substance to another (Agentschap Zorg en Gezondheid, 2012). 
 
In Europe, about half of the countries (45.5%) appear to have separate policies 
for alcohol and for illicit drugs (Room, 2010) and also on the level of the 
European Union separate policy and action plans were developed to address the 
adverse effects of alcohol and illicit drug use. Whereas for alcohol, the EU has 
developed a strategy in 2006 to support Member States in reducing alcohol 
related harm, a separate strategy and policy plan were developed for illicit drugs: 
the EU drug strategy for 2005-2012 and the EU drugs action plan for 2009-2012 
(Commission of the European Communities, 2006; Council of the European 
Union, 2004, 2008). Except for one small reference to alcohol in the EU drugs 
strategy (in the context of poly drug use), no cross-references to either alcohol or 
illicit drugs can be found in either of these plans (Vander Laenen, 2012). Also in 
the way that the European Commission organizes data monitoring to support the 
implementation and evaluation of these policy and action plans, separate 
strategies were developed. In order to gather sound and comparable information 
on illicit drugs in Europe, the European Monitoring Centre on Drugs and Drug 
Addiction (EMCDDA) was established in 1993 (Council of the European Union, 
1993). For monitoring alcohol use and alcohol use problems, the European 
Union Information System on Alcohol and Health (EUSAH) was set up in 
cooperation with the World Health Organisation Regional Office for Europe 
(WHO, 2012).  
 
Based on the findings of our studies and following Vander Laenen (2012), we 
recommend comprehensive policy plans rather than separate alcohol and drug 
policy plans. Whereas Belgium has explicitly chosen this path, the European 
Union (still) adopts separate strategies. We believe a rapprochement between 
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both could be beneficial for both domains. At present, an interesting but 
controversial merger is taking place in the United States where in October 2013 
the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the 
National Institute on Drug Abuse (NIDA), separately established in the 
seventies, will merge in one National Health Institute (Roizen, 2012).    
 
 
7.3.2. Adopt a multiple substance focus in substance abuse treatment research  
 
The high prevalence rates of poly drug use and of co-occurring alcohol and drug 
use problems more in particular not only have implications at policy level but 
also have implications for future studies on substance abuse treatment. In 
Belgium as well as in other countries, this sector is increasingly being confronted 
with a strong movement towards more evidence-based practice, including the 
development, implementation and use of evidence-based guidelines (Broekaert, 
Autrique, Vanderplasschen & Colpaert, 2010). However, guidelines for 
evidence-based practice are mostly developed for one particular substance use 
disorder (Autrique, Vanderplasschen, Broekaert & Sabbe, 2009) without taking 
into account that the overall majority of substance users are poly substance users 
and that alcohol and drug problems frequently go hand in hand. On June 15th 
2012, the Cochrane library, established by the International Cochrane 
Collaboration, contained 114 systematic reviews on tobacco, drugs or alcohol 
dependence. Whereas 106 can be considered substance-specific, only 8 can be 
considered non-substance-specific including a systematic review on case 
management for persons with substance use disorders (Hesse, Vanderplasschen, 
Rapp, Broekaert & Fridell, 2007) and a systematic review on therapeutic 
communities for substance related disorder (Smith, Gates & Foxcroft, 2006). 
 
Randomized controlled trials (RCTs), which are considered as “the gold 
standard” within this evidence-based discourse (Broekaert et al., 2010, p.229) 
often adopt a one drug focus. Both the in- and exclusion criteria of respondents 
are often very rigidly defined. In order to be included in the study, persons are 
supposed to have no other substance use disorders than the one where the 
treatment is focusing on (Rounsaville, Petry & Carroll, 2003). In the light of the 
findings on co-occurring alcohol and drug use problems reported in this 
dissertation, this raises important questions with regard to the clinical relevance 
of the results of these RCT studies.  
 
Therefore, we agree with Rounsaville and colleagues (2003) that it is 
indispensable to adopt a multiple substance focus in clinical trials and by 
extension to all follow-up studies examining the overall effectiveness of 
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substance abuse treatment, which can be obtained through three specific actions. 
First, a broad systematic assessment of psychoactive substances should take 
place in all clinical trials and the effect of the treatment being evaluated should 
be measured on the patterns of use of all substances. Second, they advise to 
include persons who use or abuse various substances, even when the treatment 
under evaluation is a substance-specific intervention, apart from a few clearly 
defined exceptions. Third, it is recommended to include persons who are abusing 
or are dependent on multiple substances (Rounsaville et al., 2003). In addition, 
we want to stress the importance of taking the whole spectrum of psychoactive 
substances into consideration, which means that not only the illicit substances 
but also alcohol and other licit substances need to be taken into consideration. 
 
 
7.3.3. Dividing lines between alcohol and drug use problems will fade 
 
Based on the findings of this dissertation we can confirm that within substance 
abuse treatment services, persons with illicit drug use problems differ from 
persons with alcohol use problems in many ways (cf. Chapters 2 and 5). Using 
or not using illicit drugs, rather than using or not excessively using alcohol, 
appears to make up the distinctive criterion as demonstrated both in this 
dissertation as well as in the organization of Belgian substance abuse treatment. 
Persons with alcohol use problems clearly have a different profile from persons 
with illicit drug problems (whether or not in combination with co-occurring 
alcohol problems) with regard to socio-demographics (Colpaert, 
Vanderplasschen, Van Hal & Broekaert, 2005b) but also with regard to 
personality pathology. Especially the 17-year difference in mean age between 
persons with alcohol versus drug use problems is a crucial element in the 
discussion. In clinical settings, this is often reflected in everyday terminology 
such as “young drug users” versus “older alcoholics”.  
 
However, it can be expected that in general, the dividing lines between alcohol 
and illicit drug problems will continue to fade and that also the large age gap 
between persons with alcohol and illicit drug use problems seeking treatment 
will shrink.  
At present, the US is increasingly confronted with increases in the number of 
older individuals using illicit drugs, especially among the baby boomers born 
between 1946 and 1964 (Han et al., 2009). This can be related to the fact that 
generations or age cohorts that are accustomed to consuming illicit drugs become 
older (Fahmy, Hatch, Hotopf & Stewart, 2012). Although in Belgium, the overall 
lifetime prevalence rates of cannabis and other illicit drug use have always been 
considerably lower compared to the US, it can be expected that in the coming 
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years the lifetime, and possibly also the current, prevalence rates of cannabis and 
other illicit drug use will rise in the older age groups. Not only the drug using 
generations becoming older but also the increase in harm reduction initiatives, as 
opposed to abstinence-oriented programs only, can result in treatment agencies, 
and society at large, being increasingly faced with a group of older illicit drug 
users. In the Belgian categorical treatment agencies for illicit drug users, an 
overall increase in the average age of illicit drug users of 2.3 years can be 
observed over the past 20 years, but in certain treatment modalities (e.g. centers 
for medico-social care providing substitution treatment), even a 4-year increase 
in average age was observed and this over the past five years (VVBV, 2009).   
 
Both for the categorical as well as the generic (mental) health care services this 
will bring along important challenges. Whereas categorical substance abuse 
treatment services were traditionally oriented towards young drug users and will 
possibly have to re-think their programs, generic (mental) health care services 
will probably encounter more and more alcohol-dependent people who also use 
or abuse illicit substances among their client populations. As these changes do 
not take place from one day to the next, it is important to start reflecting on the 
possible implications for treatment provision and planning. For instance, in 
residential treatment settings for illicit drug users with a strong 
(ortho)pedagogical approach, this generational aspect can also be one element 
that needs to be considered when thinking about overall group climate and 
composition of the group. For Kok (1973), this consists of the important first 
degree strategy (creating a pedagogical climate), which provides the foundations 
for the second (therapies and interventions) and third (individual accents) degree 
strategies. When a group is well-composed, this creates a certain dynamic that 
makes personal growth possible.  
 
 
7.3.4. Pay sufficient attention to alcohol use problems among illicit drug users 
seeking treatment 
 
As this dissertation shows that about half of all regular illicit drug users in 
substance abuse treatment are also regularly and excessively using alcohol (cf. 
Chapter 1, 2, 4), it is important that treatment agencies with a predominant focus 
on young, illicit drug users also carry out a thorough alcohol assessment at intake 
and keep attentive for clients’ (changing) alcohol use patterns during the whole 
in- or outpatient treatment episode. Although we know that many treatment 
services assess the whole spectrum of substance use behavior in a standard way, 
e.g. by using the European Addiction Severity Index (Raes & Lombaert, 2004), 
we are convinced that paying special attention to the alcohol issue could possibly 
Chapter 7 
 
210 
have positive effects on treatment retention and outcome. Indeed, research has 
demonstrated that heavy drinking has an unfavorable effect on drug treatment 
retention and outcome (Chatham, Rowan-Szal, Joe & Simpson, 1997; Joe, 
Simpson & Broome, 1999; Marsch et al., 2005).  
 
As confirmed in this dissertation, it is quite realistic that, next to their drug 
problems, clients also engage in frequent binge-drinking (cf. Chapter 3) or meet 
the criteria for current DSM-IV alcohol dependence (cf. Chapter 5). However, 
clients may well be situated on different levels of readiness to change with 
regard to their use of illicit drugs versus their excessive use of alcohol, possibly 
resulting in a need for different interventions according to the substance. Also 
when reaching the final phase of treatment or when relapse prevention activities 
are set up, it can be important to particularly focus on the role and function of 
alcohol in relapse. Previous studies have shown that heavy drinking increases the 
risk of illicit drug relapse after treatment (McKay et al., 2005) and have 
hypothesized that the reduction in illicit drug after drug treatment could possibly 
be replaced by an increase in alcohol use (Slesnick, Bartle-Haring, Glebova & 
Glade, 2006).  
 
Overall, although we could not confirm that persons with drug use problems only 
and those with co-occurring alcohol and drug use problems are two clearly 
distinct groups, early intervention and preventive as well as treatment actions 
related to co-occurring alcohol problems may be indicated among illicit drug 
users (Gossop et al., 2002; Room, Babor & Rehm, 2005), especially among those 
having problems with stimulants (cocaine, amphetamines, ecstasy). Treatment 
programs that are focusing on one particular substance (e.g. substitution 
treatment for opiate-dependent individuals or community reinforcement 
approach (CRA) + vouchers for cocaine abusers), can have a strong evidence-
base. However, it is important that substance-specific interventions always keep 
the patterns and functions of use of other licit as well as illicit substances in mind 
during the intervention (Vanderplasschen et al., 2012). Even within more generic 
or non-substance-specific programs, it can still be important to carefully monitor 
clients’ alcohol use patterns. After all, alcohol and illicit drugs have very 
different socio-cultural meanings and levels of acceptance in our present-day 
society (Weisner, 1992) and therefore also among the clients and clinicians 
themselves. 
 
 
 
 
 
General Conclusion and Discussion 
 
211 
7.3.5. Move further towards an integrated and comprehensive network of 
alcohol and drug treatment services  
 
As demonstrated in the introduction of this dissertation (Chapter 1), Belgium 
currently has an extensive and varied array of services for substance users, which 
have been gradually developed over time against a background of different 
prevailing addiction models (van den Brink, 2005). Both abstinence-oriented as 
well as harm-reduction initiatives, both programs with a strong medical focus as 
well as programs with a strong (ortho)pedagogical focus and both programs with 
a strong focus on young, illicit drug users and programs with a strong focus on 
older persons with alcohol use problems, are essential components of this 
comprehensive and varied network of services for substance abusers.  
 
On the one hand it is important that treatment services stick to their core business 
and principles and keep safeguarding their own identity, in order to avoid a shift 
towards full eclecticism. Therefore, we also agree with Pittman, who already 
stated at the end of the sixties that merging alcohol and drug treatment based on 
the simple fact that both are concerned with “dependence” is perhaps too simple 
(Pittman, 1967, as cited in Bergmark, 1998). Taking into account the 
sociological and generational differences and large differences in ways of life 
between persons with alcohol and drug problems can be equally important and 
can support the need for an extensive and varied treatment offer including 
treatment methods and approaches belonging to different paradigms of care. A 
context in which certain centers focus more on illicit drug users and others more 
on problem alcohol users, should therefore in no way seen as problematic but as 
a strength, in order to make sure that the overall objective of realizing a 
meaningful improvement of clients’ situation can be achieved for each client 
(Broekaert et al., 2010).  
 
On the other hand, services should not stay blind for new insights which could 
improve the quality of their programs. In view of the significant overlap and 
fading dividing lines between alcohol and drug use problems, collaboration and 
exchange of expertise between agencies with a strong alcohol and those with a 
predominant illicit drug focus should be encouraged. Furthermore, flexible 
instead of a rigid inclusion and exclusion criteria according to the type of 
substance dependence, should be considered as the large age gap between 
persons with alcohol and illicit drug use problems will possibly shrink and also 
the strict distinction between alcohol and illicit drug problems will further 
continue to fade in the future.  
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Since only recently a uniform treatment demand registration system for 
treatment-seeking substance users was installed at the federal Belgian level that 
will be able to deliver data across various treatment settings and modalities 
(Colpaert & De Clercq, 2003; Lamkaddem & Roelands, 2010), the results of our 
first two studies as presented in chapters 2 and 3 of this dissertation but also in 
the more comprehensive research reports (Colpaert et al., 2005a; 
Vanderplasschen, Colpaert, Lievens & Broekaert, 2003), were found to be very 
useful for local treatment providers and policy makers. 
 
Over the past 15 years, important initiatives were developed in order to provide 
clients with complex and multiple problems with an integrated and 
comprehensive answer to their treatment needs. This resulted in an increased co-
ordination between services at regional levels, under the impulse of the federal 
and provincial governments. In East-Flanders, this entire process was 
scientifically supported (Vanderplasschen, 2004) and resulted in the 
establishment of a formalized integrated treatment system for illicit substance 
users, the organization of monthly co-ordination meetings between treatment 
agencies to address the treatment needs of “shared clients”, the introduction of 
regional substance abuse care coordinators, the common search for a good local 
and regional distribution of treatment services in the province and also the 
introduction and implementation of case management (De Maeyer, Cole, 
Franssen & Vanderplasschen, 2007; PopovGGZ, 2011; Vanderplasschen, 2004). 
Although also in other provinces similar evolutions can be observed, the 
concrete elaboration can differ. Case management is a client-centered approach 
specifically aimed at improving co-ordination and continuity of care and which 
consists of assessment, planning, advocacy and effective linking to the most 
appropriate services and resources in the community (Hesse et al., 2007). A 
systematic review has shown that current evidence exists that case management 
can improve linking with other services (Hesse et al., 2007) but also in-depth 
interviews with clients who had been through a case management trajectory 
positively evaluated case management and highlighted the importance and 
necessity of tailor-made interventions (De Maeyer et al., 2007). It is 
recommended that this successful path of realizing more continuity and co-
ordination of care is pursued, but (re)connecting with more generic treatment 
services with a predominant alcohol focus should be considered.  
 
 
7.3.6. Increase attention for personality functioning and pathology 
 
Our fourth study showed that many alcohol and drug users seeking treatment met 
the criteria for one or more personality disorders. Among persons dependent on 
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alcohol only about one third met the criteria for at least one personality disorder, 
whereas among persons dependent on illicit drugs (with or without alcohol 
dependence) this was the case for about two thirds (cf. Chapter 5). Not only in 
view of the fact that personality disorders have a large impact on the course of 
addiction problems after discharge (van den bosch & Verheul, 2007), but also in 
view of the significant impairment or distress that personality disorders can bring 
about in the lives of the individual and/or his surroundings, it is important to pay 
sufficient attention for personality functioning and pathology during intake and 
assessment and throughout the whole treatment process. Furthermore, the 
presence of personality disorders appears to be an important determinant of 
Quality of Life, as demonstrated both in our own study (cf. Chapter 6) as well as 
in other studies (Cramer, Torgersen & Kringlen, 2006; Karow, Verthein, Krausz 
& Schäfer, 2008).  
 
A first step to increase attention for personality functioning and pathology can be 
to routinely include personality disorder screening and assessment in the intake 
and assessment phase of substance abuse treatment. The new DSM-5 (to be 
published in 2013), can provide interesting opportunities in this respect. In the 
new manual, a hybrid dimensional-categorical model will be introduced. This 
model will make it possible to describe all persons’ personality characteristics 
according to five higher order traits and 25 lower order traits, whether or not they 
meet the criteria for a certain personality disorder. As it is a “hybrid” model, the 
DSM-5 will not radically leave the categorical pathway. In the most recent 
proposals for the DSM-5 section on personality disorders, six prototypes will 
remain, which are closely linked to some of the personality disorders included in 
the DSM-IV. The manual will allow clinicians to describe persons’ personality 
functioning and associated impairment (self and inter-personal) from a rather 
global or from a more detailed or specific perspective, depending on the 
necessity, expertise and available resources and time (APA, 2012; Skodol, 
2012). The Personality Inventory for DSM-5 (PID-5) could be a promising 
instrument which was recently developed and is in line with the new approach as 
proposed in the DSM-5 (Hopwood, Thomas, Markon, Wright & Krueger, 2012; 
Krueger, Derringer, Markon, Watson & Skodol, in press). However, as it is a 
220-item questionnaire by self-report and therefore requires substantial effort 
from individuals in substance abuse treatment, it might be useful to adopt a two-
step screening and assessment procedure in which only persons identified via a 
screening instrument as individuals showing a significant degree of personality 
pathology, are assessed more thoroughly. The Standardised Assessment of 
Personality: Abbreviated Scale (SAPAS) could be a possible screening 
instrument in this respect (Hesse & Moran, 2010). On the other hand, having 
information on personality functioning of all clients and not only on a certain 
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“high-risk” subgroup could be very useful when combined with clinical 
observations and could substantially contribute to the further course and outcome 
of the treatment process. 
 
Further, it is important to tailor substance abuse treatment to clients’ personality 
pathology profile (Staiger, Kambouropoulos & Dawe, 2007; Verheul, 2001) and 
to incorporate specific evidence-based treatment methods within the overall 
treatment. In this respect, two promising psychotherapies which were 
specifically adapted for persons with both a substance-related and a personality 
disorder need to be mentioned here: Dual Focus Schema Therapy (DFST) (Ball, 
1998) and Dialectical Behavioural Therapy targeting Substance abuse (DBT-S) 
(Linehan, Schmidt & Dimeff, 1999). However, the effectiveness of these specific 
treatments still needs to be proven in larger samples (van den bosch & Verheul, 
2007). Others (Dimaggio & Livesly, 2012) are rather in favor of an integrative 
treatment approach which should be provided in a consistent way and tailored to 
the specific situation of the client. Dimaggio and Livesly (2012) also raise 
important methodological questions on randomized clinical trials that have 
demonstrated the effectiveness of special, narrow-focused therapies and wonder 
if the observed change is not largely due to rather generic aspects of the 
treatment (e.g. the establishment of a positive therapy relationship and 
transparency in treatment goals), rather than to the specificity of the treatment as 
such. 
 
Third, cooperation between substance abuse and mental health services should 
be encouraged given the large prevalence rates of both personality as well as 
clinical disorders among treatment-seeking substance users. Cooperation can 
take various forms (e.g. basic training on personality disorders, supervision or 
case reviews, linking with mental health teams), but should overall lead to an 
increase in expertise of professionals working in both the field of substance 
abuse treatment as well as in mental health care and in an improved treatment 
provision for clients (Graham, 2004; Walters, Matson, Baer & Ziedonis). 
According to Drake and colleagues (2007) integrated treatment of both substance 
use as well as mental health problems is preferred over sequential or parallel 
treatment. An important upcoming evolution in the Belgian mental health care 
sector concerns the “article 107” reform, referring to the number of the particular 
article in the Belgian hospital law. With the reform, a reduction in the number of 
beds in psychiatric hospitals is envisaged in favor of more community-based, 
out-reaching and rehabilitation services. However, concerns arise in the field of 
categorical treatment services for illicit drug users as they were only marginally 
involved in the preparatory phases of this reform and possibly the reform could 
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lead to an even larger gap between substance abuse and mental health care 
services than before the article 107 reform (Vanderplasschen et al., 2012).    
 
 
7.3.7. Emphasis on the human prerogative of care 
 
Across the various studies carried out in the framework of this dissertation, it 
became clear that persons with alcohol and drug use problems have complex 
problems in various other life domains (e.g. legal problems, unemployment) and 
often have high levels of psychiatric comorbidity including personality disorders 
(cf. Chapters 2 and 5).  Whereas one third of the persons with alcohol use 
problems met the criteria for at least one personality disorder, this was the case 
for about two thirds of the persons with illicit drug use problems (with or without 
co-occurring alcohol use problems). People with alcohol and drug use problems 
can therefore be considered as persons with multiple treatment needs.   
 
In the current world of substance abuse treatment, great importance is attached to 
evidence-based practice and to the empirical-analytical paradigm of care and 
knowledge (Broekaert et al., 2010). Often the starting point for randomized 
controlled trials, systematic reviews, meta-analyses and the development of 
evidence-based guidelines is one particular, well-delineated problem or disorder 
and often a specific focus is placed on examining the effectiveness of one 
particular treatment intervention for one particular (substance use) disorder. 
However, providing adequate support and treatment to persons with multiple 
problems is more than simply mathematically combining evidence-based 
guidelines for the various disorders present as the whole is often greater than the 
sum of its parts (Claes, et al., 2010). Practitioners are challenged by this multiple 
problem reality and are found to be rather reluctant to follow the evidence-based 
path. The human prerogative of care could possible offer an alternative 
framework to address this apparent discrepancy (Broekaert et al., 2010).   
 
Achieving the best possible solution, support or treatment for substance users 
that are being faced with complex and multiple problems can only occur when 
the human prerogative of care is the guiding principle and when a true dialectical 
integration of various paradigms of care and underlying paradigms of knowledge 
takes place. Not the paradigms in itself, but the human prerogative of care is the 
central issue and makes up the interconnection between the various paradigms of 
care. Seeing and accepting this interconnection forms the starting point for an 
open, methodical and meaningful search aimed at the improvement of 
individuals’ situations. This process is based on making responsible choices and 
decisions, free of any dogma (Broekaert et al., 2010). 
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7.3.8. Focus on improving Quality of Life  
 
Since the nineties, addiction is more and more seen as a chronic relapsing 
disorder (McLellan et al., 2000) and as a brain disease (Leshner, 1997; van den 
Brink, 2005). This changing view and focus on chronicity implies that also the 
treatment focus needs to shift. It has already been abundantly demonstrated that 
recovery takes time and that often long substance use and treatment careers 
precede stable recovery (Dennis, Scott, Funk & Foss, 2005; Hser, Grella, Anglin, 
Longshore & Prendergast, 1997). Therefore, a shift from a short-term, acute 
treatment model focusing on symptoms to a long-term, chronic care perspective 
supporting clients with substance use problems throughout their lives and 
focusing on the person and not merely on the symptom is quintessential 
(McLellan et al., 2005). In this respect, the concept of Quality of Life can be 
used as an indicator of recovery (Laudet & White, 2010) instead of abstinence, 
which was until recently often seen as the only possible indicator of recovery or 
treatment success. Quality of Life is a subjective concept that refers to 
individuals own perspective on and perception of life and is a highly dynamic 
phenomenon (Holmes, 2005; Schalock & Verdugo Alonso, 2002).  
 
In our fifth study, we assessed Quality of Life at the beginning of a long-term, 
intensive residential treatment episode (cf. Chapter 6). Overall, we observed that 
about one third of the respondents rated their QoL as poor or very poor but that 
also about 3 out of 10 respondents rated their QoL as good or very good. In a 
way this is remarkable as many of these individuals are going through a very 
difficult period in life. However, the decision to start residential treatment can 
also have a liberating effect which generates new perspectives on the future and 
on their lives. When the domain-specific scores were considered, clear 
differences across domains were observed. Whereas individuals were most 
satisfied with the domains “environment” and “physical health” and least 
satisfied with “social relationships” and “psychological health”. The necessity of 
studying QoL from a multidimensional perspective is also illustrated in other 
studies (De Maeyer, Vanderplasschen, Lammertyn, van Nieuwenhuizen & 
Broekaert, 2011). 
 
When examining the determinants of QoL in our sample, the type of dependence 
(alcohol, drugs or dual dependence) did not appear to be an independent 
determinant of overall Quality of Life or overall perception of health as 
measured by the WHO-QoL-BREF. In bivariate analyses, persons with co-
occurring alcohol and drug use problems had the lowest QoL scores as compared 
with persons with either alcohol or drug problems only but multivariate analyses 
showed that not the type of the dependence but rather the addiction severity and 
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the presence of mood, anxiety and personality disorders were significantly and 
independently associated with Quality of Life. These findings have concrete 
implications for clinical practice as it is not only important that treatment 
interventions focus on reducing the severity of the substance use problem, also 
early intervention programs are necessary to avoid progression from a moderate 
to a more severe substance use problem which causes an increased impairment of 
persons’ QoL. The close relationship between axis I and II disorders and QoL 
has been demonstrated in various review studies (De Maeyer, Vanderplasschen 
& Broekaert, 2010; Mendlowicz & Stein, 2000). Not only a thorough screening 
and assessment for co-occurring psychiatric disorders at intake, but also the 
development of an integrated mental health and substance abuse treatment 
approach (McGovern, Xie, Segal, Siembab & Drake, 2006) are concrete 
measures that can be considered.  
 
 
7.4. Strengths and limitations  
 
The search for specific socio-demographic characteristics, psychopathology, 
quality of life and treatment utilization patterns of persons with co-occurring 
alcohol and drug use problems made up the central theme of this dissertation. It 
is the intrinsic merit of this dissertation that specific attention was paid to the fact 
that persons in treatment for alcohol use problems also use illicit substances and 
that persons in treatment for drug use problems also use alcohol in varying 
degrees. Especially in contexts where alcohol and drug treatment systems have 
developed separately and have a rather low degree of integration, it is important 
to always keep this reality in mind. The studies reported in this dissertation have 
several limitations, including difficulties in generalizability of the findings, but 
also have a number of strengths, including a high participation rate of treatment 
agencies and high quality data. The most important strengths and limitations are 
discussed in this part of the discussion. 
 
 
7.4.1. Strengths 
 
For the first time, a comprehensive study of the specific position and 
characteristics of persons with co-occurring alcohol and drug use problems was 
carried out. Although the joint use or misuse of both alcohol and illicit drugs is 
for most substance users a normal and natural behavioral pattern, this is not 
always considered as such in the organization of substance abuse treatment, 
neither in alcohol and drug policy planning nor in scientific research. In a way, it 
seems like many alcohol and drug researchers have specialized in either alcohol 
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or drugs and are engaged in different research contexts (Cook & Reuter, 2007; 
Hakkarainen & Metso, 2009). With this study, we have made a serious attempt 
to build bridges between both worlds.  
 
An important strength of all empirical studies was the high, non-compulsory, 
participation of all envisaged treatment agencies. In the second study, nearly all 
specialized alcohol and drug treatment agencies in the province of Antwerp 
participated in the study. Furthermore, the participating agencies represented the 
wide variety of available treatment modalities and settings : both inpatient as 
well as outpatient, both specialized (with a RIZIV/INAMI convention) as well as 
categorical, both alcohol as well as drug treatment and both abstinence-oriented 
centers as well as methadone maintenance treatment centers took part in the 
registration study. Both the high participation rates as well as the diversity of 
treatment agencies were also the case in the first study which took place in East-
Flanders but here, only agencies involved in the treatment of persons with illicit 
drug problems were involved. This difference in orientation was a result of the 
specific research objectives that were formulated in agreement between the 
researchers and the commissioning and financing authorities.  
In both studies, all clients that had an intake interview were registered. For the 
fourth and fifth study, all units situated in psychiatric hospitals in East- and 
West-Flanders that provide intensive, residential alcohol and/or drug treatment 
following an initial detoxification phase agreed to participate. Each client that 
met the inclusion criteria within the data collection period (n=434) was 
introduced to the research objectives and were free of choice to participate or 
not. When comparing the age, gender and type of dependence (alcohol, illicit 
drugs or both) between persons who participated in the study (n=280) and those 
who refused (n=154), no significant differences were found.  
In conclusion, in all studies nearly all treatment agencies that were approached 
participated and either all clients were registered (study 1 & 2) or no differences 
were found between clients who participated and those who refused (study 4 & 
5). Therefore, we can say that our findings are representative for clients in in- or 
outpatient drug treatment (cf. Chapter 2), in- or outpatient alcohol and/or drug 
treatment (cf. Chapter 3) and in residential, intensive substance abuse treatment 
within generic psychiatric hospitals (cf. Chapters 5 and 6), and this within the 
various regions studied. In each study, relatively large sample sizes (n=1,139 - 
n=1,626 - n=274 respectively) could be obtained.  
 
In all studies, we also took various measures in order to ensure a high quality of 
the collected data. For the first two empirical studies, data were registered by 
practitioners during the initial intake interview or the first face-to-face contact 
with the client. This has the large advantage that the persons registering data are 
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also the ones who are in direct contact with the clients for clinical purposes. 
They are all specialists in the domain of substance abuse treatment, have a good 
understanding of specific terminology and are therefore assumed to 
conscientiously register client data with a high degree of validity and reliability 
(Simon et al., 1999; EMCDDA, 2000). The provision of a detailed registration 
manual, training sessions and an electronic helpdesk were also measures to 
increase overall data quality and to simultaneously avoid a possible decrease in 
data quality due to the involvement of many different practitioners as well as 
staff turnover. Furthermore, by limiting the registration efforts to a six-month 
period, we wanted to avoid so-called “registration fatigue”. No validated 
screening or assessment instruments were used. However, most variables were 
derived from either the “Treatment Demand Indicator” protocol of the Pompidou 
Group/EMCDDA or from the European Addiction Severity Index (EuropASI) 
(McLellan, Luborsky, Woody & O’Brien, 1980; Simon et al., 1999). The two 
registration studies also had the significant advantage that the data were 
specifically collected in function of the overall study objectives and that no other 
underlying motives (e.g. insurance and other financial issues, …) could hamper 
accurate and truthful registration. Whereas theoretically, it would possibly be 
easier and more cost-effective to rely on administrative data (in case of 
availability), other studies have drawn attention to a number of difficulties when 
using for instance the Minimal Psychiatric Data (Dom, De Groot & Koeck, 
2004). In studies 4 and 5, clients were interviewed by trained researchers using 
the EuropASI and the Mini International Neuropsychiatric Interview (M.I.N.I.), 
which are internationally widely used, reliable and validated instruments. During 
the interview, the anonymous character was stressed several times in order to 
enhance the reliability of the gathered data. In addition to the EuropASI and the 
M.I.N.I., also the ADP-IV and the WHO-QoL-BREF were used in the study. The 
latter are self-administered questionnaires. Especially regarding the use of self-
administered questionnaires for the assessment of personality disorders, various 
concerns have been raised in the literature including the risk of overdiagnosis 
(Hersen, Hilsenroth & Segal, 2004). However, the ADP-IV has the advantage 
that not only the personality traits are measured but also the distress that is 
associated with these traits which could possibly reduce this risk. Also questions 
regarding clients’ sincerity as well as ability to accurately understand and 
recognize axis II symptoms as listed in the questionnaire (Meyer et al., 2001; 
Oldham, Skodol & Bender, 2005) have been raised. We personally feel that an 
interview could possibly be even more threatening to clients and have therefore 
explicitly chosen for a self-administered questionnaire. However, we did observe 
that some clients had difficulties to understand certain questions. Some other 
clients found it extremely difficult to answer questions on personality traits 
because they were unable to indicate which personality traits were solely present 
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when they were under the influence of substances and which were present also in 
clean and sober periods. After all, many of them had long substance use careers 
with very few periods of abstinence. 
 
A final strength of this dissertation is that in the fifth study both axis I as well as 
axis II disorders were included and that within each axis a wide variety of 
psychiatric disorders was included. In other studies often only axis I or axis II 
disorders are assessed although a previous study has demonstrated the 
importance of obtaining both axis I and II diagnoses in substance abusers in 
treatment (Verheul et al., 2000).  
 
 
7.4.2. Limitations 
 
   Treatment demand data 11
 
 
Substance use often has an illegal status, is frequently linked to other illegal 
activities or deviant behavior and is socially stigmatized. Therefore, it is not easy 
to monitor the prevalence, correlates and overall situation of substance use in 
society (Simon et al., 1999; Stimpson & Judd, 1997; Saxena & Donoghoe, 
2000). Due to its hidden character, substance use is a phenomenon that is 
difficult to grasp and to understand (Wiessing, Hartnoll & Rossi, 2001). Next to 
case-finding studies, general population sample studies and studies among 
specific risk groups, treatment sample studies can be of great help. In this 
dissertation, data were gathered among persons starting alcohol and/or drug 
treatment. For the registration studies in the provinces East-Flanders (n=1,139) 
and Antwerp (n=1,626), data were registered by clinicians, whereas for the study 
in the units for substance abuse treatment in psychiatric hospitals (n=274), 
interviews were held by trained researchers, including the author of this 
dissertation who interviewed the overall majority of the respondents. When 
substance users come in touch with agencies providing social, psychological or 
medical support or treatment, they are – for a certain period – no longer 
“invisible” or “hidden” (Simon, 1997). Treatment demand data can be 
considered as an indirect indicator of overall trends regarding (problematic) 
substance use in the general population, as well as a direct measure of the extent 
to which persons with substance use problems seek treatment (Hartnoll, 
Hendriks & Orrival, 1998). Treatment sample studies can be of great value to 
                                                          
11 This paragraph is  partly based on : Colpaert, K. & De Clercq, T. (2003). Implementing the 
« Treatment Demand Indicator » in Belgium: registration of drug users in treatment. IPH/IHE 
REPORTS Nr. 2003-018. Brussels: Scientific Institute of Public Health (Epidemiology Unit).  
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improve treatment processes and to help policy makers and treatment providers 
in order to make deliberate decisions regarding treatment planning and 
organization (Caetano & Schafer, 1996). Still, several limitations are inherent to 
treatment sample research, which are discussed below.  
 
First, our findings cannot be generalized towards alcohol and drug users who are 
(currently) not in treatment. Overall, substance users in treatment settings are 
known to have a higher problem severity and psychopathology than users in the 
community (Johnson, Brems & Fisher, 1996). It is generally acknowledged in 
epidemiology that persons with two or more conditions have a greater 
probability of seeking treatment than persons with only one condition (Berksons’ 
bias) (Schwartzbaum, Ahlbom & Feychting, 2003) and that therefore substance 
users in treatment can be expected to have a higher comorbidity and problem 
severity than those out-of-treatment. On the other hand, other studies have 
demonstrated the opposite and have found substance users out-of-treatment to 
have a higher problem severity, suggesting that so-called “hitting bottom” 
(Schwartz, Kelly, O’Grady, Michell & Brown, 2011, p.27) is perhaps a 
necessary but certainly not sufficient precondition for entering treatment. 
Clearly, large differences exist between substance users in- and out-of-treatment 
and research findings on substance users in treatment cannot simply be 
generalized towards the overall group of substance users and vice versa.  
 
Second, each regional or national treatment system has been established and 
needs to be situated within its societal context (Klingemann & Hunt, 1998). Not 
only the specific trends in drug use, but also the socio-political context, financing 
structures, legislation, overall substance abuse policy, specific treatment 
admission policies … can influence the extent and nature of the treatment offer 
and can also have a significant impact on the number and characteristics of 
(problem) substance users in society and the proportion of those who find their 
way to treatment. Therefore, findings from treatment sample studies in one 
country or region have to be interpreted with the necessary caution and cannot be 
generalized to or compared with those found in other countries or regions just 
like that (Simon et al., 1999). For instance, in the registration study in the 
province of Antwerp (cf. Chapter 3), the high number of young cannabis users 
seeking treatment catches the eye: about 27.1% of all clients regularly using 
illicit substances reported cannabis to be their main problem drug (Colpaert et 
al., 2005a; Colpaert, Vanderplasschen, Van Hal & Broekaert, 2008). When 
examining differences between clients with cannabis versus those with other 
substances (alcohol, opiates, amphetamines or cocaine) as main problem, we 
found that the former were mostly young male students using no other 
substances. Contextually, the measure of “therapeutic advice” certainly needs to 
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be mentioned here because it can partially explain the high number of cannabis-
related treatment demands. Therapeutic advice is a measure that can be 
suggested by police, youth court or public prosecutor to young people who came 
in contact with the law due to drug-related (mostly cannabis-related) offences. 
When they accept this proposal, they are referred to an outpatient substance 
abuse treatment center for a few sessions in order to assess the severity of the 
drug problem and the necessity of continued treatment (Colpaert, 
Vanderplasschen, Van Hal, Schuyten & Broekaert, 2009). 
Also the way general and specialized healthcare is organized in Belgium can be 
considered important contextual factors to fully understand treatment utilization 
patterns of substance users, and multiple service utilization more in particular (cf. 
Chapter 2). The Belgian healthcare system is characterized by a rather liberal 
tradition where patients have a large freedom in choosing both health care 
professionals as well as health care institutions. Persons have direct access to 
general practitioners, specialists as well as other healthcare professionals. Thus 
far, unlike in other countries, no gatekeeping system has been installed and 
referral is not compulsory. Together with the fact that personal contributions are 
low, this makes access to Belgian health care easy and rather equitable (Gerkens 
& Merkur, 2010). 
 
Third, in the fourth and fifth study we have selected one particular treatment 
modality to thoroughly assess substance dependence, addiction severity, 
psychiatric comorbidity and quality of life, notably the units for intensive, 
residential substance abuse treatment situated in the psychiatric hospitals. As we 
aimed at comparing persons with alcohol, drug and dual dependence, the second 
study (cf. Chapter 3) demonstrated that this setting was the most appropriate to 
meet persons with these varying substance use problems. However, although a 
certain proportion of substance users are shared clients across categorical and 
generic treatment centers (Colpaert et al., 2005a), categorical and generic 
treatment centers also have own client populations that differ in certain ways. 
Besides the fact that categorical centers only allow problem alcohol users by 
exception, it has to be taken into consideration that for instance illicit drug users 
seeking treatment in categorical treatment centers more often have legal 
problems and were more often born in another country than Belgium as 
compared to illicit drug users seeking treatment in generic treatment services 
(Colpaert, Vanderplasschen, Van Hal & Broekaert, 2006).   
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   Self-report data 
 
Self-report data were an important feature of all studies. We did not use 
biological testing, nor did we call upon other informants (such as family 
members) to verify clients’ statements. Since all clients were starting alcohol or 
drug treatment at the time of the interview, we made the implicit assumption that 
clients had nothing to win or lose by withholding or distorting the truth about 
their substance use and that the validity and reliability of the collected data was 
therefore not severely endangered. Other studies have indeed demonstrated that 
self-report data on the use of licit or illicit substances can be considered valid 
and reliable (Del Boca & Noll, 2000; Vitale, Van de Mheen, Van de Wiel & 
Garretsen, 2006). Nonetheless, we cannot completely rule out that certain clients 
have either minimalized or exaggerated their use of some but not all substances, 
e.g. a client who tells the practitioner during the intake interview that he is in 
need for treatment for a problem with cocaine could possibly minimize his use of 
alcohol because he doesn’t regard is as a problem and doesn’t want the 
practitioner to thoroughly assess his alcohol use behavior.  
 
 
    Distinction between persons having alcohol, drug and co-occurring 
alcohol and drug use problems  
 
In this dissertation, we examine similarities and differences between individuals 
with alcohol, drug and co-occurring alcohol and drug use problems. Three 
distinct, mutually exclusive, categories are proposed: persons who regularly use 
alcohol, drugs or both (cf. Chapter 3) and persons who are currently dependent 
on alcohol, illicit drugs or both (cf. Chapters 5 and 6). Categorization occurred 
on the basis of clearly defined and transparent criteria, notably the definition of 
regular use as included in the EuropASI and of the definition of DSM-IV 
dependence, as measured with an internationally recognized and validated 
instrument (the M.I.N.I.). This trinomial categorization partly reflects what is 
generally observed in clinical practice, where alcohol and drug users are 
considered as distinct phenomenological realities. Based on their clinical 
experience, the overall majority of practitioners will confirm alcohol and illicit 
drug users to have a different profile in many ways. This view can also be 
encountered in the organization of substance abuse treatment, in which a separate 
treatment system was developed for illicit drug users.  
 
However, research shows a significant overlap between both groups: persons 
with illicit drug problems also use alcohol in varying degrees and persons with 
alcohol problems also use other substances. This observation raises questions on 
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the adequacy of split alcohol and drug treatment systems. Furthermore, there is 
some evidence that individuals having problems with both alcohol and illicit 
drugs possibly have a different and more severe treatment profile as compared to 
individuals with alcohol or drug problems only. Therefore, in this study the 
phenomenological realities of “persons with alcohol and persons with illicit drug 
problems” were further refined into the mutually exclusive “persons with alcohol 
problems, problems with illicit drug problems and persons with both alcohol and 
illicit drug problems” categorization. 
 
Categorization can be considered as a cognitive process in which people classify 
observations in order to process large amount of information and to structure and 
better understand the complex reality around them. It is inherent to human nature 
because it is the only way to reach symbolic order. Language is the example par 
excellence of this intrinsic need for categorization (Broekaert, 1997). Within the 
framework of diagnostic assessment, classification can provide clinicians with a 
framework that not only incorporates information on symptoms but also on 
etiology, course, prognosis and treatment responses (APA, 2000). However, 
categorization and the use of diagnostic labels in particular may have 
implications for public stigma, self-stigma and active label avoidance among 
individuals (Ben-Zeev, Young & Corrigan, 2010). Classifying on the basis of 
one problem or diagnosis (e.g. alcohol and/or illicit drugs) emphasizes the 
similarities and homogeneity within one class and stresses the differences with 
the other class(es). However, also within classes substantial diversity and 
heterogeneity can be found, even with regard to the problem or diagnosis that 
makes up the foundation of the classification. In the new DSM-5 of the 
American Psychiatric Association, the new and broader diagnosis of “alcohol use 
disorder” implies meeting 2 or more out of 11 polythetic criteria. Skodol (2012) 
illustrates that this diagnosis of “alcohol use disorder” in fact result in over 2,000 
possible combinations of 2 or more criteria.  
 
 
   In search of the best possible English addiction terminology 
 
According to Babor and Hall (2007), the field of addiction science language still 
has many issues to overcome as addiction terminology is characterized by ill-
defined terms, inconsistencies in terminology and important differences between 
scientific and popular terminology. In this dissertation, the choice for certain 
concepts and terms was always prompted by the enhancement of scientific 
communication, international comparability and recognizability but as time, and 
also my Ph.D. study, progressed both the scientific insights and preferences as 
well as my own insights advanced.   
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An example of these advancing scientific insights and preferences in 
terminology can be found in the word “dependence”. Whereas “dependence” 
was introduced in the DSM-III-R as a more neutral term compared to 
“addiction” or “addictive disorder”, the new DSM-5 will probably move away 
from the concept “dependence” in favor of “substance use disorder” as it 
clinicians have serious problems with its dual meaning. In fact, dependence can 
refer to uncontrolled and compulsive drug-seeking behavior but also to normal 
adaptive processes that occur when medication for depression, anxiety or pain 
treatment is prescribed (Kranzler & Li, 2008; O’Brien, 2010). On the other hand, 
many clinicians and researchers involved in the preparatory phase of the DSM-5 
are in favor of a return to the word “addiction” as it is a less confusing concept 
and over time it is felt to have become commonplace and to have lost its 
pejorative meaning. However, for the moment, there is no consensus yet and 
therefore the compromise “substance use disorder” is suggested (O’Brien, 2010).   
 
A concrete example of my own advancing insights relates to the use of the 
concept “substance abuser”, especially as applied in chapter 3 of this 
dissertation. The concepts “substance abuse”, “substance abuse treatment” and 
“substance abusers” are frequently found in scientific literature, sometimes 
referring to the various diagnostic categories in the DSM-IV such as alcohol 
abuse or cocaine abuse, but most of the time used as an overall indication of 
problem use. The latter is also the way that it was used in chapter 3 when we 
discuss dual substance abusers. However, people might consider the terms 
“substance abuse” or “substance abusers” as stigmatizing in view of the 
associations with illicit activities including child, sexual or domestic abuse 
(SAMHSA, 2004). Furthermore, as the editor of Substance Use & Misuse notes: 
“substances are used or misused; living organisms are and can be abused” 
(Colpaert, De Maeyer, Vanderplasschen, Broekaert & De Fruyt, 2012, Editors’ 
note on page 649). Indeed, language matters and not only for researchers and 
policy makers but also for the people themselves. The labels that are applied to 
individuals have consequences for the way these individuals perceive themselves 
and are perceived by others (White, 2009). A recently published study (Kelly & 
Westerhoff, 2010) demonstrated that referring to an individual as "a substance 
abuser" or to an individual as “having a substance use disorder" indeed had 
considerable consequences for the way people conceive the causes of the 
problem and can induce stigmatizing attitudes. The term “substance abuser” 
appeared significantly more often associated with seeing the individual as 
personally culpable and with the need of punitive measures.  
Using or not only using terms like substance abuse, addiction or dependence but 
also using or not using short words such as “other” can have important 
consequences related to the underlying line of reasoning, which was not always 
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sufficiently acknowledged throughout this dissertation. The following two 
examples can be used as illustrations.  
 
First, whereas throughout the various chapters the following two passages may 
have been used interchangeably “alcohol-dependent individuals with psychiatric 
disorders” or “alcohol-dependent individuals with other psychiatric disorders”, 
using or not using the word “other” has everything to do with how substance use 
problems or disorders are seen in relation to the whole of psychiatric disorders 
(Unger, Starzer & Fisher, 2012). Although alcohol as well as drug use disorders 
(abuse and dependence) are included in the DSM-IV, one could argue that 
alcohol use disorders are nearly always seen as psychiatric disorders and are also 
treated accordingly within a psychiatric treatment model; this is not the case for 
drug use disorders. Drug use disorders or problems can be addressed from 
various perspectives, including a more behavioral or pedagogical standpoint. 
Also contextual differences, e.g. between Europe and the US, can be observed 
with regard to the relation between substance use and (other) psychiatric 
disorders (Unger et al., 2012).  
Also in the following two passages, the word “other” is a very important word: 
“alcohol and drugs” or “alcohol and other drugs”. Whereas it is generally 
acknowledged that alcohol is indeed a drug and that consequently the latter 
passage is the correct one, the former passage can be often found in (scientific) 
literature, also in this dissertation. This can be linked to the historical analysis of 
the interconnection between alcohol, tobacco and other drugs of Courtwright 
(2005). At a certain point in time, alcohol was deliberately separated from all 
other drugs and emphasis was placed on the fact that alcohol was a completely 
difference substance, a so-called “benign non-drug” (Courtwright, 2005, p. 118). 
This idea still lives on in everyday language in which for most citizens the word 
“drugs” (similar in Dutch and English) predominantly refers to illicit substances 
other than alcohol. Therefore a tendency can be observed to talk about 
“substances” in English or “middelen” in Dutch to refer to the whole of psycho-
active substances. 
 
 
7.5. Recommendations for future research 
 
In this dissertation we have addressed the prevalence of co-occurring alcohol and 
drug use problems among persons seeking substance abuse treatment settings 
and examined similarities and differences between persons with alcohol, drug 
and dual dependence with regard to socio-demographics, addiction severity, 
psychiatric comorbidity and Quality of Life. Furthermore, the impact of the type 
of substance use problem (alcohol, drug or dual) on psychiatric comorbidity and 
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Quality of Life was assessed, while simultaneously taking into account also 
addiction severity and a number of socio-demographic variables. While carrying 
out this study, we discovered that the very essence of this dissertation, notably 
the interconnectedness between alcohol and drug use (problems) within a poly 
drug use reality, has increasingly become a topic of current interest at  scientific 
and policy level and is currently subject of serious discussions and controversy. 
Researchers question the separate policy strategies for alcohol and drug use in 
the European Union (Vander Laenen, 2012), the upcoming merger of the NIDA 
and NIAAA is hot news (Roizen, 2012), the necessity of a separate diagnosis 
such as poly substance dependence is being discussed in the progress of the new 
DSM-5 (Auriacombe, 2012, personal communication), in some countries an 
“alcoholisation” of cannabis can be observed (Roizen, 1993) and overall the 
dividing lines between licit and illicit substances are fading (Bergmark, 1995). 
Clearly a revitalized paradigm of alcohol, tobacco and other drugs can be 
observed and various disciplines (e.g. history, criminology, neurology, medicine, 
political sciences) are studying this interconnectedness based on different 
interests and concerns (Courtwright, 2005). Incorporating insights from these 
various disciplines, as was also aimed for throughout this dissertation, should 
also be strived for in future studies as it increases our overall understanding 
when studying the specific situation of persons with complex and multiple 
problems, including alcohol and drug use problems.  
 
Whereas this dissertation has addressed the issue of co-occurring alcohol and 
drug use problems among persons in substance abuse treatment from a 
quantitative perspective (which is also the dominant perspective in addiction 
research), in-depth qualitative studies can provide valuable insights in the nature 
of co-occurring alcohol and drug use problems. Engaging in qualitative 
interviews with persons who use both alcohol and illicit drugs can shed light on 
their subjective perspectives with regard to the functions of alcohol and illicit 
drugs in their everyday lives. Whereas this dissertation has adopted objective 
criteria to assess problem alcohol and drug use, notably regular use (cf. 
EuropASI) and DSM-IV substance dependence, listening to substance users and 
explore their perspective on the continuum of use versus problem use could 
prove to be very useful. When is use considered as problem use? When does 
problem use give rise to a perceived need for treatment? What is the role of 
socio-cultural differences between alcohol and illicit drug use in this respect? 
How do substance users themselves perceive the interconnectedness between 
alcohol and illicit drug use? Why do people engage in multiple service use and 
which elements and motives guide their choice of treatment settings?  
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As this dissertation adopted a cross-sectional research design, future studies on 
the interconnectedness between alcohol and illicit drugs in relation to treatment 
trajectories should seek to apply a longitudinal approach. Interesting research 
questions including the role of alcohol in illicit drug relapse and in maintaining 
recovery, on the relation between abstinence and recovery and on the role of 
treatment and continuing care as factors influencing persons’ Quality of Life and 
long-term recovery remain. In view of the fact that substance use disorders are 
increasingly seen as chronic, relapsing disorders which call for a continuous care 
approach, this shifting perspective should also be translated into research 
methodologies (McLellan et al., 2000; McLellan et al., 2005). When assessing 
the effectiveness of treatment it is important to move beyond traditional 
treatment outcome studies in which treatment interventions are evaluated 6 or 12 
months after they were concluded. Instead, treatment should be evaluated both 
during as well as after the treatment episode in order to assess clients’ progress 
in recovery, referred by McLellan and colleagues (2005) as “concurrent recovery 
monitoring”. It is important that substance users are followed over a longer 
period of time and that different treatment modalities should be included in 
longitudinal research.      
 
As shown in our study, large age differences exist between persons with alcohol 
use problems and persons with illicit drug use problems. Also in clinical 
practice, this generational difference is often seen as a distinctive characteristic 
between groups. Based on a number of arguments, we hypothesized that the 
dividing lines between alcohol and drug use in general would fade and that also 
the age gap would shrink. In the US and in Great Britain, social and health 
services but also substance abuse treatment services and society at large are 
increasingly being confronted with older drug users (Fahmy, Hatch, Hotopf & 
Stewart, 2012; Han et al., 2009). As substance abuse treatment has traditionally 
been concerned with younger drug users, this evolution will give rise to 
important questions for treatment organization and planning (EMCDDA, 2010). 
Therefore, exploratory studies should try to understand the specific current and 
future health and social needs of older drug users in order to make the necessary 
improvements within specialized as well as generic treatment services.    
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Middelenafhankelijkheid wordt steeds vaker gezien als een chronische 
aandoening, waarbij herval als een inherent deel van het herstelproces wordt 
gezien. Personen met alcohol- of drugproblemen hebben vaak ook problemen op 
andere leefgebieden (vb. werk, familie, justitie) en er worden hoge 
prevalentiecijfers inzake psychiatrische comorbiditeit gerapporteerd. Daarnaast 
blijken personen met alcohol- of drugproblemen hun kwaliteit van leven, op 
verschillende domeinen, eerder laag in te schatten. Hoewel studies hebben 
aangetoond dat herstel wel degelijk mogelijk is, blijken de meeste personen met 
alcohol- of drugproblemen langdurig en veelvuldig misbruik te maken van 
psychoactieve middelen. Bovendien maken zij tevens frequent en intensief 
gebruik van zowel de reguliere gezondheidszorg alsook van de gespecialiseerde 
alcohol- en drughulpverlening. Een betere inschatting van de kenmerken van de 
personen die een beroep doen op de alcohol- en drughulpverlening en van de 
manier waarop zij gebruik maken van de zorg kan bijdragen tot een betere zorg 
op maat van elke cliënt.  
 
Veelal wordt er een opsplitsing gemaakt tussen sociaal aanvaarde psychoactieve 
middelen (zoals alcohol, tabak en medicatie) en middelen die minder aanvaard 
worden in de samenleving (zoals heroïne, cocaïne, amfetamines en synthetische 
drugs). Deze indeling wordt wettelijk geformaliseerd in internationale verdragen 
en nationale wetgeving op het moment dat een product de status “illegaal 
middel” krijgt en het gebruik aldus gereguleerd wordt. Doorheen de geschiedenis 
heeft de samenhang tussen alcohol, tabak en andere middelen, alsook tussen 
legale en illegale middelen, belangrijke wijzigingen ondergaan. Er kan een 
slingerbeweging worden vastgesteld waarbij vanaf het einde van de 19de eeuw 
vooral de samenhang tussen de verschillende middelen werd beklemtoond, 
gevolgd door een tegenbeweging in het midden de 20ste eeuw waarbij alcohol en 
tabak werden losgekoppeld van de andere (illegale) drugs om heden ten dage 
opnieuw de gemeenschappelijke kenmerken, eerder dan de verschillen, van deze 
productklassen te beklemtonen. Het tot stand komen van een gespecialiseerde, 
categoriale drughulpverlening eind de jaren ’70 kan beschouwd worden als een 
voorbeeld van de loskoppeling van alcohol en illegale drugs. De gespecialiseerde 
centra ontwikkelden een eigen, autonome identiteit en organiseerden de 
hulpverlening initieel vanuit een pedagogische benadering waarbij de 
therapeutische gemeenschap centraal stond. Verslaving werd beschouwd als een 
symptoom van een onderliggende persoonlijkheidsproblematiek die via 
(her)opvoeding kon worden aangepakt. In de loop der jaren werden ook andere 
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categoriale hulpverleningsvormen ontwikkeld, zoals de crisisinterventiecentra, 
de kortdurende therapeutische programma’s, de dagcentra en de medisch-sociale 
opvangcentra. Deze centra ontwikkelden zich los van de hulpverlening die 
binnen de reguliere (geestelijke) gezondheidszorg werd georganiseerd voor 
mensen met alcoholproblemen en die eerder op een medisch-psychiatrisch 
discours was gestoeld. In de beginjaren stonden deze laatste centra eerder 
afzijdig ten aanzien van het begeleiden en behandelen van problematische 
druggebruikers. Vanaf het einde van de jaren ’80 werden evenwel ook in de 
reguliere (geestelijke) gezondheidszorg gespecialiseerde initiatieven voor illegale 
druggebruikers ontwikkeld. Dusver bestaan er echter weinig cijfergegevens over 
de actuele verhoudingen inzake personen met alcohol- versus illegale 
drugproblemen, bijvoorbeeld in de afdelingen voor verslavingszorg binnen de 
psychiatrische ziekenhuizen.         
 
Onderzoek heeft uitgewezen dat er grote verschillen bestaan tussen 
problematische alcohol- en druggebruikers, onder andere op het vlak van 
sociodemografische kenmerken, ernst van verslaving, delinquent gedrag en 
psychiatrische comorbiditeit. In de meeste van deze studies werd echter weinig 
of geen rekening gehouden met het feit dat problematische alcoholgebruikers 
niet zelden illegale middelen gebruiken of misbruiken en dat problematische 
druggebruikers vaak (overmatig) alcohol drinken. Zoals reeds veelvuldig werd 
aangetoond, is polydruggebruik eerder regel dan uitzondering bij mensen die 
zich richten tot de alcohol- en drughulpverlening.. Alcohol blijkt in deze 
patronen van polydruggebruik een belangrijke positie in te nemen. Een aantal 
recente studies wijzen er bovendien op dat personen die zowel een alcohol- als 
een drugproblematiek hebben een specifiek en ernstiger hulpverleningsprofiel 
hebben dan personen die enkel een alcohol- dan wel een drugprobleem hebben. 
Toch zijn er dusver weinig studies die het profiel van personen met een 
zogenaamde “dubbele afhankelijkheid” hebben in kaart gebracht, met name op 
het gebied van sociodemografische kenmerken, zorggebruik, psychiatrische 
comorbiditeit en kwaliteit van leven. Meer inzicht krijgen in de omvang van deze 
groep, hun specifieke kenmerken en hulpverleningsprofiel kan helpen om de 
verdere ontwikkeling van de alcohol- en drughulpverlening in België te 
ondersteunen.  
Meer specifiek werden in dit doctoraat vooreerst twee registratie-onderzoeken 
opgezet in de provincies Oost-Vlaanderen en Antwerpen met het oog op het in 
kaart brengen van de socio-demografische kenmerken en zorggebruik van 
cliënten in de alcohol- en drughulpverlening. Na afronding van een 
systematische literatuur met specifieke focus op het samengaan van alcohol- en 
drugproblemen, werd een studie opgezet binnen één specifieke 
behandelingssetting (nl. units voor verslavingszorg in psychiatrische 
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ziekenhuizen) om op zoek te gaan naar gelijkenissen en verschillen tussen 
personen met een alcohol-, drug- of dubbele afhankelijkheid op het vlak van 
persoonlijkheidspathologie en kwaliteit van leven. Op die manier wil dit 
doctoraat dan ook een bijdrage leveren aan het realiseren van een zinvolle 
verbetering in het leven van jongeren en volwassenen met multipele en complexe 
problemen die zich in moeilijke leefsituaties bevinden. 
 
In een eerste studie werden alle cliënten geregistreerd die ten gevolge van een 
illegaal drugprobleem een vraag stelden naar behandeling in één van de 18 
deelnemende gespecialiseerde centra voor drughulpverlening in de provincie 
Oost-Vlaanderen (cf. Hoofdstuk 2). Gedurende zes maanden registreerden 
hulpverleners een beperkt aantal variabelen voor elke cliënt die op intakegesprek 
kwam. Op basis van een anonieme maar unieke cliëntcode kon een adequate 
inschatting worden gemaakt van het aantal cliënten dat tijdens deze periode 
meerdere keren werd geregistreerd, hetzij binnen één en dezelfde voorziening, 
hetzij in verschillende voorzieningen, de zogenaamde “gedeelde cliënten”.  
Tijdens de registratieperiode werden 1,500 intake interviews geregistreerd, die 
betrekking hadden op 1,139 unieke cliënten. Terwijl de overgrote meerderheid 
slechts één keer werd geregistreerd, bleek ongeveer 15% van de geregistreerde 
cliënten tijdens de registratieperiode een intakegesprek te hebben gehad in méér 
dan één voorziening en kunnen deze dan ook beschouwd worden als “gedeelde 
cliënten”. Gedeelde cliënten waren vaker regelmatige gebruikers van cocaïne, 
opiaten en slaap- en kalmeermiddelen, hadden vaker ooit drugs geïnjecteerd en 
gebruikten vaker meerdere middelen zonder dat er één belangrijker bleek te zijn 
dan de andere (categorie “polydruggebruik” als primair product). Bovendien 
hadden gedeelde cliënten frequenter een behandelingsgeschiedenis en werden ze 
vaker geregistreerd in residentiële voorzieningen. Voor de cliënten die 
daarentegen slechts in één voorziening werden geregistreerd, werd vaker 
cannabis geregistreerd als primair product. Bovendien werden zij vaker 
geregistreerd in ambulante voorzieningen en zetten zij eerder op eigen initiatief 
of op aanraden van familie, vrienden of een huisarts de stap naar de 
hulpverlening. Deze studie toonde verder ook aan dat illegale druggebruikers 
zich meestal niet beperken tot één middel en polydruggebruik eerder regel is dan 
uitzondering (78.8%), alsook dat méér dan de helft van de geregistreerde 
druggebruikers (56.4%) op regelmatige basis (cf. EuropASI definitie: minstens 
twee opeenvolgende of drie dagen per week) overmatig alcohol (>= 5 glazen) 
dronken. Gezien internationaal onderzoek verder ook heeft aangetoond dat 
druggebruikers die bijkomend afhankelijk zijn van alcohol een ander profiel en 
een hogere probleemernst kennen in vergelijking met diegenen die niet 
afhankelijk zijn van alcohol, gaven onze bevindingen aanleiding tot een aantal 
belangrijke vragen inzake de algemene prevalentie en determinanten van 
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zogenaamde “dubbele afhankelijkheid” in de Belgische alcohol- en 
drughulpverlening. 
 
Gezien België lange tijd niet over een uniform registratiesysteem beschikte om 
cliënten in de alcohol- en drughulpverlening te registreren, werd een tweede 
studie opgezet om een betrouwbare inschatting te kunnen maken van het 
percentage cliënten dat zowel een alcohol- als illegaal drugprobleem heeft alsook 
van hun kenmerken en behandelingsnoden (cf. Hoofdstuk 3). Naar analogie van 
de eerste studie werd in de provincie Antwerpen een registratie-onderzoek 
opgezet waarbij evenwel niet enkel cliënten met een illegaal drugprobleem maar 
ook cliënten met een alcoholprobleem werden geregistreerd.   
Gedurende de registratieperiode werden 1,626 unieke cliënten geregistreerd. 
Ongeveer 45% van de geregistreerde cliënten bleek uitsluitend op regelmatige 
basis (cf. EuropASI definitie) overmatig alcohol (>= 5 glazen) te hebben 
gedronken in de periode voorafgaand aan het intakegesprek, terwijl 28% 
uitsluitend op regelmatige basis illegale drugs gebruikten. Iets meer dan een 
kwart (27%) van alle geregistreerde cliënten bleken zowel regelmatig alcohol als 
illegale drugs te hebben gebruikt. De onderzoeksresultaten toonden belangrijke 
verschillen aan tussen cliënten met zowel een alcohol- als een drugprobleem en 
cliënten met uitsluitend een alcoholprobleem. Deze eerste groep bleek jonger, uit 
een hoger percentage mannen te bestaan, vaker werkloos en minder vaak samen 
te leven met een partner en/of kinderen. Bovendien bleken ze vaker geboren te 
zijn in een ander land dan België en vaker problemen te hebben met justitie en 
politie. In vergelijking met cliënten die uitsluitend een drugprobleem hebben, 
bleken cliënten met een zogenaamde “dubbele problematiek” vaker man en 
ouder te zijn en vaker alleen te leven. Tevens stelden we vast dat zij – qua 
productgebruik – voornamelijk stimulerende (bv. cocaïne) eerder dan dempende 
middelen (bv. heroïne) gebruikten en ook minder vaak drugs bleken te 
injecteren. Dit is in overeenstemming met de internationale literatuur die onder 
meer significante verbanden heeft aangetoond tussen het gebruik van alcohol en 
cocaïne. In vergelijking met cliënten die uitsluitend een drugprobleem hebben, 
blijken cliënten met een dubbele problematiek significant vaker een 
hulpverleningsgeschiedenis te hebben, werden ze vaker geregistreerd in 
residentiële voorzieningen en in voorzieningen die gesitueerd worden binnen de 
(reguliere) geestelijke gezondheidszorg (eerder dan in de categoriale 
voorzieningen). Omgekeerd werden zij, in vergelijking met cliënten die 
uitsluitend een alcoholprobleem hebben, significant vaker geregistreerd in 
ambulante centra.  
Concluderend zien we dat het socio-demografisch profiel en zorggebruik van 
cliënten die op regelmatige basis alcohol en illegale drugs gebruiken veel dichter 
aansluit bij dat van cliënten die uitsluitend een drugprobleem hebben dan bij dat 
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van cliënten met uitsluitend een alcoholprobleem. Deze studie bevestigt de 
belangrijke verschillen tussen problematische alcohol en illegale druggebruikers 
zoals deze in de klinische praktijk ervaren en tot uiting komen in de organisatie 
van de hulpverlening. Vooral het grote leeftijdsverschil springt hierbij in het oog. 
Toch werden ook tussen druggebruikers met en zonder bijkomend regelmatig 
overmatig alcoholgebruik een aantal verschillen vastgesteld. Hoewel deze 
minder uitgesproken zijn, liggen vooral de eerdere hulpverleningsgeschiedenis 
en het feit dat zij vaker een beroep doen op de residentiële hulpverlening en op 
korte tijd meerdere intakegesprekken hebben gehad, in de lijn van de 
internationale literatuur. De vaststelling dat ongeveer de helft van alle 
druggebruikers die een vraag naar behandeling stellen op regelmatige wijze grote 
hoeveelheden alcohol drinkt, toont de noodzaak aan om ook in de categoriale 
drughulpverlening voldoende aandacht te besteden aan de patronen van 
alcoholgebruik bij illegale druggebruikers, en dit in alle fasen van hun 
hulpverleningstraject (bv. assessment en terugvalpreventie). Eerder onderzoek 
heeft immers aangetoond dat overmatig drinken een belangrijk effect heeft op de 
retentie en uitkomsten van behandeling. Er dient evenwel rekening gehouden te 
worden met het feit dat cliënten zich in verschillende stadia van verandering 
kunnen bevinden naargelang het product en dat hier mogelijkerwijs op 
verschillende manieren zal moeten op ingewerkt worden. Bovendien dient 
rekening gehouden te worden met het feit dat de mate van socio-culturele 
aanvaarding van alcohol en illegale drugs in de samenleving, en dus ook bij de 
cliënten en hulpverleners, in belangrijke mate verschilt.      
  
In de derde studie werd de beschikbare literatuur geanalyseerd voor wat betreft 
gelijkenissen en verschillen tussen personen met alcohol-, drug- en zowel 
alcohol als drugproblemen op het vlak van socio-demografische kenmerken 
(leeftijd, geslacht, etniciteit en socio-economische status) en psychopathologie 
(stemmings-, angst- en persoonlijkheidsstoornissen en eerder algemene 
psychische problemen) (cf. Hoofdstuk 4). Uit deze review bleek duidelijk dat 
personen met een alcoholprobleem een ander socio-demografisch profiel hebben 
in vergelijking met personen met zowel een alcohol- als drugprobleem (ouder, 
vaker vrouw, vaker blank en een hogere socio-economische status). De socio-
demografische verschillen tussen cliënten met uitsluitend een drugprobleem en 
deze met zowel een alcohol- als een drugprobleem daarentegen bleken niet zo 
uitgesproken. Enkel voor wat betreft de socio-economische status zijn alle 
beschikbare studies het erover eens dat er geen verschillen zijn tussen groepen. 
Voor de andere indicatoren (geslacht, leeftijd, etniciteit) kon er geen consensus 
worden gevonden over de verschillende studies heen. Voor personen die zowel 
alcohol- als drugproblemen hebben, wordt overwegend een ernstigere vorm van 
verslaving gerapporteerd dan deze met uitsluitend een alcoholprobleem, maar 
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tegenstrijdige bevindingen werden gevonden wanneer de vergelijking werd 
gemaakt met personen die uitsluitend een drugprobleem hebben. De ernst van 
verslaving werd in de geselecteerde studies op verschillende manieren 
geoperationaliseerd: aanwezigheid van DSM-IV misbruik of afhankelijkheid, 
aantal DSM-IV criteria voor middelenafhankelijkheid waaraan voldaan wordt, 
leeftijd waarop het probleem ontstaan is, duur van het gebruik en specifieke 
instrumenten om de ernst van verslaving te meten zoals de EuropASI. Personen 
met zowel alcohol- als drugproblemen bleken in belangrijke mate te verschillen 
van personen die uitsluitend een alcoholprobleem hebben op het vlak van 
psychopathologie, maar in vergelijking met personen die uitsluitend een 
drugprobleem hebben kon over de verschillende studies heen geen consensus 
worden gevonden.  
 
In een vierde studie werden in totaal 274 cliënten geïnterviewd die een 
residentiële opname startten voor een alcohol- en/of illegaal drugprobleem in één 
van de elf deelnemende afdelingen voor verslavingszorg binnen een 
psychiatrisch ziekenhuis in Oost- of West-Vlaanderen (cf. Hoofdstuk 5). 
Historisch gezien wordt deze behandelingsmodaliteit gekenmerkt door een sterke 
focus op alcoholproblemen, maar vanaf het einde van de jaren ‘80 ontstond er in 
de reguliere (geestelijke) gezondheidszorg, alsook in deze psychiatrische 
ziekenhuizen, een grotere openheid ten aanzien van het opnemen van personen 
met illegale drugproblemen. In de studie werd gebruik gemaakt van gevalideerde 
instrumenten (EuropASI, M.I.N.I., ADP-IV en de WHO-QoL-BREF) met het 
oog op het in kaart brengen van gelijkenissen en verschillen tussen personen met 
een alcohol-, drug- of dubbele afhankelijkheid voor wat betreft de ernst van de 
verslaving, psychiatrische comorbiditeit en kwaliteit van leven. Op basis van de 
M.I.N.I. bleek ongeveer driekwart van de steekproef (74.0%) uitsluitend 
afhankelijk te zijn van alcohol, terwijl 12.8% uitsluitend afhankelijk bleek van 
één of meerdere illegale middelen en 13.2% afhankelijk bleek van zowel alcohol 
als één of meerdere illegale middelen. Binnen de totale steekproef werd een hoge 
mate van persoonlijkheidspathologie (42.6%) vastgesteld, waarbij cliënten vaak 
voldeden aan de criteria van méér dan één persoonlijkheidsstoornis. De meest 
voorkomende persoonlijkheidsstoornissen waren borderline, ontwijkende, anti-
sociale, obsessief-compulsieve en paranoïde persoonlijkheidsstoornis. Personen 
uitsluitend afhankelijk van alcohol voldeden significant minder aan de criteria 
van één of meerdere persoonlijkheidsstoornissen (34.0%) in vergelijking met 
personen afhankelijk van illegale middelen, met (67.6%) of zonder (66.7%) 
alcohol-afhankelijkheid. In tegenstelling tot de hypothesen die in de literatuur 
werden teruggevonden met betrekking tot een hogere mate van psychopathologie 
bij personen met een dubbele afhankelijkheid, werden in deze studie geen 
significante verschillen vastgesteld tussen personen uitsluitend afhankelijk van 
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illegale middelen en personen afhankelijk van zowel illegale middelen als 
alcohol op het vlak van persoonlijkheidspathologie. Bovendien bleek niet de aard 
van de afhankelijkheid maar wel de ernst van de verslaving (zoals 
geoperationaliseerd op basis van de ernstscores van de EuropASI) een 
belangrijke en onafhankelijke determinant voor een ernstigere 
persoonlijkheidspathologie.  
Concluderend kunnen we stellen dat deze vierde studie heeft aangetoond dat 
persoonlijkheidspathologie heel frequent voorkomt bij cliënten in behandeling 
voor alcohol- en/of drugproblemen. Daarnaast toont deze studie duidelijke 
verschillen aan tussen het profiel van personen afhankelijk van alcohol en deze 
afhankelijk van illegale middelen (mét of zonder bijkomende 
alcoholafhankelijkheid). Persoonlijkheidspathologie komt significant vaker voor 
bij personen die afhankelijk zijn van illegale middelen ten opzichte van alcohol. 
Persoonlijkheidspathologie heeft niet alleen belangrijke gevolgen voor het 
algeheel functioneren van mensen, maar onderzoek toont ook aan dat het een 
impact heeft op het verdere verloop van middelengebruik en -misbruik na 
behandeling. Zowel bij aanvang als tijdens de behandeling is het belangrijk om 
niet alleen een goede inschatting te maken van persoonlijkheidsstoornissen bij 
cliënten in de alcohol- en drughulpverlening, alsook van hun algehele 
persoonlijkheidsfunctioneren. De nieuwe DSM-5, en in het verlengde hiervan de 
“Personality Inventory for DSM-5” bieden in dit verband interessante 
mogelijkheden. Daarnaast is het noodzakelijk om in de begeleiding en 
behandeling van cliënten, rekening te houden met de aanwezige 
persoonlijkheidspathologie en desgevallend specifieke, evidence-based 
behandelingsmethoden aan te bieden of eerder te opteren voor een écht 
integratieve benadering op maat van elke individuele cliënt. Samenwerking 
tussen de geestelijke gezondheidszorg en de verslavingszorg is dan ook 
noodzakelijk met het oog op het bieden van een meer geïntegreerde zorg.  
 
In de vijfde studie werd gefocust op de kwaliteit van leven en op het subjectieve 
perspectief van personen die een alcohol of drugbehandeling zijn gestart (cf. 
Hoofdstuk 6). Gezien het groeiende bewustzijn dat middelenafhankelijkheid een 
chronische aandoening is, gekenmerkt door herval, kan kwaliteit van leven een 
belangrijk richtinggevend concept zijn. In deze vijfde studie werd gebruik 
gemaakt van de data die in het kader van de vierde studie werden verzameld.   
Deze studie toonde aan dat personen die afhankelijk waren van zowel alcohol als 
illegale drugs de laagste scores hadden voor ‘algemene kwaliteit van leven’ en 
‘algemene perceptie van gezondheid’ in vergelijking met personen uitsluitend 
afhankelijk van alcohol of illegale middelen. Wanneer evenwel in de 
multivariate analyses ook de ernst van de verslaving en de aanwezigheid van 
comorbide stemmings-, angst- en persoonlijkheidsstoornissen mee in rekening 
Samenvatting 
 
248 
werden gebracht, bleek het type afhankelijkheid geen significante determinant 
van de ‘algemene kwaliteit van leven’ of de ‘perceptie van gezondheid’. De 
aanwezigheid van een angst-, stemmings- of persoonlijkheidsstoornis, werkloos 
zijn en een hoge ernstscore op het leefgebied ‘alcohol’ van de EuropASI bleken 
significant geassocieerd met een lagere kwaliteit van leven. Man zijn, de 
aanwezigheid van een angststoornis en hogere ernstscores op de leefgebieden 
‘alcohol’, ‘drugs’, ‘fysieke gezondheid’ en ‘emotionele en psychologische 
gezondheid’ bleken significant geassocieerd met een lagere perceptie van 
gezondheid.  
  
In het laatste hoofdstuk wordt ten slotte ingegaan op de belangrijkste 
bevindingen en worden een aantal concrete implicaties voor beleid, onderzoek en 
klinische praktijk toegelicht (cf. Hoofdstuk 7). Tot slot worden de sterktes en 
beperkingen van de verschillende studies toegelicht en worden een aantal 
aanbevelingen voor verder onderzoek geformuleerd. Eén van de belangrijkste 
conclusies die in dit hoofdstuk naar voren wordt geschoven, is de noodzaak aan 
een alomvattend beleid voor wat betreft alcohol, tabak, medicatie en illegale 
middelen. Hoewel het aangewezen kan zijn om voor bepaalde middelen gerichte 
strategieën uit te werken, is het steevast belangrijk om deze in te bedden in een 
geïntegreerd beleid gelet op de hoge mate van polydruggebruik, en het 
samengaan van alcohol en illegaal druggebruik in het bijzonder. Ook in 
onderzoek is het belangrijk om zoveel mogelijk deze “polydrug-realiteit” voor 
ogen te houden bij het uitwerken van onderzoeksmethodologieën en op zoek te 
gaan naar manieren om dit complex fenomeen beter te begrijpen. Op die manier 
kunnen de nodige handvaten voor begeleiding en behandeling geboden worden 
om tot een zinvolle verbetering te komen van de situatie van personen met 
alcohol- en drugproblemen en mensen in moeilijke leefomstandigheden in het 
algemeen. Het streven naar een betere coördinatie en continuïteit van de zorg, 
zowel binnen de alcohol- en drughulpverlening alsook met andere sectoren, 
waaronder de geestelijke gezondheidszorg in het bijzonder, is hierin 
noodzakelijk. Daarnaast is het cruciaal om binnen de verschillende paradigma’s 
van zorg en ondersteuning steeds de gehele persoon en zijn context centraal te 
stellen met aandacht voor het persoonlijkheidsfunctioneren en de subjectieve 
beleving van het individu.  
